Text

Rev 14 to LGS Units 1 & 2 Odcm
	ML20080N140
Person / Time
Site:	Limerick
Issue date:	06/09/1994
From:	Boyce R; PECO ENERGY CO., (FORMERLY PHILADELPHIA ELECTRIC
To:	;
Shared Package
ML20080N087	List: ML20080N085; ML20080N106; ML20080N112; ML20080N117; ML20080N129; ML20080N140; ML20080N146;
References
	PROC-940609, NUDOCS 9503060160
	Download: ML20080N140 (185)
	v • d • e

..

.A_

r. -

ji

[

W" ii PECO ENERGY :

l Limerick [ll Generating Station i

t i

l l

t

! I s

i 1 u

I i

l I

i i

t i

i i

i s

l l

9503060160 950215 i PDR ADOCK 05000352 R PDR i, L J

j 7_,_

l

'I PORC YES i 1

SQR. YES !

i

+

NQA NO i

50.59. YES RESP.MOR. YES i d E LIMERICK GENERATING STATION UNITS 1 AND 2- #

OFFSITE DOSE CALCUIATIOK MANUAL '

l Revision 14 ;

I PECO' ENERGY COMPANY -

DOCKET HOS. 50-352 AND 50-353 Approval:

/I's a t M Plan't Mandger I f k((

/

f

_ _ . . - , , - , _ , . . , - e

L, >: _ ,

j@ 1A 'ODCM Rav.~141 '

2 T h,

~

6/94l f m -;

Table of' Contents

-Page-- 1

>Part IL RADIOLOGICAL EFFLUENT. CONTROLS-

,< 1.' O DEFINITIONS- 1 1 !

~

U' 2.0 BASIS FORLEFFLUENT MONITORING CONTROLS; 6 '

2.1 METEOROLOGICAL-MONITORING INSTRUMENTATION 6- 1

[

2.2 MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY- ;

FOR RADIOACTIVE GASEOUS AND LIQUID EFFLUENTS 6 .;

2.3' RADIOACTIVE LIQUID. EFFLUENT MONITORING INSTRUMENTATION 6, I

s 2.3.1 Concentration -9 l

2. 3. 2' Dose 9-2.3.3 Liquid Radwaste Treatment System 10. ;

2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION 10- l 2.4.1 Dose Rate 10 !

.I 2.4.2 Dose - Noble Gases 11- 5 2.4.3 Dose'- Iodine-131, Iodine-133, Tritium, and Jh i Radionuclides in Particulate Form 12 2.4.4 Ventilation Exhaust Treatment System 12 -}

2.4.5 Venting'and Purging 13 l 2.4.6 Total Dose 13' I

2.5 MONITORING PROGRAM 13- !

2.5.1 Land Use Census '

14' .!

i

i. 2.5.2 Interlaboratory Comparison Program 14' :

-i 2.6 APPLICABILITY 14 ;

i 13 . 0 METEOROLOGICAL MONITORING INSTRUMENTATION CONTROLS 16 3.1 METEOROLOGICAL MONITORING INSTRUMENTATION 17' f --

i t

d l p i

T w ,-- - , . - - - ,

~

O. _ , ,' l f~: '

3'

' ~

ODCM'Rev.,14 :

l..

6/94 g Page

. 3.2 RADIOACTIVE LIQUID' EFFLUENT MONITORING INSTURMENTATION 21' 3.2.1 Radioactive. Effluent Monitoring' Instrumentation Controls 21'

'3.2.2 Concentration 24 3.2.3 Dose 28 3.2.4 Liquid Radwaste Treatment System 29 l 3.3 GASEOUS EFFLUENTS ,

3.3.1 Radioactive Gaseous Effluent Motoring Instrumentation 30 ;

3.3.2 SITE BOUNDARY Dose Rate 35 '

3.3.3 Dose - Noble Gases 39 3.3.4 Dose - Iodine-131, Iodine-133, Tritium, and Radionuclides in Particulate Form 40 3.3.5 Ventilation Exhaust Treatment System 41 3.~3.6 Venting or Purging 42 3.3.7 Total Dose 43, ,

3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING r 3.4.1 Monitoring Program 44 f

3.4.2 Land Use Census 57 -I 58 3.4.3 Interlaboratory Comparison Program l

3.5 ANNUAL RADIOLOGICAL ENVIRONMENTAL' OPERATING REPORT 59 3.6 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT 60 I

3.7 MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS 62 ,

-1 i

i i

ii

< j: : o:

^

. ODCM RavJ 14

~

4^ , . ,

- - f 6/94 l t >

0 ~ : LIMERICK' GENERATING STATION.

OFFSITE DOSE CALCULATION MANUAL. >

TABLE CONTENTS. ,

u 'Page Part II;--CALCULATION METHODOLOGIES -

1.0 ' LIQUID EFFLUENTS 163-1.1~ RADIATION MONITORING' INSTRUMENTATION AND CONTROLS- ~63 ,

5

'1.2 . LIQUID EFFLUENT MONITOR SETPOINT DETERMINATION 64 1.2.1 Radwaste Discharge Monitor 64.

1.2.2' Service Water Radiation Monitor 67 j 1.2.3 RHR Service Water Monitor 68

1.3 LIQUID EFFLUENT DOSE' CALCULATIONS - 10 CFR 50 .69

1. 3 '.1. Member of the Public Dose - Liquid Effluents 69-

-t 1.4 LIQUID EFFLUENT DOSE PROJECTION 74

'1 2.0 GASEOUS EFFLUENTS 75- 1

2.1 RADIATION MONITORING INSTRUMENTATION AND. CONTROLS 75 .-;

+

2.2'LGASEOUS EFFLUENT MONITOR SETPOINT. DETERMINATION 1 75=

l 2.2.1 . North Vent Noble. Gas Effluent Monitors 77 l 2.2.2 South Vent Noble Gas Effluent Monitors' 79 2.2.3 Noble Gas Effluent-Fractional. contribution -81 ,;

j 2.2.4 . Noble Gas Effluent Default Setpoints 82 I, 2.2.5 WRAM Noble Gas Effluent Monitor 86 ;

2.3 GASEOUS EFFLUENT DOSE EVALUATIONS- 91 .j

.92 2.3.1 Site Boundary Dose Rate - Noble Gases ,

2.3.2 Site Boundary Dose Rate - Radiciodine and -

Particulates- 94 2.3.3 Noble Gas Air Dose 95~

2. 3 .'4 Radiciodine and Particulate Dose Calculations j 10 CFR 50 96 i b iii (

d r.-.- ,.- - , ,# , ,4--- . , - .- . ., ,,,,w- - , , + ,

, f0DCMLRhv. 14 6/94 Page-2.3.5 Annual Dose Evaluation 95L 2.4- GASEOUS EFFLUENT. DOSE' PROJECTION 102

- o 3.0 SPECIAL DOSE ANALYSIS 103 -

3.1 TOTAL DOSES TO MEMBERS OF THE PUBLIC 103 ;

3.2 DOSES DUE TO ACTIVITIES INSIDE THE SITE BOUNDARY 104 4.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM. 106 4.1 -SAMPLING PROGRAM 106 4.2 INTERLABORATORY' COMPARISON PROGRAM 106 APPENDICES ,

Appendix A - Technical Specification /ODCM 159 Appendix B - Radiological Environmental Monitoring 162 Program - Sample Type, Location and Analysis l

4 s

iv

p_

1 ODCM Rnv. 14 f 6/94 LIST OF TABLES I 1.1 Surveillance Frequency Notation I 3.1-1 Meteorological Monitoring Instrumentation I 3.1-2 Meteorological Monitoring Instrumentation Surveillance Requirements I 3.2-1 Radioactive Liquid Effluent Monitoring Instrumentation I 3.2-2 Radioactive Liquid Effluent Monitoring Instrumentation Surveillance Requirements I 3.2-3 Radioactive Liquid Waste Sampling and Analysis Program I 3.3-1 Radioactive Gaseous Effluent Monitoring Instrumentation I 3.3-2 Radioactive Gaseous Effluent Monitoring Instrumentation Surveillance Requirements I 3.3-3 Radioactive Gaseous Waste Sampling and Analysis Program I 3.4-1 Radiological Environmental Monitoring Program I 3.4-2 Reporting Levels for Radioactivity Concentrations In Environmental Samples I 3.4-3 Detection Capabilities For Environmental Sample Analysis II 1.1 Ingestion Individual Dose Factors (Daipj) For Liquid Effluents II 1.2 Assumptions Used In Limerick Effluent Dose Evaluations II 2.1 Dose Factors for Noble Gases II 2.2 Ingestion Individual Dose Factors (DFk,1,n) For Gaseous Effluent 4

II 2.3 Assumptions Used In Limerick Gaseous Effluent Dose Evaluation ,

II 2.4 Nearest Gaseous Effluent Dose Receptor Distances (Meters)

A.1 Technical Specification /ODCM Matrix B.1 Radiological Environmental Monitoring Program v

j ODCM'Rav.114 l 6/94-LIST OF FIGURES I' -2.2-la Map Defining' Exclusion Areas for Radioactive Gaseous and Liquid Effluents I 2.2-1b Map Defining Low Population Areas for Radioactive Gaseous.and Liquid Effluents I 3.1-1 Meteorological-Tower Location II 1.3.1-1 LGS Dilution vs River Flow (Outfall)

II,1.3.1-2 LGS Dilution vs River Flow (Citizen's Utility)-

II 1.3.1-3 LGS Dilution vs River Flow (Phoenixville)

II 1.3.1-4 LGS Dilution vs River Flow (Philadelphia Suburban)

II 1.3.1-5 LGS Dilution vs River Flow (Crew Course)

II 1-1 Liquid Effluent Flow Diagram II 2-1 Gaseous Effluent Flow Diagram - North Stack II 2-2 Gaseous Effluent Flow Diagram - South Stack II 2-3 Gaseous Effluent Flow Diagram - Hot Maintenance Shop i B-1 Environmental' Sampling Location on Site or Near the Limerick Generating Station B-2 Aquatic and Terrestrial Environmental Sampling Location at Intermediate Distances from the Limerick Generating l Station B-3 Airborne and TLD Environmental Sampling Locations at Intermediate Distances from the Limerick Generating Station B-4 Environmental Sampling Locations at Remote Distances from the Limerick Generating Station I

vi a

~

12 ,

~

1 i

3

8 1

4

)

,j: PURPOSE The purpose of the Offsite Dose Calculation Manual.is to establish methodologies and procedures for calculating' doses to individuals in- I areas at and beyond the SITE BOUNDARY due to radioactive effluents, from Limerick Generating. Station.

t 4

A 9

e e

k l

PART I RADIOLOGICAL EFFLUENT CONTROL _S.

T f

,- . , : - s u-

?' ..~

u

. . .ODCM'Rsv.s14 y.}.; ' - PageflE '

19: l; ,

' 6/ 9 4 . .,

? :

[bT liO[ DEFINITIONS ,

iThe followin'g terms are taken-from~ LGS Unit-1, Unit!2; Tech Specs.'

1.1 ACTION Hs ACTION'shall be that part of-asspecification whichiprescribes; ;

-remedial measures required under. designated conditions.- .l

~

1.2 CHANNEL CALIBRATION .

, e a A CHANNEL. CALIBRATION shall be the adjustment, as necessary,Jof? l the channel ^ output such-that it responds with.the necessary L ,

range and accuracy.to known values of'the parameter.which the- -

a channel monitors.. The CHANNEL CALIBRATION"shall'encompassLthe' ,

entire channel including the sensor and alarm and/oritrip- '

. functions, and shall include.the CHANNEL FUNCTION TEST. ' The .l' CHANNEL CALIBRATION may:be performed by any series of sequential, overlapping or total. channel. steps-such that the ..

entire channel is. calibrated. H e

^

1.3 CHANNEL CHECK l A CHANNEL' CHECK shall be the qualitative assessment.ofLchannel !

behavior during operation by observation.- This1 determination shall include, where possible, comparison.of the channel indication and/or status with other indications and/or' status- ,

derived from independent instrument channels measuring.the?same: , i parameter.

I 1.4 CHANNEL FUNCTIONAL TEST s 1

0 A CHANNEL FUNCTIONAL TEST-shall be:

a. Analog. channels-- the' injection of,a simulated signali ,

into the channel as close to the sensor asipracticable' '

to verify OPERABILITY including alarm and/or: trip functions and channel failure-trips. :

_ 1

b. Bistable channels - the injection of a simulated signal' .i into the sensor to verify. OPERABILITY including alarm : I and/or trip" functions.- '

~

, , The CHANNEL FUNCTIONAL TEST may be. performed by any series lof-sequential, overlapping or total channel. steps such that the -

entire ~ channel is tested.

[

4

'l J

'l 1

t-ry-'- y v gnnn.> -nn ..-v- -s- 1-- w-1=-0v ==+-,- 1 a * -r-++"* ,, ne T -

,, , ,, j -

. . , ., m m f7 ,

'l qc s ,F p ; f E

ODCM R'svf 14 ppJ ;

~

Pags-2f 4.y.? ',. < d_ .. ,

y m 6/94 ;

J p '

41251 <

CONTINUOUS SAMPLING .

tm ' .

[ 'PercASTM. Standard (1987)/Section II-(Water,and: Environmental, i

^

1 Technology),. Volume:11.03, Article'D1356;Jis defined

? as" sampling.without! interruptions throughoutfan operation or-for a predetermined' time." A CONTINUOUS SAMPLE 0is the opposite ofLa GRAB-SAMPLE. LThe~ time: period involved'to'securef(shut-g- down)Jventilation or re-establish' sampling of the release 1 pathway shall meet the intent'of CONTINUOUS SAMPLING.. .

Consistent"with industry = standards, the time < allowance shall.

, not-exceed 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months .

, .1. 6 . DOSE EOUIVALENT I-131 DOSE 1 EQUIVALENT:I-131~shall be that concentration of.I-131,'

microcuries per' gram,.which alone,would produce the'same

. thyroid ~ dose.as'the quantity and: isotopic mixture of I-131, I-132, I-133,_I-134 and I-135,actuallyLpresent. LThe thyroid dose! ]'

conversion factors used for this calculation ~shall be-those listed in Table III of TID-14844, " Calculation of Distance i Factors for Power and Test Reactor Sites."

1.7 FREOUENCY NOTATION-The FREQUENCY: NOTATION specified for the performance of ,

F Surveillance Requirements shallecorrespond~to the: intervals ~l defined in. Table I1.1. j 1.8 -MEMBER (S)-OF THE PUBLIC-L - .. .

d C

2~

MEMBER (S) OF THE _ PUBLIC shall include allipersons :who are not' occupationally associated with'the plant'. . This category?does 4

not. include employees-of the utility, itsLeontractors,.or) -

P vendors. Also' excluded from this categoryfare. persons who enter the site to service equipment or>to make deliveries.

6 This category does~ include persons who,use~ portions of~the sit'e -

for recreational, occupational or other purposesLnot; associated.

~ '

, with the plant.

1.9 OFFSITE DOSE CALCULATION MANUAL t-4 The'OFFSITE DOSE CALCULATION MANUAL (ODCM)~shall contain the methodology and parameters used:in the calculation of offsite doses resulting from radioactive gaseous and111guid effluents,.

in the calculation of gaseousLand liquid effluent: monitoring l Alarm / Trip Setpoints, and in the conduct of:the Radiological?

Environmental Monitoring Program. 'The ODCM shall also contain (1) the Radioactive Effluents Controls and Radiological

Environmental Monitoring Programs requiredtby Technical' Specification 6.8.4 and (2) descriptions of the l

r-k s

W 4 "

e4E*_____-__ . . -

- y -.

, --i p'r ^;mh'2 '

Jl3 f

~

.ODCM Rtv.E14 'i

.- 4r _ Paga'3'

, lj ' 6/ 94 : ,

d', Linformation.that should'be included in'the AnnualLRadiological

" Environmental Operating and~ Semi-annual ~ Radiological.-Effluent:

Release; Reports required by Technical; Specifications.6.9.1.7' and 6.9.1.8., E(3)s ~ ' description of meteorological monitoring controls.

El.10 OPERABLE - OPERABILITY r A' system,. subsystem,. train, component orLdevice'shall be' ..

OPERABLE or have OPERABILITY.wheniit'is: capable:of performing; its-specified functions (s) and.when all necessaryLattendant-

< instrumentation, controls, electricalipower,: cooling =or sealL-

. water, lubrication or other auxiliary equipment-that'are' .

required.for the system,: subsystem, train, component ~orL device to perform its function (s) are.also capable of performing their,,

l related< support function (s).

1.11 OPERATIONAL CONDITION - CONDITION -

An OPERATIONAL CONDITION, i.e.,. CONDITION, shall be'any one inclusive combination of mode switch position and average 1 reactor coolant temperature as defined in the Technical Specifications. )

, 1.12 PURGE - PURGING ;

PURGE or PURGING shall be the controlled process of discharging.

. air-or. gas from a' confinement to maintainctemperature, '. a pressure, humidity,. concentration or other operating condition,,**

in such a. manner that replacement air.or gas is required 1to purify-the confinement.

1.13- RATED THERMAL POWER See current.IGS Tec'h Spec definition. . -'

1.14 REPORTABLE EVENT C

A REPORTABLE ~ EVENT shall be any of those conditions.specified-in Section 50.73 ofE10 CFR Part 50.

1.15 SITE BOUNDARY J'. The SITE BOUNDARY shall be that'line as defined in Figure:I2.2-la. -

e

+

c, _, _ . _ . . . p. . - -, ,.m.-~...

mu s I-[ ODCM Rsv.-14 i 1 Pagm 4 j c lC 6/94 1.16' SOURCE CHECK A SOURCE CHECK shall be the qualitative assessment-of channel response when the channel sensor is exposed to a radioactive source.

1.17 ' THERMAL POWER THERMAL POWER shall be the total reactor core. heat transfer ,

i rate to the reactor coolant.

1.18 UNRESTRICTED AREA An-UNRESTRICTED AREA shall be any area at or beyond the' SITE-BOUNDARY access to which is not controlled by the licensee for ,

purposes of protection of individuals from exposure-to .

'l radiation and radioactive materials, or any are within the SITE BOUNDARY used for residential quarters or for industrial, i commercial, institutional, and/or recreational purposes. ;

1 1.19 VENTILATION EXHAUST TREATMENT SYSTEM '

A VENTILATION EXHAUST TREATMENT SYSTEM shall be any system designed and installed to reduce gaseous radioiodine or 1 radioactive material in particulate form in effluents by:

passing ventilation or vent exhaust gases through charcoal absorbers and/or HEPA filters for the purpose of removing iodines or particulates from the gaseous exhaust stream prior-to the release to the environment (such a system is.not considered to have any effect on noble gas effluents).

Engineered Safety Feature (ESF) atmospheric-cleanup systems are not considered to be VENTILATION EXHAUST TREATMENT SYSTEM components.

1.20 VENTING VENTING shall be the controlled process of discharging' air or gas from a confinement to maintain terperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is not provided or required during VENTING. Vent, used in system names, does not imply a VENTING process.

~

?50

^

]!

ODCM R3v. 14:

'Pago.51 j'

6/94:

TABLE II.1 SURVEILLANCE FREOUENCY NOTATION NOTATION FREOUENCY S (Shift) At least once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months . .

D (Daily) At least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months .

W (Weekly) At least once per 7 days.

M.(Monthly) At least once per 31 days, f

Q (Quarterly) At least once per 92 days.

SA (Semi-annual) At-least once per 184 days.

A-(Annual) At'least once per 366 days.

E At least once per'18 months (550 days).

R At least once per 24 months (731 days). ,

1 S/U Prior to each reactor startup.

P Prior to each radioactive release. ,

N. A. - Not applicable.

l l~

l' l-s I

.[ ODCM Rav. 14 Pagn.6

l 6/94 2.0 BASIS FOR EFFLUENT MONITORING CONTROLS 2.1 METEOROLOGICAL INSTRUMENTATION The OPERABILITY of the meteorological monitoring instrumentation ensures that sufficient meteorological data is available for estimating potential radiation doses to the public as a result of routine or accidental release of radioactive materials to the atmosphere. This capability is required to evaluate the need for initiating measures to protect the health and safety of the public. This instrumentation is consistent with the recommendations of Regulatory Guide 1.23 "Onsite Meteorological Programs,"

February, 1972.

Site data compiled since January 1972 provide correlation between Elevation 1 (Tower 1) and Elevation 1 (Tower 2), and between Elevation 2 (Tower 1) and Elevation 2 (Tower 2). This ,

correlation serves as justification for the use of the I appropriate Tower 2 instrument as a back-up to the Tower 1 instrument as shown in Table I3.1-1 and Table I3.1-3.

2.2 MAPS DEFINING UNRESTRICTED AREAS AND SITE BOUNDARY FOR EbDIOACTIVE GASEOUS AND LIOUID EFFLUENTS Information regarding radioactive gaseous and liquid effluents, ~.

which will allow identification of structures and release points as well as definition of UNRESTRICTED AREAS within the SITE BOUNDARY that are accessible to MEMBER (S) OF THE PUBLIC, shall be shown in Technical Specifications Figures 5.1.3-la and 5.1.3-lb.

The exclusion area and low population zone shall be as shown in Figures I2.2-la and I2.2-1b.

2.3 RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm / trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM part II to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20.

The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50.

-l ODCM Rev. 14 Page 7

,l '

6/94 FIGURE I2.2-la EXCLUSION ZONE hf j s- .,* l * ' %, , ., '

j, - s,D...~..%.

t.[ ; ,. ,j k1 .w w- x. f w . J ?EA

.r.

. E.C

.o

..f.-

2 ;, M Y '-- f .m.f .:::m

4. .

9 'd . Q,s:., i

~

r.:

L -

ne \ *"'" p \ \f ~, z , .\,.)..' :~k

<.(i.cr'/ ':,= u ~'c..: /, p t -

(U \\ w[N_d ' O '

r_

- %;1-

.. V. hW_.s% ,L

. W } i ~ W =5=~'

Nsh. d .:'f'W<c*>9 ~

1;'l'ERMp>.~

9n p \ ,\r\,y'>n..e:.\9...../>O:...r.ie..y

=-

> ," .e u

p- ..in'.\- \ .

r , .- .,, ar u. .::. u u;u:n;: u 1-f.i \

N<yM. . $% S... 'sMk.I '

. \ )d:' %.5#*.b..: M

.6.

M ..h; f g$)'h k W k Li k

h' - .[ $," [

f. ;

.-h hg@f .1%

y7M-:--jjjiig! . t %".h.5 -@f'

'- ~'

s . 'qx.r

. ,.1 1

T'm~ 1 yo.~.y \ ?, .

. y .. -

. /

, c. .

m i 'K'W du

..p..

r g

\

\g r i > ,. -

- .- z

,, s w .

I

'/

f '.* ~' ,p N ,5' .,,/ / 'I f- . i . 4. e/ $ * -

( . I('s. .-- k wS ,4,l /h}t, (c;QK,iycs._: _ _.;f .a Q . , :-:.. \ .,\, <

. i{.! . h' _::u

_.gw ., d .1 2t se~ t!N '

d- 2 . . .v,,;,,.T \%q;z.' n.'

5 e !

%@m:,.ii'*MJ m 'A

s. % g.c; ; . w YVd8'.;-

Q h.d'=-

.y..u., -.. r...:[3 a !

?c -s .

. ' ..s w.y u.: s.

m. ..

1

-~ - a v 9,.%qs

. s 'a 'x m - ' < . +w u ::/: ,p s.,a. ,-

e.3c;i,. 4 I '

.~ , S. r- \ s,

.... ; Nh,.

Wh%

'h. #j kki} { ]gd' N ' 5 ' O 0 N % I

I) b'. . \ 50 \ \ h_= - -<0YP'".*L3

' ~

.c \ j

. .c y s.

" Y w t =-. !

.,\ N+y qwgE6S2.gs.'.\

W ' .,.F,p%.: ="

-J ,-. ne hgC..M.R.n~ b. 8- i mD. .. - .. .- - - --

l l ODCM Rev. 14 Page 8

-l 6/94 FIGURE I2.2-1b LOW POPULATION ZONE t

~

35FDf Wff%s%n$ssfdh~,QW gp N'?'.bn' $ i j G Qx ?. % ?h . M7&..,...a f.. @. l f -

. ~

w \...

\. g. .. . q Q4 s- W 4.,L y$ hi %.a -

= -.

\

.g . -\- . . - ;,...A. ,.c. . - .

a- . .

- y-g

-:% r.

s

- '~ g- g, _. , -

9 '

h

l. ' '

+ M W [:lN'. .p'~ /l,.

r l*l* l i}'A ..:.;,cy;,,gl.hCr=

r@:.@I'-. R;gW ,

% (W. -

F-

,. .. g _

. '. 4 . A ~~ .il,.,5\ '

~

%*'N.

~~

g

. AL . ,' 3, e f.. .

g 9 .e j ,/ l

~

S' gGh N 'k. /

? ,,, ~S. ,' ' '

W-~. $~%D$h&MW.b)?'5.J k ~~. . -

.~-

qn:::, m;y'c-::. , ' ~ -'.-2, Xi.~-K L. A. t. .8 M .

gn.

.. hWk.h :~.I.- " -

~6:~ ,y </,3::'( 3s'

,',,.'-$,sy, L. - - M ...

g03

~_

i . -

^a- - - -i .. / .- . w, w a %y

~

%,,,,,,, s , . ,\ g' \

. . r. .p, ( \:

.Y \

'*.r--

. / *! s**

if, '

, s' Ca) - - - _. e. iy , ' ..4 . ( (':.Q..v/.

. . . ,/

< *' . e _

M' n-.,

- u ,-

.. Ag, j\nd*

i ,....% c.

\h G...Pw. w.~mt>,:,n

'~'

ac .. .. a ..

N li D ' 'd * ~

I

- -~~'

g=

, s

~-

g

~

~ ([ --.'

$'I e ,s

.\..

7Tgb .,,,,, Q- Q M **/.,; D. x r [-=.= *g ,\

~20 '

.- 47A 3 s

4\'g. [-(?'-~,'. $ 8. hn,g l~p$%.-

a e ., e..,. - . ,,, na.m Y. s ,. -

w ..v..f %

f' j ..... . .

m. s.

9.. .

s.

>= =

n. rm,. ,,NN,# g m ,: a ~.e-R. -

,.m.# .- a 4 M>

-.w~. ~ .m. s $n T m.A m..,. S.

\ n #'x

. \

. .u - .

~ '

v 9

l l

.c ..o .

n hz e ,l fN ' , ~ . ,p e ;

w <

m

/ODCM Rav.f1'4- 1 J '

Paga19=' y

' 'pI ' g; ,; y 4 l6/94: __

7. .

. t- '

4

" 2 2 . 3 .1" CONCENTRATION i 7j 1

c This'controliis provided tojensure.that theoncentration'of' ._

! radioactive materials-released?in liquid'wasteneffluentsstol :

J ~

UNRESTRICTED ~AREASswill be lessithan the concentration levelse '

specified;in"10-CFR Part 20, Appendix B,;TableIII,fColumn.2.. -;

This limitation provides. additional' assurance that?thetlevelsK H

'of radioactive materials in bodies:ofLwater in UNRESTRICTED. l AREAS-will. result in; exposures-within-(1) the.Section:II.A .. .;

. design objectives of Appendix I, 10;CFR'Partl50,7 toJa; MEMBER OFe l THElPUBLIC,(and (2) the z limits.of 101CFR'20.106(e) toLthe ,

ji population.; The concentration' limits ifor. dissolved org , .

j entrained. noble gases are based upon.the: assumption;thatsXe-135: 0

. is the controlling radioisotope and'its MPC in air!was d converted to an equivalent concentration in waterjusing~the.:

methods described in the-InternationalcCommission on Radiological' Protection - (ICRP) Publication'2.

The required' detection capabilities for, radioactive materials n "in liquid' waste samples.are tabulat'ed in terms'of the' lower u '

limits of detection (LLDs).. Detailed discussion ofctheLLLD, and other detection limits can be found in HASL' Procedures - + 1 Manual, H&SL-300 (revised annually), Currie, L.A.,:"LimitsEfor-Qualitative Detection and Quantitative Determination - .

l Application to' Radiochemistry," Anal. Chem.~40. 586-93-11968), d and Hartwell. J.K.. " Detection Limits for Radioanalytical !!

Countina Techniuues," Atlantic Richfield Hanford: Company 1 Report ARH-SA-215 (June, -1975)...

_ j 2.3.2 DOSE

.. i This control is provided to implement the requirements-of l' Sections II.A, III.A, and IV.A of-: Appendix I,2 10 CFR;PartJ50. ,

The Control implements the' guides l set;forth in"Section1II.'ALof

Appendix I.- The ACTION statements. provide theLrequired _

operating flexibility ~and at.the.samectime implement 1the' guides 1 set.forth in Section IV.A of Appendix I:to' assure that the j o releases of radioactive material;in liquid effluents:willibe- !

kept "as low as: reasonably achievable".Also, fortfresh: water' .

- sites with drinking water supplies which can'be potentially >

,'z affected-by plant operations, thereiis reasonable assurance that-the operation.of the facility will notfresult:in- .

radionuclide concentrations'in the finished drinking water that- .;

are in excess.of the. requirements of 40 CFR Part 141. The dose '{

, calculation methodology and parameters in the ODCM implement-g the requirements in Section III.A of Appendix'I-that f conformance with-the guides of Appendix ILbe shown by. .

1 calculational procedures based on modelstand data, such that ;

the actual exposure of a MEMBER OF THE PUBLIC-through ,

appropriate pathways is unlikely to be substantially .

underestimated. The equations specified.in the ODCM for calculating the doses due to-the actual' release rates of ,

radioactive materials in liquid effluents are consist Mt'with 4 the methodology provided in Regulatory Guide 1.109, .i

" Calculation-of Annual Doses to Man from Routine Releases of ;

Reactor Effluents for the Purpose of Evaluating Compliance with l,

.e 9- , ,. -s*f e -2 --s . , .- - - - -

w

-ll ODCM R v. 14 Pags 10 l 6/94 l

10 CFR Part 50, Appendix I," Revision 1, October, 1977 and ,

Regulatory Guide 1.113, " Estimating Aquatic Dispersion of I Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April, 1977.

2.3.3 LIOUID RADWASTE TREATMENT SYSTEM The requirement that the appropriate portions of this system be used when specified provides assurance that the releases of I radioactive materials in liquid effluents will be kept "as low as reasonably achievable". This specification implements the requirements of 10 CFR 50.35a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section II.D of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix I, 10 CFR Part 50, for liquid effluents.

2.4 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION The radioactive gaseous effluent instrumentation is provided to l monitor and control, as applicable, the releases of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The alarm / trip setpoints for-these instruments shall be calculated in accordance with the procedures in the ODCM to-ensure that the alarm / trip will_ occur ;

prior to exceeding the limits of 10 CFR Part 20. The l OPERABILITY.and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50. j 2.4.1 DOSE RATE I This control is provided to ensure that the dose at any time at and beyond the SITE BOUNDARY from gaseous effluents from the site will be within the annual dose limits of 10 CFR Part 20 to UNRESTRICTED AREAS. The annual dose limits are the dose associated with the concentrations of 10 CFR Part 20, Appendix B, Table II, Column I. These limits L provide reasonable assurance that radioactive material l discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, to annual average concentrations exceeding the limits specified in Appendix B, l

l Table II of 10 CFR Part 20 (10 CFR 20.106 (b) (1) ) . For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy factor for that MEMBER OF THE PUBLIC will usually be y sufficiently low to compensate for any increase in the l atmospheric diffusion factor for above that for the SITE

! BOUNDARY. Examples of calculations for such MEMBERS OF THE PUBLIC, with the appropriate occupancy factors, are given in the ODCM. The specified release rate limits restrict, at all times, the corresponding gamma and beta dose rates above background to a MEMBER OF THE PUBLIC at or beyond the SITE BOUNDARY to less than or equal to 500 mroms/ year to the total l

l

^~ ' -* - J' y ,-\, - , ; - ,

[~

O ha , f ' - , ,

i fs LODCM Ravh14 4

~

, , Page(11- ,;

3 '

4 ,

6/94 .t v;W 4 p ~

/? ' ' body!or to tiess tha'n: : or' equal' to ' 3000; mrems/yearito theYskirm j

-Theseirelease rate limits also' restrict,Lat:allitimes, the'_ .

y 9g , '

corresponding.thyroidfdose rate above_ background to a childevia :

- ^

theiinhalation.pathwayito11ess than3or equal to: '

1500.mrems/ year.

'This" Control applies-toLthe. release offradioactive: materials [in '

gaseous; effluents from all reactors'at the site.

b - .TheTrequired detection capabilityifor. radioactive materials:in ,

( :gaseousLwaste. samples are tabulated in terms-of._the' lower, limits of' detection'(LLDs). Detailed;discussi'on"of theLLLD, and other. detection limits can beufoundDin HASL Proceduresi ' '

Manual, HASL-300 (revised annually),4 Currie, J L. A. , " " Limits 7 for L; Qualitative Detection'and-Quantitative? Determination - :

Application to Radiochemistry,"-Anal. Chem. 40.'586-93 11986). ,

and Hartwell, J.K., " Detection Limits-for Radioanalytical' Countina Techniaues." Atlantic Richfield Hanford-Companv-Renort ARH-SA-215 - (June .1975) .

2.4.2 DOSE -NOBLE GASES i

, - This control is provided to implement the requirements'ofL . ..

Sections II.B,-III.A,' an;d IV. A of Appendix ' I, 10 CFR' Part 50. !

The' control: implements'the guides set forthlin SectionLII.B'of. 1 a Appendix I. The ACTION statements' provide 1theLrequired ,

L . operating flexibility and at_the'same time: implement the guides ,

, ' set;forth:in Section IV.A of' Appendix I to assure"that2the4 _,

i.. releases of; radioactive material 11n gaseous. effluents will1 be' kept "as' low.as reasonably achievable".- The Surveillance! ,

o Requirements implement-the requirements'iniSection III'.A~of-1: _ Appendix I that conformance withithe; guides of Appendix I'be; l shown by calculationalf procedures: based on:' appropriate pathways -

in unlikely to be substantially underestimated. DThe' dose calculation established'in~~the ODCM for calculating _the doses, 7 l due to the actualLrelease ratessof radioactive' noble lgasesiin .

b gaseous' effluents are consistent with the methodologyiprovided i- ~ in Regulatory Guide 1.109, " Calculation offAnnual Doses to Man .

L from Routine Releases of Reactor Effluents for the Purpose'of ,

l Evaluating Compliance with 10-CFR:Part 50,LAppendix I,": 't Revision I, October 1977-and Regulatory? Guide 1.111, " Methods' for Estimating Atmospheric. Transport 'and Dispersion: of~ Gaseous?

Effluents in Routing Releases from : Light-Water Cooled . .I

'. Reactors," Revision 1, July 1977 with site specific dispersion ~

e curves.and deposition methodology. - The'ODCM equations provided j for determining the air doses at'an beyond the. SITE. BOUNDARY'

~

l are based upon the historical-average atmospheric conditions. a l

n.

}

u 1

o.

--+-o= a +- n w ,s-

.. s m. . m----- 7

, a' ;

gjp % Q '" ( ' a : Lq ,g

]

9 p 'k'? '

e '

'ODCM-Rev.'14-

, :PageT12.

' g3 , ,

[ ,

16/94l

- 1p -

-32 2.3f' DOSE - IODINE-131. IODINE-133 ' TRITIUM.~AND RADIONUCLIDES IN:

PARTICULATE FORM

~

M N ~

.This contro11is provided to. implement.the.requirementsLof Sections.II.C,s III.A, and,IV.A of AppendixJI, 10=CFR Part-50.,

The-controlsLare the guides; set.forth-in Section'.II.C of.

Appendix.I.: The ACTION: statements. provide the; required:

operating flexibility and at the(same time implement 3the-guides / -

. set forth in Section IV.A of AppendixLI'tofassure that the:

releases of radioactive' materials in gaseous effluentsfwill.be kept "as low as is reasonably achievable." The'ODCM" calculational methods lspecified'in.the Surveillance 1 p LRequirements: implement the requirements lin-Section III.A ofo H Appendix.I be shown;by_ calculational; procedures lbasedLon models<

and data, such=that the actual. exposure of'a' MEMBER OF THE PUBLIC:through. appropriate' pathways is unlikely;to rbe substantially underestimated. . The'ODCM' calculational methods for calculating the doses due to the:actualerelease rates'of l the. subject materials are consistent with the' methodology provided in Regulatory Guide 1.109, Calculation of' Annual Doses' to Man from Routine Releases of' Reactor Effluents'for:the -

Purpose of' Evaluating. Compliance with 10 CFR-Part'50, Appendix I," Revision I, October 1977 and RegulatoryiGuide'1.111,

" Methods for Estimating Atmospheric Transport:and Dispersion of, Gaseous. Effluents in Routine Releases from Light-Water-Cooled: ' >

Reactors," Revision 1, July 1977 with siteEspecific! dispersion curvesLand: deposition methodology. 1These equationsLalso: '

. provide-for determining,the' actual doses based:upon.the historical average' atmospheric conditions.-'Th'e release rate specifications for iodine-131, iodine-133, tritium',. ands radicuurlides in particulate form with half-lives: greater than-8 F.ays are dependent on the existing radionuclides pathways to m2n in arets'at and beyond the SITEiBOUNDARY. The pathways Ohich were sxamined in the development of;these' calculations ~

vere: (1) ir.dividual inhalation of airborne radionuclides,.-(2) deposition of radionuclides onto greenileafy vegetation with oubsequent consumption by man,"(3) deposition ontosgrassy areas where mfth cnimals and-meat-producing animals graze;with-ccnsumrtion of the milk and meat by man, andL(4) deposition on the grr.und with subsequent exposure of man.

2.4.4 yJNTILA? ION EXHAUST TREATMENT SYSTEM The requirement'that the appropriate portions of-this system be used, when specified, provides reasonable assurance that the releases of radioactive materials'in gaseous effluents will be kept "as low as is reasonably achievable." This control' implements the requirements of 10 CFR 50.36a, General Design Criteria 60 of Appendix A to 10-CFR Part 50, and the design objectives given in Section II.D of Appendix I to~

10 CFR Part 50. The specified limits governing the use

y , ,

7

.? . '

J ['y

' " '~

ODCM:Rav. 14L f

" v- LP aga 13 1[ f 6/94' ])

of appropriate. portions'of the'systemstwere specifiedfas.a _

suitable fraction of the dose' design objectives set forthiin l Section II.B and'II.C of Appendix I, 10'CFR'Part 50, for- 1 gaseous effluents.

J2.4.5 VENTING OR PURGING .

This' control provides reasonable assurance that releases from- ;

drywell purging operations will not exceed the annual dose j L limits of 10 CFR'Part 20 for UNRESTRICTED AREAS.

2.4.6 TOTAL DOSE ,

This control is provided to meet: the dose limitations 'of 40 CFR Part 190 that have been incorporated into 10 CFR Part'20 <

, by 46 CFR 18525.- The control requires the preparation =and-submittal of a Special Report-whenever the calculated doses i from plant radioactive effluents exceedctwice the design objective doses of Appendix I. For. sites containing up to four <

reactors, it is highly unlikely that the resultant dose <to a MEMBER OF THE PUBLIC will-exceed the dose limits of 40 CFR 190 ,

if the individual reactors remain within the reporting-

~ .i

. requirement level.

The Special Report.will describe a course o'f action'that should l result in the limitation of the annual dose to:a MEMBER OF THE' i PUBLIC to within the 40 CFR Part :190 limits. ForitheLpurposes of the Special Report, it may be assumed that,the dose. . ;

commitment to the MEMBER OF THE'PUBLIC from other uranium' fuel.

cycle sources is negligible, with the exception that: dose 1 l' contributions from other nuclear fuel: cycle facilities ~at the ,

l same site or within a radius of 5 miles must be considered.- If l the-dose to any MEMBER OF THE.PUBLIC is estimated to exceed the requirements of 40 CFR Part 190,' the :Special" Report' with' a~

request-for a variance (provided the releasefcondition resultingJin violation of 40 CFR Part'190 have notcalreadycbeen '

corrected), in accordance with the provisions of'40 CFR 190.11' and 10 CFR 20.405c,11s considered to be a timely request and-fulfills the requirements of 40 CFR Part 90 until'NRC staff 1 .

action is completed. An individual is not considered'a MEMBER- I OF THE PUBLIC during any period'in which he/she..is engaged in l carrying out any operation that is part of the nuclear fuel i cycle. j j

2.5 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM j; .')

The Radiological Envircnmental Monitoring Program (REMP) )

required by hiiis control provides representative measurements 1 of radiat. ion and of tadioactive materials in those exposure- 1 pathways and for those radionuclides that lead to the highest l potential ladictj6.1 exposures of MEMBER OF THE PUBLIC resulting from the station operation. This monitoring program implements Section'IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected-1 a

r ..,- -,--v ,- -

l' , ODCMERovk14

.. -P;gDjl4 d; 6/94 on the basis?of the effluent measurements and modeling'of the environmental exposure pathways.

'The required detection capabilities for environmental sample analyses are tabulated =in. terms of the' lower limits of

' detection ~(LLDs). The LLDs required by Table ~I3.4-3 arel

-considered optimum for routine environmental 1 measurements in industrial laboratories. It should be recognized-that the LLD.-

is defined as an a oriori (before the fact) limit' representing; '

.the capability of a measurement system and'not an after the fact limit for a particular measurement.

Detailed discussionLof the LLD, and other detection' limits, can be found in HASL Procedures Manual, HASL-300.(revised annually);. Currie L.A., " Limits for Qualitative Detection and-Quantitative Determination - Application to Radiochemistry,"

Anal. Chem. 40, 586-93-(1968). and Hartwell. J.K., " Detection Limits for Radioanalvtical Countina Technicues." Atlantic Richfield Hanford Comoany Report ARH-SA-215 (June. 1975).

2.5.1 LAND USE CENSUS This control is provided to ensure that changes in the use of -

areas at and beyond the SITE BOUNDARY are_ identified and that.

modifications to the monitoring program are madeLif required by the results of the census. The best information from the door-+

~

to-door survey, aerial survey-or consulting with local agricultural-authorities or any combination of:these methods-shall be used. This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. Restricting the census to gardens of greater than 500 square feet provides assurance that significant exposure' pathways via leafy vegetables will be identified and monitored since a garden of1 this size isLthe minimum required to. produce the' quantity-(26 Kg/ year) of leafy vegetables assumed in' Regulatory Guide 1.109' for consumption by a child. To' determine this minimum garden size, the following assumptions were'used: (1)'that 20% of the garden was used for growing broad. leafy vegetation-(i.e.

similar to lettuce and cabbage), and (2) a. vegetation yield of:

2 kg/ Square meter.

2.5.2 INTERLABORATORY COMPARISON PROGRAM r

The requirement for participation in an Interlaboratory Comparison Program ensures that independent checks on_the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring-in order to demonstrate that the results are reasonably valid.

for the purpose of Section IV.B.2:of Appendix I to 10 CFR Part 50.

2.6 APPLICABILITY #

2.6.1 Compliance with the controls contained in the succeeding controls section is required during the OPERATIONAL CONDITIONS

- .~

ay - ,

m t< ODCM Rev.;14 Paga-15 f .6/94t

+ .

.orfother conditionstspecified-therein;;except.that;upon ' failure-

~ '

~

to meet the controls, the associated ACTION requirements'shall be met.

226.2 - Non jcompliance: with a ' control shall exist :when the requirements-of'the control'and associated ACTION' requirements are not performed-within the specified time. intervals. .If

the control is restored prior to expiration of the.specified time <

intervals, completion of'the ACTION requirements is not' required.

.2.6.3 There are~no actions in the ODCM which would require an operational-' condition change.

2.6.4 There are no restrictions on changing operating conditions in any of the controls ~on the ODCM.

2.6.5 Surveillance Requirements shall be met during thef0PERATIONAL CONDITIONS or other conditions specified for individual controls unless otherwise stated in an individual Surveillance Requirement.

2.6.6 Each Surveillance Requirement shall be performed within the-specified interval with a maximum allowablu extension not1to exceed 25% ofethe surveillance interval.

c

.2.6.7 Failure to perform a Surveillance Requirement within'the .

allowed surveillance' interval defined-by-control 2.6~6,.shall constitute noncompliance ~with the OPERABILITY requirements'for:

a control. The time limits of the ACTION requirements are.

applicable at the time it is' identified that a'Surveillancei .

Requirement has not been performed. -The ACTION requirementsL.

may be delayed for up_to 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months .to permit the completion of. , '

the' surveillance when the allowable outage time limits'of the l ACTION requirements are less than 24' hours. LSurveillance requirements do'not have to be performed on inoperable

l equipment.

i l

The associated bases from the LGS Technical' Specifications applies to this section.

l t

,I r s v ~ < .e~- c - - -

t) _

jll ODCM Rsv.'14 y"

8 >

P:gs 16;

,ll 6/94- l

^

4

. 3 '. 0 ' METEOROLOGICAL MONITORING INSTRUMENTATION CONTROLS 13;1' The> meteorological monitoring. instrumentation' channel'sLshownL in Table'I3.1-1:shall be OPERABLE..

, APPLICABILITY:'At all times.-

ACTION:

With;1ess than the minimum required instrumentation-channels operable for more Ethan -7 days, prepare and: '

submit-a Special ReportJto the Commission. pursuant--to' LGS Technical Specification 6.'9.2;within the next:10 l days outlining the cause of/the malfunction'and the plans for restoring the instrumentation-to OPERABLE status.

SURVEILLANCE REQUIREMENTS

'3.1-1 Each of the above required meteorological-monitoring instrumentation channels shall be demonstrated OPERABLE by the performance of the CHANNEL CHECK and CHANNEL.

CALIBRATION operations at the frequencies shown in Table I3.1-2.

a.

i i

1 l

l l

l 1

. ... -. . . .. - .~-..-. . - ,- .,

s

'< > 1 ODCM'RaviJ14-Page:17 lll[

l 6/94 TABLE I3.1-1

+

, ;; METEOROLOGICAL MONITORING INSTRUMENTATION MINIMUM Tower;1 Tower 2. INSTRUMENT-

. INSTRUMENT (Primary) '(Backup) OPERABLE -

1. Wind Speed.

a. . Elevation 1 30. feet 159 feet 1 b.' Elevation 2 175-feet '304 feet < 2. Wind Direction

a. Elevation 1 30 feet 159' feet l'

b. Elevation 2- 175 feet 304 feet 1

~

3. Air Temperature Difference (AT)

a. Elevations. 266 feet- 300 feet-26 feet 26 feet 1 e

I-1 TABLE I3.1-2 METEOROLOGICAL MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS' Channel Channel- -

INSTRUMENT Check ' CALIBRATION

!' '1. Wind Speed l-

a. Elevation 1'(Tower 1 and Tower 2) D SA-i

b. Elevation 2 (Tower.1 and Tower 2)L D SA 2.; Wind' Direction

a. Elevation 1 (Tower 1 and Tower 2)' D SA L b. Elevation.2 (Tower 1 and Tower 2) D SA

'3. Air Temperature Difference (AT) ,

l

a. Elevations 266 - 26'ft (Tower 1) 'D SA j b.' Elevations'300 - 26 ft (Tower 2) D SA 1 i

l I

l NOTE: )

The meteorological towers shall be located as shown on !

-Figure I3.1-1. For backup sources of data retrieval, refer to Table I3.1-3. H l

l

< - = - ~ ~ = ,a

- - 4rg. y; ..

r ,

7 A $

-l 'ODCM'Rav.'#14 ),, ..

, J<. -

Pcga 18; " - -

.! 6/94' 4

TABLE I3.1-3

' METEOROLOGICAL TOWER DATA RETRIEVAL , y y

INSTRUMENT- TOWER 1 TOWER 2 DATA LOGGER DATA' Strip Chart i Strip Chart # :RM-21A Channel-#

Wind Speed 1 (TWR1) a.-Elev. 1 XR-MS-012C XR-MS-020B RM-21A 14 (TWR2)

Wind Speed . 5.(TWR1). -

b. Elev. 2 XR-MS-012B XR-MS-020A RM-21A 21 (TWR2)

Wind Dir. '.0 ; (TWR1)

a. Elev. 1 XR-MS-012C XR-MS-020B. RM-21A' '13 (TWR2) 4 Wind Dir. 4 (TWR1) l b. Elev. 2 XR-MS-012B XR-MS-020A RM-21A 20 (TWR2)

Multi-pt Rec #' Multi-pt Rec i DELTA T XR-MS-091 XR-MS-092 7 (TWR1)

Point 2 Point'2 RM-21A 23 (TWR2)

PRIMARY OPTION: _

.i IE DATA IS UNAVAIIABLE . FOR TOWER 1 (Strip Chart #'s XR-MS-012C,-XR-MS-012B, Multi-Point' I l Recorder iXR-MS-01' point 2),

THEN verify corresponding. data available on Tower 2 (Strip Chart #'s XR-MS-020A,:XR-MS-020B,.

Multi-Point' Recorder-#XR-MS-092 point 2).

.l SECONDARY OPTION: '

IE data.is not available'from Strip'. Charts or Multi-Point Recorders,.

]

THEN verify data on.RM-21A._- 2. .

L TERTIARY OPTION:

IE RM-21A is not available,

, THEN, verify data on Data. Logger;(corresponding. channel' numbers).

F f

r

~m ~ _ _ _ _ _ _

____-------7--------~---_-~--.

rn .-

{s e ,g;

+

P; 1- q; .

s' g.' ODCM' Rov. 14'

~Page 19

' ' ']c .; 6/94 _]j

-Floure I3.1-1 Meteorological Tower Location

.t.

4 k

f i k1 f '.'* *. $ f t h ' h l h h % h h .$ ' k h Y '

Y

^t ..

q/iyi W M Lasn_..g rit.dr".4t W 1 bi k \ i. f. \b l,

U.4. M. teat..$,h ., .5

.;'i-Y." .p.- " Y . v:-:.:Mn:

f : 1 ,

g t' is,t:a r q 30 m #1 yp ,(q<. j .7.,d 7eT] l 9.#r M?

sgA \\ \$..M N '# ( 4 .

'_/ N f.Md.: E.

h ,h 'I!' , 48.*( . A*'N9.$

M% \t \ .

4Ag M s%

N % Q W1.! y y ;/r u qu.b MO,'.k.kN'k. s

(\ <

\1 (% \ \\h hrN::=---T .?

/ / \\ g C00HM M-- y Ys%'- /* 1 10 b s g7s_ .. d.. i.:- < A iM

/ ,'

a$ m V:-. i: +.4 g..

- w -

.ge3 '

7 s\ h 't D ..

t . ama.asse i

~ -

\ ( _

Ti== @ !f 1.W /,

1 t ti t ~i- *:

e

.Y r , ' I .w6 8,e,

,,amans*,j.p/,E

- - n . .: j u .

\-s :. 3 .-

. -e o v . . =='.- s _ -

a % '. t= s u._ E s _ = :1 -

%:. MY$N

% I/-

NN$Dj, %g. ,:vrTructosien s 4rn.,_Q .f . g g. , p.ak]%.@

y .ogy .%

4.- .. Tom n \

W**.;su isimon

" T ' *c% fi'{ / *\ h \\.- .wRr '^*k'rV%g.. 7. .:n e.,

.. ..t. .I,

- d . w@ 4 N I S 6 i 8 % w' & g E, '. *a L M J- N,@

y' . ~y . uc; r - .. -" l N..

'h=41.$>dk..q, BEE

't -. h -h .[

s.

p.

-~:---

.'.*,M N.. s 8 w .

.':=.*O. g. --

J%':b).N'M ' .+. =3 n. .

,'"N*. **,

' * - ( . M

~.x ../ '

. ,./. 5 R.- w~ ..

, 1

x . . . .. . . . .

- / .,

fxh' 5 'l ~ '

I 9

e

- - - - - - - - _ - - - _ _ . _ - _ _ _ _ _ - . - - - _ _ . _ _ . - _ - _ _ - _ - _ - _ . _ _ _ - - - - _ - . _ . - - _ _ _ _ - _ . . - - _ - - - . - - _ - _ - _ ~ _ . . . - - _ - - _ - . _ . - . - - . . - - - _ _ _

d

_ ,J- '

ODCM R:v'.:14< l it Paga 20 i ,

6/94 j l

3 . 2 ., RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION CONTROLS ' -

13.2.1 The radioactive liquid. effluent monitoring' instrumentation i channels shown in Table I3.2-1-shall be. OPERABLE with'theiri

~

alarm / trip setpoints set to ensure that control I3.2.2 is not exceeded. The alarm /setpoints* of these' channels'shall be. !

determined and adjusted in accordance with the methodology and' ;

parameters in'the ODCM - Part II, Section 1.2.- 1 m

APPLICABILITY:-At all times.

ACTION:

a. With a radioactive-liquid effluent monitoring instrumentation.

channel . alarm / trip setpoint less . conservative? than required -

.by the above control,- immediately suspend the. release of.

' radioactive. liquid effluents monitored by the affected channel, and declare the channel inoperable. ,

l

b. With less than the minimum number of radioactive liquid. '

effluent monitoring instrumentation channels OPERABLE, take 4 the ACTION shown in Table I3.2-1. Restore the inoperable. '

l instrumentation to OPERABLE status within the time specified.

in the ACTION or explain in the next Semiannual Radioactive )

Effluent Release Report why this inoperability was not- '

l corrected within'the time specified.

11 SURVEILLANCE REOUIREMENTS i

3.2.1-1 Each radioactive liquid affluent monitoring I instrumentation channel shall be demonstrated OPERABLE. I by performance of the CHANNEL CHECK, SOURCE CHECK,- !

CHANNEL CALIBRATION and CHANNEL FUNCTIONAL TEST

. performance at the frequencies shown in Table I3.2-2. .

Excluding the flow rate measuring devices which are not r determined and adjusted in accordance with the ODCM.

e

'E s ..-- - - __ _ . _ . . . _ _ _ _ . _ _ _.___ . _ _ __ _ _ _ _

. , , . .. - . = , . . ~ - ... - . . - .-

+

1 ..

44 9 4 ODCM I Rav.f14? i

~ li '

-Paga 21 j- 2 s

6/ 0 4 '-

TABLE'I3.2-1 ;

% : RADIOACTIVE LIOUID EFFLUENT MONITORING INSTRUMENTATION 2 :l

, 1 MINIMUM 4

CHANNELS

, INSTRUMENT OPERABLE ACTION

7/ 'li . Gross' Radioactivity Monitors Providing

- Automatic Termination of-Release a.' Liquid:Radwaste Effluent Line 1 :1004

b. A/B RHR Service Water Effluent Line~ '1/ loop 101; i

2. G*oss Radioactivity. Monitors Not Providing im!omatic Termination of Release-

a. Service Water Effluent Line 1 -101' i

3. Flow Rate Measurement Devices i

a. Liquid Radwaste Effluent'Line 1 102 ,

b. Discharge Line: 1 102 '

ACTION STATEMENTS Action 100- With less than the Minimum Required. Channels operable, .

effluentireleases may continue for.up to 14 days provided '

that prior to initiating a release: . .

a. At least two~ independent samples are analyzed"in accordance'with Table I3.2-3,'and . .

b. At'least two technically qualified members.of.the facility _ staff independently; verify the release rate calculations and discharge lineivalvingt'

'Otherwise, suspend release of radioactive 1 effluents via this pathway. '-

Action 101- With'less than the Minimum Required Channels. operable,,

effluent releases via this pathway'may continue for up to- t 30 days provided'that,'Lat.least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months ,fgrab l i

samples are collected'and' analyzed for radioactivity by: l gamma isotopic analysis ~(Principal Gamma Emitters, I-131, and Dissolved / Entrained Gases)-as a Lower 1 Limit of' Detection asispecified inLTable I3.2-3 or gross ,

radioactivity (beta and gamma) .;GrossEBeta is analyzed, at an LLD of~at least'1N7 microcurie /ml. Gross Gamma isi ,

analyzed ~at an LLD of at least'5N7-microcurie /m). :

Action 102- With less than the Minimum Required Channels operable, effluent releases via this pathway may continue'for.up to 30 dr.ys provided the flow ratecis estimated at leastsonce per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months during actual releases. Pump curves-

. generated in situation may be used to estimate: flow.

q

)

a 5

g e ,aye%n - , , - ,.

.--+ c ,,, , w -r-~*-- w-

- . m:m ;- pqq

~

^w.t ,

< f9 ~ :

l ODCM R v.-14 ,

.- yf%

' ^1 3 Page.22

~

l .

6/94 '.

'_ l'1 .

l TABLE 13.2-2

. RADIOACTIVE LIOUID EFFLUENT MONITORING' INSTRUMENTATION SURVEILLANCE'REOUIREMENTS

!~

CHANNEL.

FUNCTIONALI p NN CHANNEL SOURCE CHANNEL ^ h INSTRUMENT CHECK TEST-

~

CHECK CALIBRATION '

1. Gross Radioactivity Monitors Providing- '

D Automatic Termination of Release -

a. Liquid Radwaste Effluent Line P- P. R(3) -Q(1)'

i b. RHR Service Water System Effluent-Line- D M R(3) - Q(1) -

2. Gross Radioactivity; Monitored Not Providing

l. Automatic Termination of Release I

( a. Service Water System Effluellt Line D M- R(3)' Q(2).

3. Flow Rate Measurement Devices I

i a. Liquid Radwaste Effluent Line D(4) N.A. R- QI _

'b. Discharge Line- D(4) N .' A . R. Q e %

P*

u.. _ . - - - --_ - , ax .-.ew.n -- - .- P.----,___u.- -.-_.a..kok -- - - . ' ' ' ' '

6- y *

,p j; <

- ODCM s Rav. - l'4h

~

(.g Page 23' j:

'6/94-

^ ,

. TABLE T3.2-2 (Continued) ,[

TABLE NOTATIONS -

(1) The CHANNEL FUNCTIONAL. TEST shall also: demonstrate:that-automatic isolation..ofethis pathway and' control. room'alarmy annunciation'will occur if'any of the_following conditions' exists:

1. ' Instrument indicates measured levels above the alarm / trip setpoint.

2. Circuit failure. .

t

3. Instrument indicates aidownscale failure.. l

_(2) The CHANNEL FUNCTIONAL. TEST shall also.demonstr' ate.that control. room alarm ant.unciation occurs if-any of the

' following conditions exists: ;

1. Instrument indicates measured levels above the alarm-setpoint.

- 2.- Circuit failure.

3. Instrument indicates a downscale failure. .

(3) The initial CHANNEL CALIBRATION shall be performed using' reference standards certified by the National Institute of:

Standards and Technologyf(NIST) obtained from suppliers that ~

participate 11n measurement assurance activities with-NIST; These standards shall permit calibrating the system-over its intended range of energy and measurements range. For subsequent CHANNEL CALIBRATION, sources that have been

' related to the initial calibration shall be used. L

-(4) CHANNEL CHECK shall consist of verifying _ indication of flow. ,

- during periods of release. CHANNEL CHECK shall be made at- !

least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months on days on.which batch: releases are~ !

made.- ,

o 4

N

_- , + * . * . - . . - r---..,-u ...i a- , .,,-4 , .,e- ,-w,m + - ------ , , , ,ee- . -w r .

mmyg m-

_ q

j,H .-

jj:

i LODCM Rsv.'14

~

ax % Paga~24 1

j s_j,l ~6/94 q

' CONCENTRATION CONTROLS

~ ~

3.2;2~ The. concentration of radioactive material released in

, liquid effluents to UNRESTRICTEDLAREAS (see' Figure I2.2-'

la,b).shall be: limited to the concentrations-specified in 10 CFR Part 20, Appendix B,-Table II,-' Column-2_for -

radionuclides other than dissolved'oraentrained nobles-gases. . For dissolved.or entrained noble gases,'the ,

concentration shall be limited to 2E-4 microcuries/ml I total activity.-

APPLICABILITY: At all times. [

-ACTION: ~i

~ ~

i With the concentration of radioactive material-released ~1n 1 liquid effluents to UNRESTRICTED AREAS exceeding the above -)

limits, immediately restore the. concentration to within j the above limits or terminate the release. i u

SURVEILLANCE REQUIREMENTS 3.2.2-1 Radioactive liquid wastes shall be sampled and?

analyzed according to the sampling and. analysis. 1 program of Table I3.2-3.

3.2.2-2 The J results of the radioactivity analyses shall-be used-in accordance.with-the methodology and ;)

parameters in the ODCM Part II. Section-1.3 to assure that the concentrations-at the point of

release are maintained within the limits of Control I3.2.2.

7' 1

3:

a l-

. - = _ _ _ _ _ _ _ _ _ _ _ _ _ _

h

] 1ODCM Rev.'14

'5 Page 25

] 6/94

-TABLE'I3.2-3 RADIOACTIVE LIOUID WAS.TE St.MPLING AND ANALYSIS PROGRAM Lower Limit.

Minimum Type of of Detection Liquid Release Sampling Analysis Activity _ (LLD)*'

n ' Type- Frequency Frequency Analysis (uci/M1)

A. Batch Waste P P: Principal' Gamma SE-7 '

Release Each Batch Each Batch Emitters

> Tanksb I-131 1E-6

1. Floor or P' M ' Dissolved and '1E Equip. Drain One Batch /M Entrained Gases. t l Sample Tanks (Gamma Emitters)*

'2. Laundry P M H-3 1E-5 Drain Sample Each Batch Composite d Tank Gross' Alpha 1E-7' P Q Sr-89, Sr-90 5E-8 Each Batch Composite d '

Fe-55 1E-6 I B. Continuous W W Principal Gamma SE-7~ ,

i Release

Grab Sample Emitters

l l I-131 1E-6 i

I

1. RHR Service W -W- Dissolved ~and 1E-5 l Water System Grab Sample Entrained Gases l Effluent Line f (Gamma Emitters)*

2. Service Water W M H 1E-5' '

System Grab Sample Composited Effluent Line' Gross Alpha 1E-7.

f W Q Sr-89. Sr-90 SE-8 3 d

Grab Sample. Composite l- -

Fe-55 1E-6

ll ODCM Ruv.;14 Paga'26l l 6/94 TABLE I3.2-3 (Continued)

TABLE NOTATIONS Lc. The LLD is defined as the smallest concentration of radioactive materialiin a sample that will yield a net count, above system background, that will be detected with 95% probability with only.

5% probability of falsely concluding that'a blank observation represents a "real" signal.

'For a measurement system, which may include radiochemical

- separation:

-l ( 2. 71 + 4. 6 6s,) (1-exp(-AAt))

2

. l- E V 2.22E6 Y - (exp (-AAt )]( 3 AAt g) 4 LLD (Grab Samples)=

E -

V -

2.22E6 -

Y (exp - AAt i)

Where:

LLD is the a criori lower limit of detection as defined above

( as microcuries per unit mass or volume),

so is the standard deviation of the background counting rate or i

of the counting rate of blank sample as appropriate (as counts per minute),

E is the counting efficiency, as counts per disintegration, V is the sample size, in units of mass or volume, 2.22E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable, A is the radioactive decay constant for the particular radionuclide, and At3 for the plant effluents is the elapsed time between the end of the sample collection and the time:of counting.

At2 f r the plant effluents is the elapsed time between the end of the sample collection and the start'of sample collection.

j Typical values of E, V, Y, At3 and At 2 should be used in calculation.

It should be recognized that the LLD is defined as an a criori-(before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement.

w lt ODCM Rav. 14-

.Pcgn 27 1

6/94 y ,

' TABLE I3. 2-3 (Continued) ,

TABLE NOTI,TIONS sb. A batch release-is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyses, each. batch shall be

. isolated,Eand'then thoroughly mixed to~ assure representative

sampling.

c. . The principal gamma emitters for which the LLD specification applies include the following. radionuclides: Mn-54,.Fe-59, Co-58, Co-60, Zn-65,.Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144.

. The dissolved and-entrained noble gases-(gamma emitters) for-which the LLD specification app ies' include the-following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135,.Xe-135m, Xe138. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the. Semiannual Radioactive Effluent Release Report pursuant to Control 3.6.

d. - The-term " Composite-Sample" means a combination of individual samples obtained at regular intervals over a time period.- Either the volume of each individual sample is proportional to discharge

. flow rates, or the sampling interval (for constant volume samples) is proportional to flow rates over the-time period used to produce the composite.

e.. A continuous release is the discharge of liquid wastes of nondiscrete volume, frcm a Volume of a system that has an-input flow during the continuous release.

f. Whenever effluent releases are in excess of the monitor's setpoint.

l c

l 1.

i

. + + , - - - . . - . - -

,- =,

!l? ODCM-R v. 14 i W ,, peg 3 28,

'l; 6/94~

i 2

DOSE L CONTROLS l

3.2.3 The dose or dose commitment to a. MEMBER OF THE PUBLIC.from radioactive materials in liquid affluents released 1from the l site to UNRESTRICTED AREAS (See-Figure I2.2-la) shall'be.

limited:

a. During any calendar quarter to.less-than or-equal to. 'l '

3 mrems to the total body and to lesszthan or equal to 10'mrems to any organ, and

b. During any. calendar year-to less.than'or equal to 6 :

mrems to the-total. body and to less than or equal to 20 ,

mrems to any organ. l APPLICABILITY: At all times.

i ACTION:

I With the calculated dose from the release ^of radioactive materials in liquid. effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical.

Specification 6.9.2, a.Special Report which identifies 1 the.cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce i the releases and the proposed corrective actions to be. I taken to' assure that subsequent releases.will be in' ;

compliance with the above limits. This Special Report shall also include the radiological impact'on finished drinking water supplies at the nearest downstream drinking water. source.

SURVEILLANCE REOUIREMENTS 3.2.3-1 Cumulative dose contributions from liquid effluents for the current calendar quarter and the current calendar year shall be determined using ST-0-104-878-0 at least once per 31 days.

5

s '

!X , . .

, p . ODCM Rav.-14' s i +

- .Pago 29' ;

6/94

]"

LIOUID'RADWASTE TREATMENT SYSTEM-l C- CONTROLS -

3.2.41 The liquid radwaste treatment system shall be.IN._ .

SERVICE'and appropriate portions:of.theTsystem shall

be used to. reduce the radioactive: materials in liquid waste prior to.their~ discharge when the projected doses due to the. liquid effluent,.from'theLsite,cto-UNRESTRICTED AREAS'(See Figure I2.2-la) ~ would exceed' O.06-mrem >to the total body or 0.2 mrem.to any organ <

in a.31-day period.

APPLICABILITY: -At all times.

ACTION: '

a. With radioactive liquid waste being discharged withoutJ treatment or in excess of the above' limits,. pursuant to Technical Specification 6.9.2,-prepare afSpecial Report which includes the'following information:- 1

1. . Explanation of what liquid radwaste was-being. >

discharged.without treatment, identification.of any. inoperable equipment or-subsystems, and the-

~

reason:for the inoperability.

.. 1

2. . Action (s) taken to restore the inoperable.

equipment to OPERABLE' status, and

3. Summary description of action (s) taken to prevent a recurrence.

b. - Submit report to Commission.within 30 days.

EMEVEILLANCE REQUIREMENTS- :

~

3.2.4-1 Dose due to'liquidLreleases from the-site to.

UNRESTRICTED AREAS ~shall be projected at least once per 31 days using ST-0-104-878-0.- j

')

i

, ,y ,, -~ -

.n=- , - . . . ~, _._.------___._._--____._._A

IW '

i cw

iT

? ,

-a #

ODCM Riv. 14'

< 4 )l_ , , _

, Paga 30

- -l '6/94-1

'\3.3 RADIOACTIVE' GASEOUS EFFLUENT MONITORING INSTRUMENTATION-c CONTROLS' l e -1

. i 3'3.1

. The radioactive gaseous < effluents monitoring 7 instrumentation )

channels in Table I3.3-1 shall.be OPERABLE with their j alarm / trip setpoints_ sot to ensure'that.the limits of ODCM Control:Part I Section 3.3.2 are not exceeded. The alarm / trip.

setpoints of-the applicable channels shall be determined in accordance:with the' methodology.and parameters _in the ODCM.

Part II, Section 2.2.

APPLICABILITY: -As shown in Table I3.3-1. !

1 l

" ACTION: .

-)

a. With'a radioactive gaseous effluent monitoring- H instrumentation channel alarm / trip.setpoints less- .

conservative than required by Part.II Section 2.2, ~

, immediately suspend the release.of radioactive' gaseous y effluents monitored by the_affected channel or declare J the-channel' inoperable.

H

b. With/less than the minimum number of-radioactive-gaseous effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table I3.3-1.-

Restore the inoperable instrumentation'to' OPERABLE' status within the time specified in-the ACTION.: If-the inoperable instrumentation is.not restored'within l the time specified in the ACTION statement: create an '

]

.AR in PIMS to ensure.an explanation is written-by the .i responsible System Engineer and is included in SAERR I by the HP Effluent Physicist.

SURVEILLANCE REOUIREMENTS ,

1 3.3.1-1 Each radioactive gaseous effluent monitoring instrumentation channel shall be demonstrated OPERABLE by performance of'the CHANNEL CHECK, SOURCE CHECK, '

CHANNEL CALIBRATION AND CHANNEL FUNCTIONAL TEST operations at the frequencies shown in Table I3.3-2.

-i i

= _______.___________o

w 3 3 ODCM Ravi[14' [n" ^

, -Paga~312 _

. -i 6/94. >

2 TABLE I3.3-1

RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION MINIMUM CHANNELS INSTRUMENT OPERABLE. APPLICABILITY ACTION. ,

SOUTH STACK EFFLUENT MONITORING SYSTEM

a. Noble Gas Activity Monitor 1

111-

b. Iodine: Sampler 1

112-

, c.' Particulate Sampler 1

112

d. Effluent System Flow Rate Monitor 1.

113-i e. Sampler Flow Rate Monitor l'

113 NORTH STACK EFFLUENT MONITORING SYSTEM f.

a. Noble Gas 4 Activity Monitor 1

114 b.' Iodine Sampler 1

112

c. Particulate Sampler 1

112

d. Effluent' System Flow- Rate Monitor 1-

113

e. Sampler Flow Rate Monitor 1

113 HOT. MAINTENANCE SHOP VENTIIATION' EXHAUST RADIATION MONITOR

a. Iodine Sampler .. 1 ** 112.

b. Particulate Sampler. 1 ** 112

c. Effluent System Flow Rate. Monitor-1 ~**' .113

d. Sampler Flow Rate Monitor.

1 **' 113

?-

l'

The (A or B) North Stack. Normal. Range Radiation Monitors'OR the' Wide Range Accident Monitor (Low Range) may1be-used to; satisfy requirements'for the North Stack Effluent' Monitoring System.

NOTE: With regard to Actions ~ 111,~112, 113, and 114; with-lessLthan the minimum Required l Channels- ,

operable for:greaterothan-30-days prepare'and-submit a Special Report:tolthe Effluent l

?'

Physicist.within theinext':10. days outlining the cause of the. malfunction and the plans'for. i restoring the instruments to-OPERABLE' Status. Sampling shall continue.until'the minimum ,

channel operability. requirement is met.

oat all times. _.

- Duringfoperation of'the hot.maintenancefshopiventilation. system.-

_ _ - - _ - _ _ __ . _ . . . _ _ . ~ _ _- - _ . ._ _- . _ , . - _

l~ ODCM ' R$v.'. l'4 L Page 32< j

'l ,j, .6/94'

! TABLE'I3.3-1(Continued) ,

~

TABLE NOTATIONS ACTION _ STATEMENTS ACTION 111 -

With less than'the minimum Required Channels (SS Noble Gas) OPERABLE, effluent releases.via this pathwayL may continue'for up to 30 days provided grab ~

i samples'are taken per ST-5-026-580-* at least' once'per 8. hours and_these samples'are analyzed for gross activity within 24' hours.:

l With less than the minimum' Required Channels

~

ACTION 112* - j (Iodine & Part.) OPERABLE, effluent releases via this' pathway j may continue for up to 30 days provided 1 samples are continuously collected with !

auxiliary sampling equipment per,St-5-076- q 815-*, ST-5-076-820-* as required in: --

Table'I3.3-3.

JUE the Sample Pump is operable, a ; particulate and iodine sample can be obtained;' .,

AHD.the Minimum Channels operable = j requirements are satisfied. 1 ACTION 113* - With less than'the minimum Required. Channels (Eff. & Smpl. OPERABLE,_ effluent releases via NS, SS or HMS~

Flow Rate) may continue for up to 30 days provided the flow rate is estimated by adding the nominal:

. flow rates indicated in P&ID M-26 for each in-service fan. This shall be documented in

the MCR operations Shift Log at least once per 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months .

ACTION 114 -

With less than'the minimum Required Channels- l (NS Noble Gas) OPERABLE, effluent releases via this pathway may continue for up to 30 days provided grab samples are taken per ST-5-026-580-0 at least once per 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months and.these samples are.

analyzed for gross activity within 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months .

The Mechanical Vacuum Pumps may not be operated during this LCO. i

If release point is the Hot Maintenance Shop,

_N.

_ Then secure ventilation because no means exist ;

to alternately sample the ventilation.

J

- - - - - - - . . - . . ~ , . . .

,, . t_- ;

ODCM Rsv.'14: i

~

^

l -

Page 331 '

] l -6/94-TABLE I3.3 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REOUIREMENTS: [

~

CHANNEL-' MODES IN.WHICH CHANNEL- ' SOURCE CHANNEL FUNCT.- SURVEILLANCE--

INSTRUMENT CHECK CHECK:CALIBR. TEST IS-REQUIRED.

4 1. SOUTH STACK EFFLUENT MONITORING SYSTEM

a. Noble Gas Activity Monitor D M' R(2) Q(1) *'

i b. Iodine Sampler W(3) N.A. -N.A. N.A. *

c. Particulate' Sampler W(3) N.A.- N.A. N.A. *- - -

d. Effluent System Flow Rate Monitor D 'N.A; R' Q *

e. Sampler Flow Rate Monitor D N.A. R Q- *-

p

2. NORTH STACK EFFLUENT MONITORING SYSTEM #

a. Noble Gas Activity Monitor D M. R(2)- Q(1) *

b. Iodine Sampler W(3) N.A. N.A. N.A. '*

c.-Particulate Sampler .

W(3) N.A. N.A. . N. A. . *:

I

d. Effluent System Flow' Rate Monitor D N.A. R Q'

3

e. Sampler? Flow-Rate Monitor D- N. A. - R Q- *

3. HOT MAINTENANCE SHOP VENTILATION EXHAUST RADIATION MONITOR

a. . Iodine Sampler W(3)_ N.A. N.A. -N.A. **

b. Particulate Sampler .

'W(3)' N . A . .- . N . A '. - ' N .' A . - **

c. Effluent' System Flow Rate Monitor D N .' A . R_ Q **

d. Sampler Flow Rate Monitor D- N.A. R' 'Q' **

Wide. Range Accident! Monitor-(WRAM) surveillance is specified in'. Technical Specification 4.3.7~5.. .

At all times.

- During. operation of the-hot-maintenance shop ventilation exhaust system.

- -. , , . . . . --_ , . . . . ,~ .,_,- . . _

IE ' ;l ODCM Rsv.-14 Pcg3 34 E l 6/94 TABLE I3.3-2(Continued)

TABLE NOTATIONS i

.(1)- The CHANNEL' FUNCTIONAL TEST shall also demonstrate that 1 control room alarm annunciation occurs if any of the !

following conditions exists:-

l

1. Instruments indicate measured levels above the alarm / trip setpoint.

2. Circuit failure.

3. Instrument indicates a downscale failure.

4. Instrument controls not set in operate mode. ,

('2 ) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards'and-Testing (NIST) or using standards that have been obtained from suppliers that participate in measurement' assurance activities with NIST.

These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that are traceable to the initial calibration shall be used.

(3) The iodine cartridges and particulate filters will be-changed and analyzed at least once per 7 days.

l 1

- .- = , ,

v W

y, d[ , \ ODCM Rsv.014 !

'c .

_ Page 35-f

,f<^

Lll '6/94-

' GASEOUS-EFFLUENTS '

CONTROLS 3.3.2 The' dose rate duetto radioactive materials releasedlin

' gaseous effluents.from'the sitetto1 areas at'or.beyond the. ,

SITE' BOUNDARY (See. Figure'I2.2-la)1shall be limited 1to:

. a .- 'For noble gases: . less than or equal to 5001 '

mrems/yr to the total body and less than or equal. ~

, to 3000 mrems/yr to the skin, and y

b. . For iodine-131, iodine-133, tritium, and for'all radionuclides in. particulate' form with half-lives greater than 8 days: less~than,or equal to 1500 mrems/yr to any organ. (Inhalation pathways only.)' j

. ' APPLICABILITY: At all times.

l ACTION:

With the dose rate (s) exceeding the above limits, .

immediately restore the release rate to within the above-limits.

SURVEILLANCE REOUIREMENTS j

,3.3.2-1 The dose rate due to noble gases in gaseous !

L effluents shall be determined to be within-the above limits using ST-0-104-879-0. When North or :

South Stack Noble Gas setpoints are exceeded, an . ]

. evaluation of the. SITE BOUNDARY doseLrate resulting.

.from the release.would be' performed using-ST-6-104-880-0.

d 3.3.2-2 The dose rate due to iodine-131, iodine-133,.

tritium, and all radionuclides.in particulate form-with half-lives greater than.8 days in. gaseous-effluents shall be determined.to be within the 1 above limits using ST-0-104-879-0 by obtaining l- representative samples and performings analyses in accordance with the sampling and-analysis program.

specified in Table I3.3-3.' ,

i i

l

'l = ODCM Rev. 14' Pago 36~

l 6/94 TABLE'I3.3-3 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM-Lower Limit Minimum Type of .of Detection Gaseous Release Sampling Analysis Activity (LLD)*

Type Frequency Frequency Analysis (uCi/M1)

A. Containment P' P _

Principal Gamma 1E-4 Purge Each Batch Each Purge Emitters *, f Release Grab Smpl.

B. North Stack / Continuousd Q Gross Alpha 1E-11 South Stack Comp. Part. -Sr-89, Sr-90 1E-11 Sample Mb Grab Smpl. Mb Noble Gas 1E-4' H-3 1E-6 Continuousd WC Char. Smp1. I-131 1E-12 I-133 1E-10 Part. Smpl. Principal Gamma Emitters 1E-11 Continuousd Continuous Noble Gas Noble Gas Beta or Gamma 1E-6 Monitor (Based on.

Xe-133)

C. Hot Mainten. Continuousd Q .

Gross Alpha 1E-11 Comp. Part. Sr-89, Sr-90 1E-11 Smpl.

Continuousd W* '

Char. Smpl. I-131 1E-12 I-133 1E-10 Part. Smpl. Principal Gamma Emitters 1E-11

- w. , c a N

^' l '

y et ,

ODCM Rsv.'-14:- -

f, s 5 Paga 37 ll .6/941

i E- . . TABLE'I3.3-3 ~ / Continued) 'c TABLE NOTATIONS

a.:' .The-LLD is' defined, asithe small'est concentration of>

radioactive material in a sample that4will yield a net; count,,

above system background, that will be detected with~95%,

probability with only.5%. probability of falselytconcluding *

,, :that a blank observation: represents a "real" signal.-'Iti ~

should'be recognized that the.LLD-is defined as an'a oriori

, (before the fact) limit representing!the capabilitysof a

' measurement-system and?not as an after.theEfact limitifor ai -

particular measurement.

o- For a.particular measurement' system,1(which'may-include:

radiochemical. separation): '

l ( 2 . 71 ' + . 4 . 6 6 s,) (1-exp(-AAta ))

LLD-=1 .

l- E V .2 .' 22E6 -Y. - [exp - (-AAt i) ) ( AAta)

(2. 71 + 4. 66. s,)

g

LLD (Grab Samples)

( Y -(exp - AAti)

[. E.- V +

'2.22E6 -

Where: .

LLD is the a oriori lower: limit of detection as definedLabove' (uC1/cc or uC1/mL), ;

, s, is the . standard deviation .of the background counting rate 1

r ' or of the counting rate of blank sample as appropriate;(as 3 cpm), shall be based on the actual observed variance'of.the- ~

background counting rate or of the; counting rate of the blanki ;

samples.(as appropriate) rather than on an unverified: i u theoretically predicted variance, g L 4 E is-the counting efficiency, as.cpdis, .i V is the sample ~ size, in units of cc or ml',

- 2.22E6 is the number'of.dpm/uci ~

Y is-the fractional radiochemical yield, when applicable, 1 is the radioactive decay. constant for the particular radionuclide, and .;

34 At 3 - for the plant . effluents isl the' elapsed time' between the. 1 end-of the sample collection and-the time ofl counting.

,~

f At2 for the plant effluents is the elapsed time between' the end of the. sample collection and the start of sample collection.

l Typical values of E, V, Y At and At 2should be used in calculation.-

3 <

4 y t g--* M V atN 7"'- Y-mT ---tw 6"gr-T ew -M v m3vt'+A k- MW W *'-*t-'2 -- ---- - - - ^ - - - - - - - - - - - - - - - - - - - - - -

4 4 ,y

' ' ji OCCM:Rav. 14-Paga 38.

6/94 4

. , ,;l

^

TABLE I3.3-3'(Continued)

F TABLE NOTATIONS sb. -Sampling'and-analyses shall also be performed following

, : shutdown, startup, or a THERMAL POWER change. exceeding 15% of

,the RATED THERMAL' POWER ~within a 1-hour. period,using-

-RT-5-000-876-*. This requirement does not" apply'if1(1)

- C. analysis show-that.the DOSE EQUIVALENT:I-131 concentration inz se the primary coolant has not increased more-than a factor of'3;-

1 and-(2) the main condenser offgas pre-treatment. radioactivity monitor shows that effluent activity has'not increased more-than a factor of 3.

L c. Samples shall be changed at least once per 7 days and. analyses shall be completed'within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months after' changing, or after-removal from sampler. Sampling:shall also be performed ~at i least.once per 24~ hours for at least 7 days following each-shutdown, startup or THERMALJPOWER change exceeding 15% oft

, RATED THERMAL POWER in 1 hour1.157407e-5 days 2.777778e-4 hours 1.653439e-6 weeks 3.805e-7 months and analyses completed within'483 hours0.00559 days 0.134 hours 7.986111e-4 weeks 1.837815e-4 months of changing. When: samples collected for 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months .are analyzed, the corresponding LLDs.nay be' increased byfa factor.

of 10. This requirement does'not applyLif (1) analysisfshows-that the DOSE EQUIVALENT I-131 concentration in the primary coolant has not increased more than'a factor.of 3; and-(2) the'-

noble gas. monitor.shows that effluent: activity has'not increased more than a factor of 3.

d.- The ratio of the sample flow' rate to the sampled' stream" flow 4

rate shall be known for the time period covered ^by each. dose I or dose rate calculation made in accordance with Controls

. 3.3.2, 3.3.3, and 3.3.4.

e. The principal gamma _ emitters for which the LLD-specification applies include the following radionuclides:LKr-87, Kr-88,.Xe-

, 133, Xe-133m, Xe-135, Xe-135m and Xe-138 for gaseous emissions and Mn-54, Fe-59, Co-58, Co-60,--Zn-65, Mo-99, I-131, Cs-124,-

Cs-137, Ce-141 and Ce-144 for particulate emissions. This list does not mean that only these nuclides are to be considered. Other gamma peaks which are identifiable, together with the above nuclides, shall also be analyzed'and.

reported in the Semiannual Radioactive Effluent Release Report, pursuant to Control 3.6

f. Under the provisions of footnote e. above,.only noble gases need to be considered.

g. Required for the hot maintenance shop ventilation exhaust only-during operation of the hot maintenance shop ventilation

! exhaust system.

l-

D .

" ODCM Rsv. 14

f ,

Paga 39 '

f[ ,

'6/94-LN .

DOSE - NOBLE GASES' l

. s CONTROLS E

3.3.3 The' air dose due to noble' gases released in gaseous effluents,

~from the site to areas at and beyond-the SITE BOUNDARY-(See Figure I2.2-la) shall be limited to~the following:

a, ' During any calendar quarter: less than or equal-to 10_mrads for gamma' radiation _and less than or equal-to 20'mrads for beta radiation, and

b. During any calendar year:- less than'or equal to 20 mrads for gamma radiation and less than or equal to 40 mrads for beta radiation. .

APPLICABILITY: At all times.

ACTION:

a. With the calculated air. dose from radioactive noble gases in gaseous effluents exceeding any'of the above

. limits, prepare and submit to the Commission within 30 .

days, pursuant to Technical Specification 6.9.2, a, Special Report'which identifies the cause(s) for exceeding the limit (s) and defines the corrective-actions that have been taken to reduce-the releases .

and the proposed corrective actions to be taken to

~

assure that subsequent releases'will be in compliance with the above limits.

SURVEILLANCE REOUIREMENTS 3.3.3-1. Cumulative dose contributions for the current quarter and current calendar year for noble gases shall be :

determined using ST-0-104-879-0, ST-0-104-881-0, ,

ST-0-104-883-0 every 31 days.

]

. l

.l e

i 4

4 4 , , , ..v,. _ _ . . ~ .e ,

o, . , .- . . _ - ,. ,_ .- -. _ _ ,

,. ex +(

, 4 Elj ' - -

ODCM R3v,r14~

yd - PagD;40~

,=.. ll 6/94 ao

" : DOSE - IODINE -'133.ETRITIUM. AND' RADIONUCLIDES IN: PARTICULATE FORM.

_'- CONTROLS !

353f4 -The doseLto a MEMBER OF THE PUBLIC fromliodine-131,fiodine ' i 133,' trit'ium and'all radionuclides in particulate' form with- ~

i

. half-lives' greater than 8. days-in gaseous' effluents released-from the site to areas at or beyond the' SITE BOUNDARYf(See -]

q l Figure-I2.2-la).shall be limited to the following a.-

^

During any calendar quarter: _ less than or. equal to

- 15 arems'to any organ and,-

b.. 'During any calendar-year: less'than or equalato- -j 30 mrems.to any organ. 'i l

APPLICABILITY: At all times. l

)

ACTION. l

a. With the calculated dose from the: release of iodine -

131, iodine-133,. tritium and all-radionuclidesLin. q particulate-form with' half-lives greater than 8 days-in gaseous effluents exceeding any of the above limits,-prepare and submit to the Commission within 30 _,

~ days, pursuantsto Technical Specification ~ 6.9.2, a 'l Special Report which identifies the.cause(s) for exceeding;the limit and defines the corrective actions

-that have been taken to reduce the releases and:the proposed corrective actions to be taken to assure that ;

subsequent releases will be in compliance with the above limits.

SURVEILLANCE REOUIREMENTS l 3.3.4-1 Cumulative dose contributions for the current calendar quarter and current calendar year for iodine-131,.

iodine-133, tritium and radionuclides in particulate; p form with half-lives greater than_8 days shall be determined using ST-0-104-879-0.once per 31 days.

4 4

0

___m - . _ _ _ . _ _ _ . _ _ _ _ . _ _ _ _ __ _ _ _ _ . _ _ _ _ _ . . _ . _ , _ _ _ , , _ , . . , . _ , ,_

m 4

'~

18 10DCM Rs'v. 14 i

' 'b , Paga.41 gl= ,

~6/94 VENTILATION EXHAUST TREATMENT SYSTEM 6 CONTROLS 3.3.5 .The VENTILATION EXHAUST. TREATMENT: SYSTEM shall'be IN' SERVICE.

~

and-appropriate portions'of'the system shall-benused to reduce radioactive material ~in gaseous waste prior to their discharge. .

when.the projected 1 doses due to gaseous' effluent releases, from >

the site.to areas at and beyond the SITE BOUNDARY 1(See/ Figure I2.2-la) when~ averaged over_31 days would exceed 0.6 mrem to' any' organ in.a 31-day period.-

]

APPLICABILITY: At'all times.

ACTION:

a. With gaseous waste being discharged without treatment,nor ,

in excess of the above limits, prepare and submit;to the

' Commission within 30 days, pursuant to Technica1'.

_ Specification 6.9.2, a Special Report which includes _the. -

following information:

' 1. Explanation-of why gaseous radwaste.was being i discharged.without treatment,f identification of.any -

L inoperable equipment or subsystems,-and the reason for-: :

L the inoperability._

i.

2. Action (s) taken to restore the inoperable equipment to ;

OPERABLE status, and'- i

3. Summary, description of. action (s)'-taken to prevent a-recurrence.

SURVEILLANCE REOUIREMENTS ,

3.3.5-1 Doses due_to gaseous releases from:the site to areas at and beyond the SITE BOUNDARY shall be projected at

-least once per 31 days using ST-0-104-879-0. i i

e i

l I

l a i

~ , - , , -, , - - . ~ , , ~

,- -. - - - _ - -2

ODCM Rev. 14

.l Page 42 l 6/94 VENTING OR PURGING CONTROLS 3.3.6 The VENTING or PURGING of the Mark II containment shall be through the standby gas treatment system.

l APPLICABILITY: Whenever the containment is vented or purged.*

ACTION:

a. With the requirements of the above specification not satisfied, suspend all VENTING and PURGING of the containment.

SURVEILLANCE REOUIREMENTS 3.3.6-1 The containment shall be determined to be aligned for VENTING or PURGING through the standby gas treatment system within 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months prior to start of and at least once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months during VENTING or PURGING of the containment.

3.3.6-2 Prior to use of the purge system through the standby gas treatment system assure that:

a. Both standby gas treatment system trains are OPERABLE whenever the purge system is in use, and

b. Whenever the purge system is in use during OPERATIONAL CONDITION 1 or 2 or 3, only one of the standby gas treatment system trains shall be used to prevent damage to both trains should a LOCA occur (LCO 3.6.5.3 ACTION a applies during this configuration).

Except after Containment is deinerted and purged while the reactor is in OPCON 4 or 5 QB for the one inch /two inch vent valves to the Reactor Enclosure Equipment Compartment Exhaust Filters when used for containment pressure control and nitrogen make-up operations.

t--_-_____

.p ; .

. -. ~- - - -- . -

- -_ ~

Q' ODCM Rsv. 14-Page :43 i

, Q 16/94 RADIOACTIVE EFFLUENTS .-

TOTAL DOSE l CONTROLS

~

e i3.'3.7 - The annual-(calendar year) dose'or dose commitment to'any.

< MEMBER OF THE PUBLIC,'due to releases of. radioactivity and' radiation' from uranium fuel cycle sources'shall be limited'to y less than or equal to 25 mrems to the totalibody or any organ, except the thyroid, which shall be limited to less thanLor-

- equal to 75 mrems..

APPLICABILITY: At all times.

ACTION:

a. With1the calculated doses from the release of radioactive materials in liquid orsgaseous effluents' exceeding twice!the limits of ODCM Controls I3.2.3.a,_:I3.2.3.b, I3.3.3.a, I3.3.3.b, I3.3.4.a or I3.3.4.b, calculations shall be made including. i direct radiation contributions from the reactor units and from outside storage tanks to determine whether the above limits of ODCM Control 3.3.7 have been exceeded. If such is.the case, prepare and submit to the Commission-within 30 days, pursuant;to- ,

Technical. Specification 6.9.2,La Special' Report that defines 1the corrective action to be taken to reduce. subsequent releases 1to j.

~

prevent recurrence of exceeding the above-limits'and. includes the schedule for achieving conformance with the above limits. "

This Special Report, as defined in:10 CFR 20.405c, shall include ,

an analysis that' estimates the. radiation exposure:(dose) to~a-MEMBER OF THE PUBLIC from the uranium fuel cycle sources, ,

-including all effluent pathways and direct radiation, for the "

calendar year that includes the release (s) covered.by.this report. It shall also describe levels of radiation and '

concentration of radioactive material-involved,--and the cause:of-

'the exposure, levels or concentrations. .If the estimated dose (s) exceeds the above limits, and if the release: condition resulting; in_ violation 40 CFR Part 190 has not'already been corrected, the:

Special Report shall include a request for a variance'in .

accordance with the provisions of 40 CFR Part 190. Submittal of L the report is considered a timely request, and a variance is '

granted until staff action on the request is complete.

' SURVEILLANCE REOUIREMENTS ,

3.3.7-1 Cumulative dose contributions from liquid and gaseous effluents shall be determined using ST-0-104-878-0, ST-0-104-879-0.

3.3.7-2 If the cumulative dose contributions exceed the limits defined in 3.3.7a,-Cumulat'ive dose contribution from direct radiation from unit operation shall be determined using ST-0-lO4-878-0, ST-0-104-879-0. .

p i

L o

r

- N +e- n u-.rs = m . . - , - . + _ = _ _ _ _ _ . _ _ _ _ _ . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ . _ . _ _ _ _ _ _ _ _ _ _ - -

~

Up ^ <1 3 3

1 ODCM Rav. 14 L[

+ Paga 44 ;

GW lp '

'.6/94 d j.' .l l

~

h l3.4 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM ~(REMP) J l

CONTROLS J' :3.<4.1 The monitoring program shall be conducted as specified inL ;"

. Table.I3.4-1.

APPLICABILITY: At-all times.. q ACTION: .

l

a. With the' radiological environmental monitoring ~ program-not beingl conducted.as~specified in Table I3.4-1; prepare and submit to the Commission, in the' Annual j; Radiological Environmental Operating Report.per'ODCM-Control 3.5, a description of the reasons for not conducting the program.as required-and the plans;for ;

preventing a recurrence.

b. With the level of radioactivity as the result of plant ,l effluents in an environmental sampling medium at a specified location-exceeding the reporting levels.of Table I3.4-2 when averaged over any calendar quarter; prepare and submit to the Commission within 30 days, pursuant to. Technical Specification 6.9.2,/a Special Report'that identifies the cause(s) for exceeding the-limit (s) and defines the-corrective actionseto be taken I to reduce radioactive effluents.so that the potential.

annual dose to a MEMBER OF THE PUBLIC is less=than-the calendar year. limits 'of ODCM Controls I3.2.3, LI3.3.3 :and ~

I3.3.4. When more than.onefof the radionuclides in Table I3.4-2 are detected in the sampling medium, this report shall be submitted if:

concentration (1) .

concentration (2) -+ ...t1.0 reporting level (1)' reporting level (2)

When radionuclides other than those?in Table I3.4-2 are detected and are the result of plant effluents, this-report shall be submitted if.the potential annual; dose to a MEMBER OF THE PUBLIC is equal to'or greater than the calendar year limits of ODCM Controls I3.2.3,EI3.3.3*

and I3.3.4. This report is not required if the measured level of radioactivity was not the result of plant effluents; however; in such an: event, the condition shall be reported and described ~in the Annual Radiological Environmental . Operating Report.

l-F t

J'" 'ODCM R3v. 14 Paga 45

[ 6/94 RADIOLOGICAL ENVIRONME 6 '(Continued)

c. With milk or fresh leafy vegetable _ samples unavailable from one or more of the sample locations required by-Table I3.4-1,' identify locations for obtaining

, replacement samples and. add them to-the radiological environmental monitoring program within 30 days. The

-specific locations from which samples were unavailable may then be deleted from'the monitoring program.

Pursuant to Technical Specification 6.14, submit as a

.partoof or concurrent with the Semiannual Radioactive Effluent Release Report, a complete, legible copy'of-the entire ODCM, including a revised figure (s) and table for the ODCM reflecting the new location (s).

SURVEILLANCE REQUIREMENTS' 3.4.1-1 The radiological environmental monitoring samples shall be collected (using ST-0-104-800-0) . ' pursuant to Table I3.4-1 from the specific locations given:in the table and figure (s).in the ODCM and shall be analyzed pursuant to the requirements of Table I3,4-1, the.

detection capabilities required by;the Table I3.4-3.

l 1

1 l

l l

TQ9 l 'ODCM R v.'14 Page'46 6/94 1

- 3 TABLE 13.4-1~

d i

l RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE

! EXPOSURE PATHWAY SAMPLES AND- SAMPLING AND- ' TYPE AND FREQUENCY.

l AND/OR SAMPLE SAMPLE IDCATION(*) COLLECTION'FREQ. OF ANALYSIS I

1. DIRECT RADIATIONS) 40 routine' monitoring stations At least Quarterly ' Gamma dose at least: J ;

either with two or more dosi- quarterly.-

meters or'with one instrument for.

measuring and recording dose 4

rate continuously placed as follows:

(1) An inner ring of stations, one in each meteorological. . ..

sector, in the general area of *t l'

the SITE BOUNDARY: .(2) An outer ring of stations, one.in each-

meteorological sector,: in.the

3-9 mile range-from the site; (3) The balance of the' stations

~

placed in special. interest areas such as. population centers, nearby: residences,- schools and in 1 or 2 areas to serve as control

. stations.

4 1

$- .___._L-_-_-___---__--.

= - - , _ - . . , _ -L

8

ODCM Rsv. -'14 ;.

, Page 47-6/94 TABLE T3.4-1 (Continued)

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY.

AND/OR SAMPLE SAMPLE IDCATION(*) COLLECTION FREQ. OF ANALYSIS

2. AIRBORNE Radioiodine'and Samples from 5 locations: Continuous, sampler Radioiodine canisters:

Particulates a.3 samples from close to the operation with sample I-131 analysis 3 SITE BOUNDARY locations (in collection weekly, or ' weekly.

different sectors) of the more frequently if highest calculated annual required by dust Particulate Sampler:

average ground level x/Q. loading *. Groes beta radio activity analysis-b.1 sample from the vicinity following filter community having one of-the highest calculated annual change:d ground level x/Q. Gamma. isotopic 1 sample from a control loca- analysis' of ~

tion, as for example 15-30 km composite (by distant'and in the least pre-valent wind direction.

location) at least' quarterly

~_

- - - " - - - - - P r

s _ -

, ~: 4 y : ,

s

' - ODCM Rav. Page-48 ,

s I 6/94 -

TABLE 13.4-1 (Continued)~

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM -

NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND- . TYPE.AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (*) ~ COLLECTION FREQ. OF' ANALYSIS ,

3. WATERBORNE

a. Surface f 1 sample upstream Composite' sample Gamma isotopic analysis'

~

1 sample downstream- over;1-month monthly. Composite'for period'. tritium analysis quarterly.

b. Ground Samples from'1 or 2 sources Quarterly.

only if likely.to be affected h

c. Drinking 1 sample of each.on 1 to 3.of Monthly. 'I-131 analysis on'each of the nearest water supplies (Composite) composite when'the dose that~could.be affected by its . calculated for the' con-discharge. _sumption of.the.watersis:

. greater than 1;arem per- ,

1-sample from'a control . year.1 Composite'for gross-location - beta. and gamma ; isotopic -

analysis monthly.- Comp-

'osite'for-tritium analysis-quarterly.

'd. Sediment from ; 1" sample:from downstream area Semiannually. ~

' Gamma isotopic analysis

shoreline with existing-or potential- 2emiannually..

a w c -- - # .-- ,,,-,-p,, , , 4 y ,.

.,.-ve,-w -- .-y v--ww..en-- e v , ,-w e- ~ -re,- mm we v,.c-r,t_-__-_a__.. - - - --u.-, 1-.- _ . . - - .

t

! ODCM Rav. 14 -

, Page 49 6/94 TABLE I3.4-1 (Continued)

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE EXPOSURE PATHWAY. SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (*) COLLECTION FREQ. OF ANALYSIS

4. INGESTION

a. Milk Samples from milking animals Semimonthly when Gamma isotopic' and;I-131 in-3 locations within 5 km animals are cni analysis semimonthly when distance having the highest pasture, monthly animals are on pasture dose potential.' If there are' at other times. (April 1 - Oct. 1):

none, then 1 sample from monthly at other. times.

milking animals in each of 3 areas between 5 to 8 km distance where dose are cal-culated to be greater than 1 mrem per year.'

1 sample from milking animals at a= control location (15 .

30 km distance) and in the

' least wind direction.

b. Fish and 1 sample of two recreationally Sample in season, Gamma isotopic *'

Invertebrates important species in vicinity _ or. semiannually analysis on edible of plant discharge area. 1 if they are not portions.

sample of same species in area . seasonal.

not influenced by~ plant discharge.

y '

s. ----p. .e-

- 's

}.

J. j a

!. ODCM.R;v. 14 Page 50 l 6/94 ,

TABLE I3.4-1 (Continued)

RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF' REPRESENTATIVE EXPOSURE PATHWAY SAMPLES AND SAMPLING AND TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATION (*) COLLECTION FREQ. OF ANALYSIS

4. INGESTION-(Continued)

c. Food Products Samples of 3 different kinds of Monthly when avail- Gamma -isotopic' and broad leaf vegetation grown able, if milk sampling I-131 analysis, nearest each of 2 different is not preformed.

offsite locations of highest predicted annual average ground level D/Q-if milk sampling is not preformed.

1 sample of each of_the similar Monthly when avail- Gamma isotopic

and broad leaf vegetation grown able, if milk sampling I-131 analysis.

15-30 km distance in the least- is not performed.

prevalent wind direction if milk ,

sampling is not performed.'

.__ - . _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ - ~ , ._ - _ ~~

f

' ODCM Rev. 14 Pago 51 l 6/94

' RADIOLOGICAL ENVIRONMENTAL MONITORING TABLE 13.4-1 (Continued)

TABLE NOTATIONS

a. Specific parameters of distance and direction sector form the centerline of the two reactors and additional description where pertinent, shall be provided for each and every sample location in Table I3.4-1 in a table and figure (s) in the ODCM. Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next sampling period. All deviations from the sampling schedule shall be documented in the Annual Radiological Environmental Operating

Report pursuant to ODCM Control 3.5. It is recognized that, at l times, it may not be possible or practicable to continue to l obtain samples of the media of choice at the most desired location or time. In these instances suitable alternative media and locations may be chosen for the particular pathway in question and appropriate substitutions made within 30 days in the radiological environmental monitoring program. pursuant to l Technical Specification 6.14, submit as a part of or concurrent

! with the next Semiannual Radioactive Effluent Release Report a l complete legible copy of the ODCM including a revised figure (s) l end table for the ODCM reflecting the new location (s).

b. One or more instruments, such as a pressurized ion chamber, for measuring and recoding dose rate continuously may be used in place of, or in addition to, integrating dosimeters. For the purpose of this table, a thermoluminescent dosimeter (TLD) is considered to be one phosphor; two or more phosphors in a packet are considered as two or more dosimeters. Film badges shall not l be used as dosimeters for measuring direct radiation.

c. Methodology for recovery of radiciodine shall be described in the ODCM.

d. Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or more after sampling to allow for radon and thoron daughter decay. If gross beta activity is air particulate samples is greater that 10 times the yearly mean of control samples, gamma isotopic analysis shall be performed on the individual samples.

c. Gamma isotopic analysis means the identification and l quantification of gamma-emitting radionuclides that may be l attributable to the effluents from the facility.

l l

l

M l ODCM Rev. 14 Page 52 l 6/94

f. The " upstream sample" shall be taken at a distance beyond

,significant' influence of the discharge. The " downstream sample" ,

shall be taken in an area beyond but near the mixing zone.

1

g. A composite sample is one in which the quantity (aliquot) of liquid sampled is proportional to the quantity of flowing liquid ,

I and in which the method of' sampling employed results in a specimen that is representative of the liquid flow. In this program composite sample aliquots shall be collected at time intervals that are very short (e.g., hourly) relative to the compositing period (e.g., monthly) in order to assure obtaining a .

representative sample.

h. Groundwater samples shall be taken when this source is tapped for i drinking or irrigation purposes in areas where the hydraulic i gradient or recharge properties are suitable for contamination. .l

1. The dose shall be calculated for the maximum organ and age group, using ST-0-104-878-0.

4 4

4 m r- - i , - , ,y_

" ~'

n r, 9:= ,

8 >

" ':g W; .

ODCM Rsv. 14-

j? ' "

Pagni53

^

, %;[ 6/94.

~

.i i;+- - TABLE 13.4-2' ;

EREPORTING LEVELS'FOR' RADIOACTIVITY CONCENTRATIONS IN' ENVIRONMENTAL' SAMPLES ]

'Reportina Levels ,

i

. WATER P LA E or FISH, ' MILK P DUCTS

ANALYSIS (pCi/L)- GASES (pCi/m3). .(pCi/kg, wet) (pCi/L) -(pCi/kg', wet) l H-3' 20,000* ,

Mn 1,000- 30,000

b 'Fa 400 10,000 l Co-58 1,000 30,000 .,

l--

l' 300 10,000 Co-60 .,

>Zn-65 300 20,000 Zr-Nb-95 400**

l I-131- 2. 0.9 3 100 ;

Cc-134 30 10 1,000 60 1,000 Cs-137 50 20' 2,000 70 2,000 i

Ba-La-140 200** 300- .}

l t l

~For drinking water samples. This is 40 CFR Part 141 value. .If no

' drinking pathway exists, a value of 30,000 pci/L may be used. !

l l ** Total for parent and daughter.

l-t L

g.4,-4. 4-4,4,, -

e

P:

1

- lJ ODCM Rev. 14 Pago'54 ll 6/94 TABLE 13.4-3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS (*) ,

1 Lower limit of Detection ( T.T.n) (b)(c)

AIRBORNE FOOD l WATER PARTICULATE or FISH MILK PRODUCTS SEDIMENTS.. !

3

' ANALYSIS (pCi/L) GASES (pCi/m ) (pCi/kg, (pCi/L)

(pCi/kg,- (pCi/kg, l wet) wet)- dry) .

Gro23 Beta 4 0.01' I

-H-3 2,000 Mn-54 15 130

-Fa-59 30 260 !

Co-58,60- 15 130 Zn-65 30 260 )

-Zr-95 30 :

1 Nb-95. 15 4 I-131 1(d) 0.07 1 60

- Cs-134 15 0.05 130 15 60 150 CD-137 18 0.06 150 18 80 180 Ba-140 60 60 La-140 15 15 1

3

, , , , - - - .. ,. - .. -. -. - ~, .- ~. , - .

,- j

.[. ,

ODCM Rav; 14. ;

. -Page.55: -

' l[

6/94 9g TAELE I3.4-3-(Continued)'

TABLE NOTATIONS (c)' .This list-dose not mean that only these nuclides areLto considered. Other peaks that are identifiable at 95%' confidence level,=together.with those~of the-above nuclides, shall also: be analyzed and reported in the Annual Radiological Environmental 4' ,

' Operating report pursuant to.ODCM Control 3.5. '

.(b) . Required detection capabilities for thermoluminescent dosimeters '

used for environmental measurements are given-in Regulatory.

Guide 4.13.

(c) --The LLD is defined, for purposes of these controls, as'the.

smallest' concentration of radioactive material in a sample that- >

will yield a net' count (above system background) that will be '

detected with 95%. probability with only 5% probability of 7 falsely concluding that a blank observation represents a "real" :

signal. +

For a particular measurement system (which-may include ,

L ' radiochemical separation): i 1.

p 4.66s,

j. LLD-s E

V

2.22

Y

exp (-AAt) .

Where:

LLD is the a oriori lower limit of detection as defined'above (as picocuries per unit mass or volume),

s, is the standard deviation of the background counting rate or of the counting rate of blank sample as appropriate (as counts per minute), !

E is the counting efficiency (as counts perfdisintegration),_

f-L V is the sample size (in units of mass cn: volume),

l 2.22 is the number of disintegrations per minute'per picocurie, Y is the fractional radiochemical yield (when applicable),

A is the radioactive decay constant for the particular radionuclide, and At.for the environmental samples is the elapsed' time'between i sample collection (or end of the sample collection period) and '

time of counting.

Typical values of E, V, Y, and At should be used in calculation.

b L i

l ODCM Rov. 14 Page 56 l' 6/94-TABLE I3.4-3 (Continued)

TABLE NOTATIONS It should be recognized that the LLD is defined as an a oriori (before the fact) limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions. Occasionally background fluctuations, unavoidably small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable. In such cases, the contributing factors shall be identified and described in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.

(d) LLD_for drinking water samples.

I l

j. ODCM Rev. 14

! Page 57 l l 6/94 I

RADIOLOGICAL ENVIRONMENTAL MONITORING LAND USE CENSUS CONTROL.

3.4.2 A land use census shall be conducted and shall identify within a I

distance of 8 km (5 miles) the location (in each of the 16 meteorological sectors) of the nearest garden

of greater than 50 m' (500 ft2) producing broad leaf or vegetables.

APPLICABILITY: At all times.

ACTION:

a. With a land use census identifying a location (s) which yields a calculation dose or dose commitment greater than the values currently being calculated in ODCM Control 3.3.4.1, identify the new location (s) in the next Semiannual Radioactive Effluent Release Report, pursuant to ODCM Control 3.6.

b. With a land use census identifying a location (s) that yields a calculated dose or dose commitment (via the same exposure pathway) i 20% greater than at a location from which samples are currently I

being obtained in accordance with ODCM Control 3.4.1, add.the new location (s) to the radiological environmental monitoring program within 30 days. The sampling location (s), excluding the control station location, having the lowest calculated dose or dose l commitment (s) (via the same exposure pathway) may be deleted from E

this monitoring program after October 31 of the year in which this land use census was conducted. Pursuant to l Technical Specification 6.14, submit as a part of or concurrent within the next Semiannual Radioactive Effluent Release Report a complete, legible copy of the entire ODCM including a revised figure (s) and table (s) for the ODCM reflecting the new location (s).

SURVEILLANCE REOUIREMENTS 3.4.2-1 The land use census shall be conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use census are documented in ST-0-107-991-0 and are included in the Annual Radiological Environmental Operating Report

pursuant to ODCM Control 3.5.

Broad leaf vegetation sampling of at least 3 different kinds of vegetation may be performed at the SITE BOUNDARY in each of 2 different direction sectors with the highest predicted D/Qs in lieu of the garden census. ODCM Controls for broad leaf vegetation sampling in Table I3.4-1 item 4.c. shall be followed, including analysis of control samples.

i l ODCM Rsv. 14- U Page 58 L l _- 6/94 ERA'DIOIDGICAL ENVIRONMENTAL MONITORING

'INTERLABORATORY COMPARISON PROGRAM CONTROL 3.4.3 JIn accordance with LGS Technical Specification 3.12.3, analyses shall be performed on radioactive materials supplied as part of an Interlaboratory Comparison Program which has been approved by the Commission.

APPLICABILITY: At all. times.

ACTION:

With analyses not being performed as required above, report the corrective actions taken to prevent a recurrence to the Commission in the Annual Radiological Environmental Operating Report pursuant to ODCM Control 3.5.

SURVEILLANCE REOUIREMENTS 3.4.3-1 The Interlaboratory Comparison Program shall be-documented in ST-0-104-990-0 and described in the ODCM" part II, section 4.2. A summary of the.results shall-be included in the Annual Radiological Environmental Operating Report pursuant to:ODCM Control 3.5.

l l

l: ODCM Rnv. 14 Page 59 l 6/94 l i

ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT

l 3.5 Routine Annual Radiological Environmental Operating Report covering the operation of Unit 1 and Unit 2 during the previous calendar year shall be submitted prior to May 1 for each year. The initial report was submitted prior to May 1 of the year following initial ,

criticality (1984). A single report is submitted for a multiple unit station. The Annual Radiological Environmental Operating l Report shall include summaries, interpretations, and an analysis of i trends of the results report period, including a comparison (as l appropriate), with preoperational studies, operational controls and previous environmental surveillance reports and an assessment of the observed impacts of the plant operation on the environment. The reports shall also include the results of land use census required by ODCM Control 3.4.2. The Annual Radiological Environmental Operating Report shall include the results of all radiological environmental samples and of all environmental radiation measurements taken during the report period pursuant to the locations specified in the tables and figures in the OFFSITE DOSE CALCULATION MANUAL, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Branch Technical Position, Revision 1, November 1979.

In the event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results. The missing data shall be submitted as soon as possible in a supplementary report.

The report shall also include the following: a summary description of the radiological environmental monitoring program and at least two legible maps. One map shall cover stations near the SITE BOUNDARY; a second shall include the more detailed distant stations.

Covering all sampling locations keyed to a table giving distances and directions from the centerline of the reactor plant; the results of licensee participation in the Interlaboratory Comparison Program, required by ODCM Control I3.4.3 discussion of all deviations from the Sampling Schedule of Table I3.4-1; and discussion of all analyses in which the LLD required by Table I3.4-3 was not achievable, l

l 1

l l

i

j ODCM Rev.1 14 Page 60 I 6/94 4

ADMINISTRATIVE CONTROLS f3.6 SEMIANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT

, A Routine Semiannual Radioactive Effluent Release Reports covering the operation of Unit 1 and Unit,2 during the previous 6 months-of operation shall be submitted within 60 days after

-January 1 and July'l of each year.. The period of the first report shall begin with the date of initial criticality. ST "'

107-992-0 shall be used to generate the report. A single unit submittal is made for the 2 unit station. The submittal combines those sections that are common to all units at the station. The-Semiannual Radioactive Effluent Release Report shall include.a. -

summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the facility as outlined .

in Regulatory Guide 1.21, " Measuring, Evaluation, and Reporting

+

Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from-Light-Water-Cooled Nuclear Power Plants," Revision 1, June 1974, with data '

summarized on a quarterly basis following the format of Appendix B thereof.

The Semiannual Radioactive Effluents Release Report to be i- submitted 60 days after January 1 of each year shall include an annual summary of hourly meteorological data collected over the previous year. This annual summary may be either in the form of 4 an hour-by-hour listing on magnetic tape of wind speed, wind direction and atmospheric stability, and precipitation (if ;

measured), or in the form of joint frequency distributions. of -

, wind speed, wind direction,. atmospheric stability. In lieu of L submission with the~first half year Semiannual Radioactive

! Effluent Release Report, the licensee has the option of retaining j this summary of required meteorological data on site in a file

! that shall be provided to the.NRC upon request. This same report shall include an assessment of-the radiation' doses due.to the radioactive liquid and gaseous effluents released from both units l

during the previous calendar year. This same report shall:also ,

include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBER OF THE PUBLIC due to their activities inside the SITE BOUNDARY (Figures I2.2-la and I2.2-lb) l during the report period. All assumptions used in making these assessments shall be included in these reports. The assessment of radiation doses shall be performed in accordance with the methodology and parameters of the OFFSITE DOSE CALCULATION MANUAL (ODCM).

l ODCM Rev. 14 Page 61 l; 6/94 The Semiannual Radioactive Effluent Release Report to be submitted 60 days after January 1 of each year shall also include an 1 assessment of radiation doses to the hypothetically highest exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources (including doses from primary effluent pathways and direct radiation) for the previous calendar year to show conformance with 40 CFR Part 160, Environmental Radiation Protection Standards for Nuclear Power Operation. Dose contribution from liquid and gaseous effluents is calculated based on Regulatory Guide 1.109, Rev 1, October 1977.

The Semiannual Radioactive Effluent Release Reports includes the following information for each type of solid waste (as defined in 10 CFR Part 61) shipped offsite during the report period:

a. Container volume, '

b. Total curie quantity (specify whether determined by measurement or estimate),

c. Principle radionuclides (specify whether determined by measurement or estimate),

d. Source of waste and processing employed (e.g., dewatered spent resin, compacted dry waste, evaporated bottoms),

e. Type of container (e.g., LSA, Type A, Type B, Highway Route controlled), and

f. SOLIDIFICATION agent or absorbent (e.g., cement; urea formaldehyde).

The Semiannual Radioactive Effluent Release Report includes a list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive material in gaseous and liquid effluents made during the reporting period.

The Semiannual Radioactive Effluent Release Reports includes any changes made during the reporting period to procedure RW-C-100 (formerly the PROCESS CONTROL PROGRAM) and to the ODCM, as well as a listing of new locations for dose calculations and/or environmental monitoring identified by the land use census pursuant to ODCM Control 3.4.2.

The Semiannual Radioactive Effluent Release Reports includes an explanation as to why the inoperability of liquid or gaseous effluent monitoring instrumentation was not corrected within the time specified in ODCM Controls 3.2.1 or 3.3.1, respectively; and description of the events leading to liquid holdup tanks or gas storage tanks exceeding the Control limits.

, , . ~-, . . - , . . . . . . , . -

W, , . > ,

4 0

~

ODCM'Ravu 14

~

50 - h' Paga 62 ";

,f "j

- .6/94 s

~ 1 1 j377? MAJOR CHANGES TO RADIOACTIVE WASTE TREATMENT SYSTEMS j fLicensee-initiated major changes-to the radioactive waste systems: d (liquid,' gaseous,.and. solid): .l '

r

~

la. Shall be reported to the Commission in the Semiannual-

^

Radioactive Effluent Release' Report for.the~periodfin- .

which the change was made; effective. -The discussioniof U each change shall contain '

1

1. A summary of the evaluation.-that led to the determination-that the; change could be madeLin accordance with 10 CFR'50.59;

2. Sufficient detailed information to totally support .;

the reason for the change without benefit of 1 additional or supplemental information;-

]

3. A detailed description of the equipment, ;

components, and processes involved and the ;

interface with other plant systems; ]

, 4. An evaluation of the change which showsithe. ,

predicted releases of radioactive materials in' liquid and gaseous effluents =and/or quantity of solid waste that differ from-those previously-predicted'in the license application and' q j, amendments thereto;. 1

5. An evaluation of.the change which shows the expected maximum exposures to individual ~in the' UNRESTRICTED AREA and to.the general population ;

that differ-from those'previously' estimated in the 1 license applicationLand, amendments thereto;

.6. e A comparison'of the predicted r'leasesiof radioactive materials,cin liquid and gaseous .i effluents and.in solid waste, to the actual. l

! releases for the period prior to when.the changes i i-are to be made i

7. An estimate of the exposure to plant operating !

personnel as a result of the change; and U 8. Documentation of the fact that the change was; :

reviewed'and found acceptable by the PORC.

b. Shall be reviewed and accepted by the PORC prior to .

~l implementation.

c. Shall be documented by ST-0-RRR-990-0.

i I

j

g ,.

PART II CALCULATION METHODOLOGIES t ,

f l-l l

l l'

l

(

f l

I l

l l

l

+Wjm T f ^ ' '

) $ k_ , 'ODCM'Rhv. 14-l)f s4 l [ ,,

y

< .Paga 63

$ :6/94 :

/M ,

^

"1.0L LIQUID EFFLUENTS <

1. 11 RADIATION MONITORING INSTRUMENTATION AND CONTROLS-oTheEliquid'effluentfmonitoring instrumentationiandi controls at Limerick for'controllingfand; monitoring normal;

-radioactive: material' releases in accordance'with the:

E, Limerick Technical Specifications: are summarizedL as:

follows:

1). Lieuld Radwaste System:- The liquidLradwaste discharge

-monitor-(RISH63-OK604) provides an? alarm andLautomatic.

termination of radioactive 4 material releases'fromJthe liquid'radwaste system as require'd by. Technical-

' Specification 6.8.4.d.1. cAdditional'designffeatures.

of the111guid radwastaJsystem;which prevent: .

inadvertent releases to the environment: include 1)

< redundant discharge valves, 2) single discharge-line-with loop seal and siphon' breaker to eliminate probability of inadvertent discharges, 3)i Low Cooling Tower Blowdown flow interlock which isolates'the radwasteLdischarge line.

.2) Service Water System: The Service Water / dis ~ charge.

monitorJ(RISH10-1K605 AND RISH10-2K605)iprovides an .

alarm upon indication offactivity in'thefservice water, system as required by Technical Specification:

6.8.4.d.l. .While the service water system.is not3a; normal release pathway, the' monitor providessan indication'of potential problems due to excessive' leakage of.the heat..exchangers. In-addition, the.

service waterLside of.the fuel pool heat exchangerslis kept at.a higher pressure than.the-shell sidetto, prevent potential radioactive contamination of-the.

service water.

3) RHR Service Water System: .The RHR Service' Water Radiation ~(RHRSW) Monitors (RISH12-0K619A,.RISH12-OK619B, RISH12-1K619C, RISH12-1K619D,cRISH12-2K619C AND RISH12-2K619D)' provide alarm and' automatic '

termination'of radioactive material' release from thel RHRSW system, as required by Technical Specification-

~

6.8.4.d.1. While the RHRSW-system is not a normal release pathway, the monitors provide indication'of potential problems due to excessive leakage of the heat exchangers.

t "1 e w t+u-- m - . -_ _ <

~

pg, '

a e _ ,_

.q sr ;[i

'ODCM'Rnv.-14

-Pagel64 ac[h4 .6/94- t g

3 1.2 LIOUID EFFLUENT MONITOR SETPOINT DETERMINATION .

'Per;the requirements of Technical Specification 6.8.'4.d.1,-

, - alarm setpoints shall: be established fors the" liquid

, ? effluent monitoring instrumentation to ensure that.the.

release concentration. limits of Specification'6.8.4.d.2 and 6.'8.4.d.3 are met (i.e., the concentration ~of' N -<

~

radioactive material released'in liquid effluents 1to -

UNRESTRICTED AREAS shall be limited'to'the concentrations ~ -

specified.in 10 CFR;20, Appendix B,TTable II,: Column 2n for' radionuclides'and'2.0E-04 #Ci/ml for' dissolved orD l entrained' noble gases).

1.2.1 'Radwaste Discharae Monitor and Discharae-Flow Rate i ,

- RISH63-OKf21

~The setpoint for the' liquid)radwaste discharge. !

monitor and flow J rate element are determined.by '

- the following equations. ..The'radwaste: discharge

!- monitor high-high alarm / isolation setroint;is;

, calculated at least monthly. based on isc' eras-I detected in the liquid radwaste sample tankst released during the previousimonth:or on any; g specific sample tank being released. (ICQ,,);Lthe' l E Required minimum cooling tower blowdown flowiat l time of discharge! (CTBD) , and average liquid ~ ;

radwaste discharge' flow (RR).: The flow-rate-determination is calculated for:each release-and- 1 the MPC fraction' calculated includes,~in_the. ]

concentration mix,.the,most recent'results from j

1) the quarterly composite.for SR-89, SR-90iand Fe-55,.and 7 2) the monthly composite'for?H-3, and

3) the -sample (s) .for dissolved and' entrained noble :

gases, q If the calculated ~setpoint is.less1than~the' l' existing setpoint, the setpoint'will'be reduced to' R j the next value.- If~the calculated-setpoint is- j L greater-than the-existing setpoint, the setpoint' '

l- may remain at the lower value or increased:to the l calculated value, j l

If there were no sample tanks released or no . .l' activity detected during'the' previous' month, then-the calculation is performed usingLrelease data from-the.most recent month during which isotopes ;

were detected. In addition,Eif there were_no- 1 sample tanks released during the' previous month,

~

chemistry, supervision may-~ substitute more restrictive values (e.g., tritium)' based'on the q plant sampling data. L I

L i

l o l

m er y e ,

.1

< ldi >*i .[ ,

~

-ODCM'Rav.L14L l

.Pagn-651 1

[ f %, _

6/94' m "

- f s.

7

1. 2 .- 1-1 ' Setnoint Determination' -- RISH63-OK604

. , - The.setpoint for~the liquid xadwaste.

' discharge, monitor,is determined'by the:

' following' equation:'

CPNgmjh * '

(S) (RR). [E (Cj ue;) /MPCjue )] (ECj M) (RR+CTBD)

(RR+CTBD) (S) (E) (RR) .[EC j ,/NPC3 , ] ("I '

--g +

j where: :

CPM gt ,3 = Calculated liquid radwaste discharge ,

monitor (RISH63-OK604).countJrate attributable to the gamma emitting-radionuclide, cpm E C , ,, = the sum of the concentration of the ;

- identified gamma emitting nuclides-(#Ci/ml), ,

'1 CTBD =

the required minimum cooling tower- ?)

blowdown rate at time of discharge. 7 (9Pm),

RR = average liquid radwaste discharge flow- Lj (9Pm), j i

BKG gte) =.-background count rate of' liquid radwasteL discharge monitor (CPM), .

1 E = the gross detection efficiency of'the liquid radwaste discharge monitor ;

(#Ci/ml/ cpm), Land

~

j S = 5; margin of safety factor to. assure _ a that the release is terminated prior.to 1 10 CFR 20 limits being. exceeded.

Included-in this factor are. errors associated with monitor uncertainty, i sampling uncertainty, flow rate uncertainty, and the cont'ribution of other release paths (Service Water and RHRSW) which are not normally contaminated. ,

Z ( C,,gMPC,,,,,,) = W eMedu gama E ra& M We mixture of radionuclides in the liquid radwaste discharge line (unitless).

t

i

,e - ,. .v-,- -

- -e -,A- one.-.-- ~ - +-a- - + . - - - - - - - --

p w .

2 '

ODCM Rev. -..-'14 j .

s Pagn 66.

,I je': l 3 -

4 6/94 N- t ,

Q[ .

where:: i 4

. C j ,,,, = - the concentration of each-identified gamma = emitting radionuclide.i in the-u#(V< .,

liquid effluent (undiluted) (4Ci/ml)- !

I

-MPC s ,,,g

= the MPC value corresponding;to radionuclide l'from 10 CFR 20iAppendix B, Table II, Column 2 ~ (dissolved and

~

entrained noble gases MPC = 2.0E' l

'yCi/ml) (#Ci/ml). .

E(Cliwa/MPC ' beta) I

= the effective nongamma MPC ratio for the. ;

mixture of. radionuclides in the liquid i radwaste discharge lineJ(unitless)

,h where:

C igu = the concentration'of each identified ,

nongamma radionuclide i inLthe liquid-effluent (undiluted) (gCi/ml)

MPC ign = The MPC value corresponding to.. 3 radionuclide i form 10 CFR 20, Appendix >

B, Table II, Column 2 (dissolved and ,

entrained noble gases MPC =: 2E pci/ml) '

(gCi/ml). >

,

NOTE: The concentration mix must include the most recent sample !

data for H-3, Sr-89, Sr-90, Fe-55 and gross alpha.

S 1.2.1-2 Flow Rate Determination -i

NOTE: If the effective MPC ratio'for the mixture ;

of radionuclides [I(C /MPC Y)]: is $1.0, THEN.a flow rate'setpoint determination is not required, Adp y there is no limit on discharge flow rate.

IE a' flow rate determination is required, ,

THEN the setpoint'for the liquid radwaste. flow rate is determined for each release by.the following equation: '

i FLOW " s (SF) [E (Cj/MPCj) -1] (1-2) j

where: ,

FLOW g ,g

= flow limit for radwaste discharge j line (gpm).

a

,CTBD = required minimum cooling tower blowdown flow for time of release (gpm).

SF = 5; margin of safety factor to assure that the -

release does not exceed 10 CFR 20 limits.

e.

- - , , ~ = ., ,,.,.s

e ..m m _

l u Lsre a> ~

[. 'M,N N '

,.ODCMLR$v'. T47 14

. . . , ,1; " ' :Paga 67)>

ll" 6/,945 m

... S

' " W W

the3effactive.MPC ratio for-the7 mixture:of-1

=

' . E (Cg /MPCg ) .

radionuclides inLthe;11guid radwaste discharge -

y line (unitless).

, , 4 d where:.

Cp ' =' .the concentration:of ea'chlidentified radionuclide

~

S j

'i in the ' liquid effluent < (undiluted) ' (#Ci/ml)'* > <

H; m

?MPC, .= the MPC value correspondingito radionuclidefi fdomi j P 10 CFR 20 Appendix!B,LTable'II, Column 12,. ' '

(dissolved and entrained 1 noble: gases MPC.=4 2E 4

C1/ml)(#Ci/ml).' j

~1 6

NOTE: The : concentration mix must include' the most recent sample data; for-H-3, Sr-89,,Sr-90, Fe-55 and; dissolved and entrained l noble

'j '

gases..

1.2.2 ' Service Water Radiation Monitor - RISH10-1K605. -

2K60E The Service Water Radiation Monitor'high-high 9

setpoint-is determined by the following equation.L The monitor-high-high alarm setpointLis calculated / ,

If j

' monthly based on the. background count rate.

the-calculated setpointEis'less than-the existing v -

monitor setpoint,-the:setpoint will be reduced.to y

. the new' value. -If L the' calculated - setpoint :is ' '

1

greater:than:.the existing setpointk the setpoint? l may remainLat-the: existing setpoint.or= increased: 1 to the new value. . .To' assure that a high-background count' rate ~does'not' prevent adequatet i monitor sensitivity.to meet-the requirements"of.

Technical'SpecificationsT6.8.4.d.2:.and 6.7.4.d.3,; ;

a maximum-background: count. rate'of 300 CPM shall be'

used for the alarm setpoint determination'

.i 1.2.2-1 Satpoint: Determination? .

i The setpointjfors.the Service: Water d "

Radiation MonitorLis1 determined.by the' following-equation::

CPN,, s Z,,(CRB,,) (1-3) ;

where:

CPM"-

= Calculated Service Water Radiation Monitor (RISH12-1K605, -2K605) count rate, CPM.

1 M

- - - i

, _ _ ~ ~ . _ . _ - _ - - - _ _ _ _ - _ __.. _ __

{ '

49 , 1

-ODCE R:P.v l'4

[g i;[lN I

+'

JPag3 68 g [ ,

'6/94

b. ;u

= [3,.multiplierfto;'establisN-

!' ,' 2Z ,

E monitor setpoint countfrate-n ,

, .above background'countTrate; b

n :(unitiess) 7:,

j' .CRB ,=.' Service-Water monitor(RISH12-~

i di 1K605, -2K605) Lcount? rate- .

b attributable to: background '

D' radiation,~; CPM-l 1.2.3 RHR Service Water Monitor -RISH12-0K619A.--OK619B.

-1K619C. -1K619D. -2K619C. -2K619D- .

D The RHR Service Water! Radiation Monitor:high-high L setpoint is determined by#the following. equation.y The monitor high-high alarm / isolation:setpoint is' calculated: monthly based lon theLbackground count-rate.- If-the calculated.setpoint-is less.than the.

existing monitor.setpoint,:the setpoint will be reduced to the new value. If the calculated setpoint is: greater than the existing setpoint,.

i the setpoint may remainLat the existing setpoint-or increased.to the new value. To' assure,that'a high' background count ratecdoes not' prevent; adequate monitor sensitivity to meet.the' requirements of Technical Specifications 16;.8.'4.d.2.

and 6.7.4.d.3,.~a maximum background: count; rate of 300 CPM shall be used for the. alarm setpoint; .

determination.

1.2.3-1 Setpoint Determination ..

The setpointifor the.RHR Service Water Radiation Monitorgisfdetermined:by the. '

following equation:'

CPMmegy 5 Znasu(CRBmasui'. (1 ~4 )-

where:

CPM,,, = Calculated RHR Service Waterl Radiation Monitor-(RISH12-l-

OK619A, -0K619B, -1K619C, -

1K619D, -2K619C, -2K619D) .

l L

count rate, CPM. ,

Z ,,, = 3, multiplier.to establish monitor setpoint'countirate-above background count rate (unitless).

i. '

' ~

hI %

~

, . , ; c..' "b

,jg .ODCM Rsv. 14-1- o Paga 69

l; 6/94' g, ,,

W ..

~'

CRBs , = RHR: Service-Water-Radiation Monitor,(RISH12-OK619A ,H-:

, OK619B, -1K619C,1-1K619D,L-

- 2K619C,w-2K619D) count'. rate ;

' attributable to. background:

- . radiation, CPM..

~1.3 Liould Effluent Dose Calculation - 10 CFR~50

1.3.1. Members of the Public Dose.

ODCM I3.2.3 limits-the'dosetor-dose--commitment to. a

~ MEMBERS OF THE PUBLIC from radioactive materials

~

in liquid effluents from Limerick' Generating Station to:=

- during any-' calendar quarter,. .

$ 3 mrem to total body.

$10 mram to any organ -

l t . .

- during any calendar year.

$ 6: mrem to total; body- y

$20 mrem to total organ.

Per ODCM I3.2.3.1 the cumulative dose contribution' from' liquid effluents for the current calendar-quarter year'shall be' determined at'least.once per 31 days in accordance with the-following-calculation methods. These' equations are'for the l three aquatic-environment exposure. pathways (potable water,. fish,: shoreline' exposure);in the Limerick aquatic environment. Only real; pathways are addressed for'ench: receptor. . The; receptors

'and associated pathways are711sted below.. . Doses.

from each real-pathway are summed to give dose at the receptor.'. The monthly resultsJare accumulated to give the. quarterly doses andsthe quarterly

'+ results are accumulated to'give-the annual doses.

Rsceptor .Dist. Pathways Location (mi) Potable Water Fish Shoreline

~ LGS Outfall E

0 .X X ,

Citizen's Utility 2.5 X X X

~Phoenixville Water 9.0 X X X Phil. Sub. Water 13.6 X X Crew Course 37.8 X 7

v

.. . . - ., r---- ,, , , +-- ,,

p,--

I., :.(,

'/ . ..-.?

l2 ODCM R3v.-14 P r.g c -7 0 -

jl 6/94-

, ... 8 1.3.1 Potable-Water Pathway R,py = 110 0 EOjD,jpj exp (-Al (12)) (l'-6 ) f 1.3.1-2 Fish (Aquatic Food) Pathway.

R,pj = 110 0 U'" E OjBjpD ,jpj exp (- Al (8') ) (1 6) 1.3.1-3 Shoreline Deposition Pathway U'# EOjTjD,jpj exp (-Aj e )p [1-exp (-Aj (1.7s2r+s)) ] (1 -7 )

R,pj = 110, 0 0 0 where:

B,p = equilibrium bioaccumulation factor for nuclide l'in pathway p, expressed as the ratio of the concentration in biota, in pCi/kg, to the radionuclide' concentration in water, in pCi/ liter..(liters /kg)

~!

l

~

i t -

i li ODCM Rsv. 147 m Page 71; u- >

} 6/ 9 4.'

BIOACCUMULATION FACTORS (pCi/kg/pCi/ liter):

' FRESHWATER SALTWATER ELEMENT- . FISH- FISH H 9. 0E 9.0E-1 C 4.6E 3 1.8E 3 '

Na 1.0E 2 6.7E-2 P 3.0E 3 2.9E'4 Cr 2.0E 2 4.0E 2 Mn- 4.0E 2 5.5E 2 Fe 1.0E 2 3.0E 3 Co 5.0E 1 1.0E 2 Ni ' 1.0E 2 1.0E 2-Cu 5.OE 1 6.7E'2 Zn 2.OE 3 2.0E 3 Br 4.2E 2 1.5E-2 -

Rb 2.0E 3 8.3E O Sr 3.0E 1 2.0E O Y 2.5E 1 2.5E 1 Zr 3.3E O 2.0E 2 Nb 3.0E 4 ~ 3.0E 4 Mo 1.0E 1 1.0E 1 Tc 1.5E 1 1.0E 1 Ru 1.0E 1 3.0E 0' 101 1.OE 1 1.0E 1 Te. 4.0E 2 1.'0E 1 I 1.5E 1 1.0E 1 Cs 2.0E 3 4.0E 1 Ba 4.0E O 1.0E 1 LA 2.5E 1 2.5E 1 Ce 1.0E O 1.0E 1 Pr 2.5E 1 2.5E 1 Nd -2.5E 1 2. 5E 1-W 1. 2 E .- 3 3.0E 1 Np 1.0E 1 1.0E 1 Rnf: 1) U.S.N.R.C Reg. Guide 1.109, Rev. 1, Table A-1

2) Letter LTR 881209L001, from R.J. Clark, U.S.N.R.C., to G.A. Hunger, Philadelphia Electric Co., December 9, 1988, transmitting evaluation of Limerick ODCM.

4 e

n . . _ _ __ __ ____ _ - _ . _ -_ _ -r__ __

- ~ ~ - -

y, , ,

~

s e 9-jv ;!.{ ,

a , ' ODCM Rtv . '1'4 :

l< : a, Par T +

ft

.y ; 6 ,

R ,

. D,,,; =: ldo'sel factor specific to'a given age group a,:.radionuclide i, pathway 1p; and organ j which:can-be_used to. calculate

~

radiation dose}(1) from an: intake ofia radionuclide, fin.

'mram/pci, :or1(2) from exposure'to a given concentration. '

of a radionuclidelin= sediment, in mrem /hr per pCi/m(.

. Values 1are: listed-bycage group:in' Table 1-1.

~ ~

F = waste dilution flow rate of liquid effluent ^ dilution flow / number of- batches (ft3 /sec)'.

M, = ' dilution factor _at. point.of exposure'or.at-point of ,

withdrawal of drinking. water-(dimensionless). Values'areE graphically listed by. receptor location in. Figures 1.3.'l :

1 to l.3.1-5. Value will be based-on average monthly' river-flow.

. r i

- Q, = total / release of nuclide 'i' for' time period (Ci).

. R,p; = total dose for calculation time period to' organ j of .

individuals of age group a from all nuclides i in pathway; .

b (mrem). ..,

T, = radioactive half-life of nuclide 1 (days) . ,

U, = usage factor specifying exposure time or intake rate for:.

l an: individual of age group a associated with pathway p; h (hr/yr, liters /yr, or.kg/yr).

-Pathway Infant Child Teen -Adult ~

P Fish _ . --

6.9* 168- 2 18 i

~ Potable Water

(1/yr) 330' 510' 510' .730' Shoreline .

Recreation

' (hr/yr) - --

14' 678 12'

. Shoreline L Rscreation l'

(hr/yr) --

90 b 600 b 600 b l Ref:

Regulatory Guide 1.109, Rev 1, Table E-5 b EROL Table 5.2.A-3 l-L w = shoreline width factor L

(dimensionless) = 0.2.

Ref: Regulatory Guide 1.109, Rev. j

1. ;

!- l L 1.752E+5 = time period during which sediment is exposed to contaminated water (hrs) (midpoint of plant j life = 20 yrs)

ff 4 x . :

'

i[:

~

ODCM-Rav. 14' Page.73.

'Ql 6/94 l

1 A, = . radioactive' decay constant of nuclide 'i' (hrd).

12 = delay time for potable water pathway-innhours to allow for

.nuclide decay during transport

-through the water purification plant and the water distribution system, Ref: . Regulatory Guide,

-1.109, Rev. 1, App. A.

24 = delay-time for. potable fish pathway in hours to allow for nuclide' decay during transport through the food chain, as well as-during food preparation.

Ref:- Regulatory' Guide 1.109,'Rev. i 1, App. A.

1100 = factor to convert from Ci/yr per ft3 /sec to pCi/ liter.

110,000 = factor to convert;from Ci/yr per ft3 /sec to pCi/ liter and.to account for proportionately constant (100) used in sediment radioactivity model.-

1 l

1 1

- - - _~

j' ODCM Rev. 14 Paga 74 l, 6/94

~1 .41 Liauid' Effluent Dose Proiections

ODCM.I3.2.4 requires that the' liquid radwaste treatment system shall be operable and appropriate portions of the systems used to reduce the radioactive materials in liquid waste prior to their discharge when the projected doses due to-the liquid effluent to UNRESTRICTED AREAS would exceed:

- 0.06 mrem /31. days to the total body or 0.2 mrem /31 days to any organ.

The applicable liquid radwaste treatment processing equipment for maintaining radioactive materials releases ALARA are ,

delineated in Figure 1.4-6.

Dose projections are made at least once per 31-days by the following equations:

D,g = (Dg /d)

31 days (1-8)

D ,p = (D ,,/d)

31 days (1-9) where:

D up = the total body dose projection for the current 31-day period (mrem).

De = the total body dose projection for the. current-calendar quarter as determined by equation 1-5, 1-6, and 1-7 (mrem).

D ,, = the maximum organ dose projection for the current 31-day period.(mrem).

D, = the maximum organ dose to date for the current calendar quarter as determined by equations 1-5, 1-6, and 1-7 (mrem).

d = the actual number of days in the current calendar quarter at the end of the release (days). The minimum time elapsed is seven (7) days.

31 days = the number of days of concern

y> -

- --- - -- - -- +- -

ll& ' "

a , ih ~

ODCM Rhv.L14J t <

Pcgu 75~ ,

jl 6/94 w '

y,

,22iOL GASEOUS EFFLUENTS i!; a .

,, 22.1' Radiation monitorino instrumentation and~ Controls ,

_ , The; gaseous: effluent; monitoring instrume'ntation and controls 7at?

+ . Limerick:for1 controlling monitoring radioactive material; _ '

'r

hq

- releases'in;accordance'with the.ODCM Part 1~_are summarized as t follows:

1) . L gorth " Vent (Common):"The plant-gaseous discharges via this

~ "1 vent,are monitored by two Particulate, Iodine and Gas.<(PIG)

, monitors (RY26-075A and RY26-075B) sin parallel and byf the -

Wide Range . Accident: Fonitor- (WRAM)J(RIX26-076)~. 'The PIGS have separate Particulate,' Iodine, and Gas samplingiand; monitoring 1 channels but the Station ODCM ControlsLrequire U only particulate and iodine. sampling'and noble' gas monitoring. iThe WRAM has~ extended-range (via three channels) noble gasEmonitoring and particulate and iodine sampling capability.- In addition,_the WRAM provides an isolation (Group A) of the large Drywell Purge and Vent c,

valves. ,;-

2) South Vent (one ner unit): The plant gaseous. discharges via

- each South Vent'are monitored by_two redundant PIG monitors ,

(RY26-285A,B). As is the case of.the North Vent, each, PIG' has. separate particulate, iodine, and gas' sampling'and.

monitoring channels-but the Station ODCM Part.I requires

, only particulate and iodine sampling with~ gas monitoring.- 1 x

3) Hot Maintenance Shon-(Common): Due-to the composition.of' the radioactive materials in the effluent steam-(i.e., very.

low potential for noble gas), this' release point is sampled.

for- particulate . and iodine (P&I) . monitors (RY26-025) , 'The P&I monitor has.a. separate particulate and_iodineLsamplingl and monitoring channels but Station ODCM Part I' requires-only particulate and iodine sampling.

~

2.2 GASEOUS EFFLUENT MONITOR SETPOINT DETERMINATION' ODCM I3.3.7.3 requires that an alarm setpoint.be established

- for'the noble gas effluent monitoring channels-(RY26-075A,B,;

RY26-185A,B,; RY26-285A,B,;-and RIX26-076) to ensure.that the release rate of radioactive materials does'not' exceed the :

limits of ODCM 13.3.2.a, which corresponds to a dose rate atl the SITE BOUNDARY of 500 mrem /yr to the total body or 3000 . 'i mrem /yr to the skin. This specification also states'that'the-dosa rates from I-131, I-133, Tritium,.and all radionuclides in ~

particulate form.with half-lives greater than eight days, shalll be limited to a maximum of 1500 mrem /yr to any organ g (inhalation pathway only).

ODCM Part I limits are expressed in terms of dose rate, while the instruments which monitor effluents produce data'in units 7 of concentration or release rate. It is therefore necessary to-identify the isotopes and calculate the corresponding release rate which will result in the dose rate limit being reached at

-u- -e- ww-. ,w

_i.,m m- , , . _ -_ __

zg , -

, jk, ODCM Rsv. 14 Page 76 -j

~

-6/94

[

the. site boundary. ;ThisicalculationLis made more complex.by

the use.of' multiple release points at LGS.

Calculation Bases =

'The' alarm setpoint~ calculation is performed monthly.and is' 1 G* based on analytical'results of grab: samples.from the appropriate release point. The concentration ofLeach" ..

i identified radionuclide.in the grab samplesfis. determined, and-the data are used.to perform a setpoint calculation for that'

'nuclide mix and release' point.

The highest calculated annual average concentration3 (X/Q)~for S an' area at or..beyond the site ~ boundary (1.1E-05sec/M , llE '

sector) is used in the setpoint' calculation.

Maximum flow rates through-the North and' South vents are used.

in;slarm setpoint. calculations. This is necessary since, flow By:using. maximum values, any flow'less than'the

< -can vcry.

maximum will assure that-the monitor will alarm before. release.-

rate limits are exceeded.- >

For-each release point the noble gas' release.which would cause' a SITE BOUNDARY total body dose rate of 500.mram/yr end'a' skin. ,

dose of 3000 mrem /yr is determined. 4 J

The fractional contribution of noble gas is calculatedLfor each i

release point. The fractional contribution to the whole body' and skin dose rates due to noble gases is calculated by taking the product of this fraction and the limiting release rate. A Li E comparison of this release? rate for whole body and skin' dose '

L rates due to noble gas release is made to determine if the. ;

l: whole body or skin dose limit will be.most restrictive. ItLis L expected that the whole body limit will always be most .;

restrictive, but the comparisonf i s'necessary to assure compliance with ODCM I.: The-sum of the. contributions from each a release point, independently calculated for' iodines and noble -

gases, will equal the maximum instantaneous release rate. 1 allowed from the site.

u l The purpose of calculating the release rate which. corresponds -;'

to the site boundary dose limit is D91 to determine an~ .

acceptable release rate, but to determine'the maximum" release- >

rate which may.be exceeded. It is B9t intended that releases- ,

will be maintained at or near this limit, and insfact, requirements ~to maintain offsite doses As Low As. Reasonably-

!= Achievable (ALARA) are specified in ODCM I3.3.3 and:ODCM I3.3.4.

't I

i l

r

. o , , . . ~ - . .- .y _

p3 _

- y ,

, , 4' s " <

ODCM Rcv.L14 w , ,

. PagD177

0

, a3 7m , 1 *

, 6/94J ,

North Vent Noble Gas - Effluent" Monitors - RY26'-075A--3, 2.2.1:

~RY26-075B-3. AND RIX26-076-2 h

The North' Vent ~ Noble Gas Effluent monitor'high-high- .,

.setpoint is: calculated monthlyjbased'onLthe grab sample 1 results performed ^in accordancetwith ODCM I3.3-3. .Due:

> to the-incorporation 1of:the.ALARA'philosophylin the

. design 1.and-operation of;the: Limerick' effluent! systems, release point grab samples may not; identify any; ' .

a radionuclides. 1In this situation, chemistry may'use.-

the resiults of:the-last. grab sample which identified-

, radionuclides or use the defaultisetpoint which is :

based on' expected concentration ratios as reported inE. .

?

> the UFSAR. If.any calculated;. alarm setpoint-isiless-than'the, existing monitor setpoint, the setpointiwill.

be reduced to-the new value. If'the calculated

~

setpoint value is greater than the existing value,'the. f:

setpoint may remain at theilower'value or' increased to>

the new value.- j 2.2.1-1 Setnoint Determination The setpoint.for-the North;VentoNoble-gas Effluent Monitor is set-at or-below'.the 4 lesser of the -NVSP,,, OR NVSPucu.value.

The Al'ert setpoint is'.not to exceedc.1.1"E 7p 04 pCi/cc, per LGS.UFSAR Table 11'.5-2, using:

the two unit maximum' North' Vent flow rate.' ,

[vF 1.[500)[IC3,1 y," , [3. 447 SE9] E [ (C ,) (Kj) ]

f

.i

[vFal [3000] [ECj,1.

gp" g ,g ,

, [3. 447 5E9] E [ ( Cj,) (Lj +1.11Mj) ]

where:

NVSPm = North Vent _Setpoint - Noble Gas WholeiBodyL(4Ci/cc)

NVS P,g,, = North Vent Setpoint - Noble; Gas-Skin (4Ci/cc)

VF,y,c = Fractional contribution to site boundary (noble gas

- dose rate from'the North Vent as'calculatedfin::

equation 2-7. (unitless).

500 = Total body dose rate limit (arem/yr) 3000 = Skin Dose rate limit (mrem /yr) p v,, -A -w e -e'.,,,r..- - e,r,e-,.--+--e, e- -w- wr,.w--t- - - - . , .,-,r- -

m,

<1 4

' ODCM R2v.,14 Il<

Paga.'78

l. 6/94 IC ay = Total noble gas activity from North' Vent grab sample (pCi/cc)'

3.4475E9 = Conversion factor (pci) (cc) ~

m3 ) (pCl)

' =_(1.1E-5 sec/m 3

) (1E6 pCl/pCi) (664,000 cfm) (1/60 min /sec)'(2.832E4 cc/ft3 )

(2-3),

where:

1.1E-5 sec/m3 = highest annual average X/Q - (NE Sector) 1E6 pCi/pci = units conversion-664,000 cfm = maximum North Vent flow rate for two-unit operation 1/60 min /sec '= units conversion 2.832E4 cc/ft 3 = units conversion C gy = concentration of noble gas nuclide i as determined by_radioanalysis of North Vent grab sample (#Ci/cc) l L Kg = Total body dose conversion factor 1for noble 3

gas nuclide 1 (mrem /yr per pCi/m ,- from Tablef2-1).

l L, = Beta' skin dose conversion factor noble gas nuclide i ~ (mrem /yr' per pCim 3

, per Table 2-1) ..

L Mg = Gamma air dose conversion factor for noble 3

gas nuclide 1 (mrad /yr per pCi/m ,- per Table 2-1).

i 1 L

4 1

I l-1 l

~+

} - ; y;

< .t :. .

'I s ODCMLRsv. 14:

, , (("U . o

. Pagn. .7 9l uh j 7l}' 6/94:

?2.2.2 South' Vent' Noble' Gas Effluent-Monitors -RY26-185A-3.

RY26185B-3; RY26-285A-3. AND RY26-285B-3 Each unit's South 1 Vent Noble: Gas Effluent monitor high-high setpoint is calculated monthly based onfthe grab sample; results' performed in accordanceLwith'ODCM I3.3-3.. Due to!

.the incorporation':of the ALARA philosophy in'theydesign and

operation of the Limerick effluent systems,frelease' point.

grab samples may-notEidentify'any radionuclides. .. With this: '

situation,^ chemistry may-use the.results of;theLgrabisample:

which' identified radionuclide or use'the default _setpoint

.which is based on expected concentration ratiosfasfreported; in the'UFSAR. If any' calculated: alarm:setpoint.is.less-than the existing monitor'setpoint, the'setpointiwill be reduced to the new'value. If the calculation ~setpoint:

value,is greater than the existing value, the setpoint mayc remain at the-lower value, or increased 1to the new value.

2.2.2-1 Setpoint determination The setpoint for the South Vent Noble Gas; Effluent.

and' Monitor value.

is set atSVSP

.the . lesser of the SVSP' and SVSP are caIUulated SVSP"eYchunit'sSoutTVent..

for ThEAlert setpointiis.

not to exceed 3.4 E-6 #Ci/cc,fper.. LGS-UFSAR Table?

11.5-2, for each unit's South-Vent Noble Gas channel, using each; unit's1 maximum-South Vent. flow rate.

~

When a containment purge occurs through one" inch /two-inch vent valves to the South Vent,:a-grab sample will be analyzed for' noble' gas activity, and the-setpointifor'_the' containment; purge will be calculated per.this section. This setpoint will.be compared-to'the= existing monitor setpoint. .

IE the calculated containment purge setpoint;is less than the' existing setpoint,.

THEN the setpoint will be reduced'to_the new.

p value.

L IE the. calculated containment' purge setpoint'is greater than-the existing setpoint, IHEH the existing setpoint_willJbe maintained. AtL the completion of.the containment purge, the setpoint will be restored to the monitor-setpoint that existed'immediately prior to the' containment ~

purge.

L [VFal [500] [E Cj,y] _,)

p" [1. 2149E9] E [ (C3 ,y) (Kj) ]

J-

3

l. l - ODCM Rtv. 14 Psgs 80 ,

y <

l. 6/94' r

{ (VFm) (3 000) (E C3 ,,)

gygp"", (2_s)

(1. 2149E9) E [ (Cj,y) (Lj +1.11Nj) 3 '

i l

l Where:

SVSP gy, -= South Vent Setpoint - Noble Gas.Whole Body (pCi/cc)

SVSPusK = ' South Vent Setpoint '- Noble Gas Skin (pCi/cc)~ {

VFsvu = Fractional contribution to site boundary noble gas dose rate from the Unit's-South Vent as calculated in equation 2-8 or' '

2-8a (unitless) 500 = Total body dose rate limit (mrem /yr) 3000 = Skin dose rate limit (mrem /yr)

IC gy = Total noble gas activity from each unit South Vent grab sample (yci/cc). .

1.2149E9 = Conversion factor (pCl) (cc) .

(m3 ) (pCl) ,

a (1.1E-5 sec/ms ) (1E6pCl/pCl) (234,000 cfm) (1/60 min /sec) (2.83E+4 cc/ft3 ) (2-6) l- where:

1.1E-5 sec/m3 = highest annual average X/Q (NE Sector) 1E6 pCi/yCi = units conversion 234,000 cfm = maximum South Vent flow rate -

1/60 min /sec = units conversion 2.832E4 cc/ft 3 = units conversion i C,

g = concentration of noble gas nuclide i determined by radioanalysis of South 4 Vent grab sample (#Ci/cc)

K, = Total body dose conversion factor for noble gas nuclide 1 (mrem /yr per pCi/m 3, from Table 2-1).

l

Qw , , '

3: - ,

s

_, _ l}

10DCM Rsv.J14 r - / i g s , [}: ~

P&gs 811

" 6/94 s

-Q ,

y

. L, , .=: Beta skin dose-. conversion factor noble-gas nuclido- iE(mrem /yr per pCi/m ,3 ._per- .i

,.*f

, Table.2-1).t ,

M'

= Ga: cia t air dose : conversion : factor ' for 3 . a noble; gas . nuclide' i -(mrad /yr -per)pCi/m , ,

per Table 2-1).

'2i2.3 Noble Gas Effluent Fractional Contribution The noble gas affluent fractional' contribution [is

+ calculated monthly using results;of:the grab-samples performed'in'accordance'withiODCM I3.3-3.

The results of this calculation are used:in

' ' equations-2-1, 2-2,.2-4,-and 2-5. This methodology: ..

~

assumes-that~the total ~ body dose is?limitingsfor:

4 noble. gas releases.. IfLequations;2-1,12-2, 2- 4, ;

and-2-5 show that the. skin dose.is. limiting,- '

fractional skin' dose'should beisubstituted-for.the whole body values-used..in-~ equations 2-7,i2-8,.and: .

2-8a. s i 2.2.3-1 Calculation of. VF,,g, c VFLswa, and VF 25wo .

VF" " * ' Z [ (Cjyy) (Kj) ) +E [ (Cj,,y) (Kj) ] +E [ (C j,,y) (Kj) 3 - ( 2 -7 ) e

~~

E [cj,,y) (Kj) ) l yy18 " ,

E [ (Cjyy) (Kj) ) +E [ (Cjj,y) (Kj ) ] +E [ (Cjf,y) (Kj) )

i (2 -7 )

VEasm = E I(Ciuv) (K J) 3 +E I(C Jsv) (K )J 3 +E I(Cassv) (K J) 3 '

where:

VF,wa = fractional contribution to~ site 1 boundary noble-gas total body dose rate'from the North Vent

. (unitless).

VF iswa = fractional-contribution to site boundary noble j gas total body dose rate from the Unit'l-South. 4 Vent-(unitless).

VF 2swa = fractional. contribution to site boundary noble gas total body dose rate from the~ Unit.2. South Vent (unitless).

y:

lI ~ODCM R v.~14 Pags 82 l[ 6/94-C gy = ' concentration-of noble gas nuclide i as determined by radioanalysis of North Vent grab sample (yci/cc)

K, = total body dose conversion factor for noble ~ gas

. radionuclide 1 (arem/yr per pCi/m 3)

C nsy = concentration of noble gas nuclide 1 as determined by radioanalysislof Unit 1 South Vent grab sample (pCi/cc)

C usy = concentration of noble gas nuclide i as determined by radioanalysis of Unit 2 South' Vent grab sample (pCi/cc) 2.2.4 Noble Gas Effluent Default SetDoint This methodology may be used when grab sample results from either the North Vent or the South Vent do not identify any radionuclides. This methodology is based on expected. release concentration ratios as outlined in~section'11.3' of the Limerick UFSAR.

2.2.4-1 North Vent Noble Gas Monitors (RY26-075A-3 and RY26-075B-3).. The default-setpoint for the North Vent noble gas effluent monitor is set at or below the L NVSP g , value $3.45E-5 pCi/cc.

[8. 9 0E-1] [500] [1.15E-6] (2 -9 )

NVSP*D s

[3.4475B9] [500] [4.30E-9]

where:

i NVSP go = Default North Vent Setpoint - Noble Gas (yCi/CC) 8.90E-1 = Default fractional contribution to site boundary noble ' gas total. body dose rate from the: North Vent (unitless)

, 4 . 3 0E-9

( 4 . 3 0 E-9 ) + ( 5 . 31E-10 ) .

where:

4.30E-9 = Summation of the North Vent concentration of noble gas nuclide i multiplied by the corresponding whole body dose factor.

(pCl) (mrem) (m3 )

(cc) (yr) (pci) i-

. = . , -_

g.. - . . . , , , . . .

ODCM T Riv.L14

7l[

Pagac83 J

. ;g -j, .; '

6/94

-i 5.31E-10' =

Summation of the' South. Vent (Unit.11&i2)-

y; concentration of noble' gas nuclide i multiplied: '

by:the corresponding whole body dose ~ factor.. ,

= (pCl) (mram) (m 3)

(cc) (yr) (pCi) =

Ref:' a) ; Based ontexpected annual release 1from UFSAR Table.11.3-1.- .f b) Based on maximum North Vent flow of 664',000 cfm and. South Vent 1 flow.of' 234,000 cfm for'UnitL1 and -.;

Unit 2 vents.

c) ODCM II Table 2-1.

500 = Total body' dose ratd. limit (mrem /yr) 1.15E = -Total nobleLgas concentration from North Vent (yCi/cc) 1 a) Based UFSAR Table 11.3-1.

Ref: . b) Based on maximum North Vent' flow of '

664,000 cfm-3.4475E9 = Conversion factor r , >

l 4.30E-9 = Summation of'the North Vent concentration 1of noble gas nuclide i multiplied by the corresponding whole body dose factor.-

(pCl) (mrem) (m3 )

(cc) (yr) (pCl) u Ref: a) Based UFSAR' Table 11.3-1. l b) Based on maximum North Vent flow ofi 664,000 cfm.- l c) ODCM II Table 2-1. , ,

gm- , ,

W ,

E 40 d,. :- , . ODCM -R$v. ::14 : ,

' lj Pigs 84-- ,

V:

Q:: 4 , 6/94 ,

C '

2.2.4-2 South Vent:. Noble Gas ' Monitors . (RY2 6-185A'-3 ~,

> RY26-285A-3, RY26-185B-3, and RY26-285B-3).-

s .The default setpoint.for each Unit's South.

Vent: noble gas offluent monitor is; set atiorc below.the SVSP,,' value (5 6. 09E-6 L yCI/cc) . .

iJ . * ,

[5.49E-2] [500] [7.14E-8] . (2-10)

S V S P " s: -

[1. 2149 E9] [2. 6 5E-10) 3

-'whcre:

SVSP,, = Default South Vent Setpoint'- Noble Gas (yCI/cc).

5.49E-2 = Default fractional contribution to site boundaryinoble gas total body dose rate from

the South. Vent (unitless) ,

,_ '2.65E-10' (4. 3 0E-9 ) + (5. 31E-10) -

' where:

~

2.65E-10 = Summation of-the Unit's South Vent: -

I concentration of noble gas nuclide-1' l multiplied by the corresponding whole body-'-

dose factor.

l_

(pCl) (mrem) (m 3)

(cc) (yr) (pCl) ,

4.30E-9 = Summation of the North Vent concentration of noble gas nuclide i multiplied-by the corresponding whole body dose factor..

(pCl) (mrem) (m 3)

(cc) (yr) (pCl).

J i

1; l:

l' l.

l

.j 4

,,l> w , - m. < ~ . , , - , , , - - . . - - - - - * - + . - - .-

- - ' - - ' - -- ~

Orc ' '

s

.l[ '

ODCM'Rsvin14'

.Paga 85-h ' ' ' [l . -6/94-

~

5.31E-10 =- . Summation of thel South, Vent.(Unit 1 & 2) concentration of noble' gas nuclide~i.

multiplied by the corresponding whole body-

' dose. factor.

- (pCl) (mrem) (m3)

(cc) (yr)-(pCJ )-

,r-Ref: . a) Based on expected annualfrelease, from UFSAR Table-11.3-1.

b) Based on maximum North Vent' flow ofs 664,000 cfm and South Vent flow of: ,,

234,000 cfm for. Unit-l'and Unit 2 vents.

c) ODCM II Table'2-1.

500 = Total body dose rate limit (mrem /yr).

a

7.14E-8 = Total noble. gas concentration from^ North' Vent n (#Ci/cc)

Ref: a) Based UFSAR Table 11s3-1.

b) Based on maximum North. Vent'. flow of 664,000 cfm.

1.2149E9 = Conversion factor '

i.

I I (pCi) (cc) )

l f

Ref: a) ODCM.II' equation'2-3 l'

2.65E-9 = Summation of the North Vent concentration of -

noble gas nuclide i' multiplied by:the corresponding whole body dose factor.

l (pci) (cc) '

L- (.m3) (pCl) ,

Ref: a) Based'UFSAR Table 11.3-1.

i b) Based on maximum North Vent flow of-L 664,000 cfm.

l c) ODCM II Table.2-1.

m-w I , . < '

il' ODCM Rsv.E14

~

Paga 86'

, . , q. 3 1;l- 6/94 q

d' '

2.2.5' Wide Ranae Accident Monitor' Noble Gas' Effluent

< Monitor (RIX-26-076-4)

The Wide Range Accident Monitor #(90UW) noble gas-

. total effluentfchannel displays the; North Vent noble: gas. release rate. :This monitor has Main:

' Control 1 Room Annunciation as well.as a group 6A.

isolation function onLthe primary containment.

purge and vent' valves.- The isolation setpoint-

~ valve of $2.1 #Ci/cc specified in> Technical'.

Specification 3.3.2-2 is-basedLon the'accidentL dose limitsLfor containment purge during an

~

accident (Ref: .UFSAR SectionL1.13)..= For? routine operations;the-total' effluent'alertfand high.

setpoints are basedLupon~the methodology.:of-Sections 2.2.5-1 and 2.2.~5-2. The setpoint units; are in microcuries per'second using the two unit .

" maximum 1 North Vent flow rate of 664,000 'scfm.' .The-total effluent _ channel High setpoint~is set-at a

value 1ess than or equalstojten. times;the. Alert;

.setpoint (not.to exceed the'2.1 #Ci/cc equivalent using the two-unit maximum. North' Vent flow? rate)'.

For containment purge operations, the high setpoint'is-based on an isotopic analysis.of;the containment atmosphere using CH-1009 (Ref: Sectionl !

2.2.5-3). These. values are always more ._.

conservative than the Technical Specification.

I

. Table 3.3.2-2 required.value of.$ 2.'l#Ci/cc.

-=If the calculate'd setpoint value is'less than the>

existing monitor setpoint, the setpoint will be-reduced to the new value. If the calculated setpoint-is-greater ~than~the. existing value,'the ]

setpoint may remain at the lower =value, or ,

j increased to the new value. ,

l u

4

,l

~

T 4

e ,

.h '

i Ll

l1 ODCM R v. 14 PCgs 87-ll .

6/ 9 4.-

2.2.5-l' Routine Operations Alert Setooint-Determination For routine' operations,:the Alert

.setpoint-for the WRAM Noble Gas total

' effluent channel is set at or below the-lesser. of the NVSP,, OR NVSPNcsc value.

The.' Alert.setpoint .ts not to exceed

-1.1 E-04yCi/cc' equivalent, using the two-unit ~ maximum North Vent flow rate,.

per LGS UFSA! Table 11.5-2.

[VF,ml [500] [E C3 ,)

p" [3. 4475E9] E [ (Cjw) (Kj) ]

[ VF,m] [3000] [E C ,]

g gp ". g 3

[3. 447 5E9] E [ (Cjw) (Lj + 1.11M )j ) .

Where:

NVSPm = North Vent Setpoint - Noble Gas Whole Body-(gCi/cc) .

NVSPucsr = North Vent Setpoint - Noble Gas-Skin =(pCi/cc)

VFNwo = Fractional contribution to site boundary noble gas. dose rate from the North Vent as calculated in equation 2-7.

.(unitless).

500 = Total body dose rate limit'(mrem /yr) 3000 = Skin Dose. rate limit-(mrem /yr)

EC m = Total noble gas activity'from North Vent grab' sample (#Ci/cc) 3.4475E9 =

Conversion factor)

(pCi) (cc) '

, (m3 ) (pCi) ,

a (1.15-5 sec/m 3) (1E6pCl/pCl) (664,000 cfm) (1/60 min /sec) (2. 832E4 cc/fC )3 ( 1 where:

1.1E-5 sec/m 3 = highest annual average X/Q (NE Sector) lE6 pCi/pCi = units conversion 1

'l

l: ODCM R:v.l14 Paga 88 l;I 6/94

.664,000 cfm =. maximum Forth Vent flow rate for two-unit ope 2ation 1/60 min /sec ==- ' units conversion-2.832E4 cc/ft 3 = units conversion C;,y' = concentration of noble-gas nuclide i as determined by radioanalysis of North Vent grab sample-(pci/cc)'

Ki = Total body dose conversion factor for noble gas nuclide i (mrem /yr per pCi/m 3, from Table.2-1).

Li = Beta skin dose conversion factor noble

. gas nuclide 1 (mrem /yr per pCi/m 3 , per Table _2-1).

M'

= Gamma air dose conversion factor for 3

noble gas nuclide i-(mrad /yr per pCi/m ,-

per Table 2-1).

The setpoint values are converted from pCi/cc.to pCi/sec using the maximum two-unit North Vent flow rate:

NVSPug =

(NVSPucw) [3.134E8) (2-14)

NVSP TEsK =

[NVSPucsK] [3.134E8] -(2-15) where:

1 NVSPnw = WRAM total effluent channel North VentL l

Setpoint - Noble Gas Whole Body' j (pCi/sec).

L NVSP TESK = WRAM total effluent channel North Vent p

Setpoint - Noble Gas Skin (pci/sec).

j. NVSP,3, = North Vent Setpoint - Noble Gas Whole Body (pCi/sec).

l. NVSP,asg = North Vent Setpoint - Noble Gas Skin I (pCi/sec).

3.134E8 =

Conversion factor (cc/sec).

=

(664,000scfm)})1/60-min (2.832E4 cc/ft /sec)

(2-16)

n ~

'[' ODCM.Rav. 14 .

. w "

Paga ]

~

, 6/94 4 Routine Ooerations'Hiah Setooint 2.2.5-2 Determination .

For routine operations,- the-high'setpoint for-the WRAM Noble Gas.. total. effluent. channel is' set at or below ten--times the lesser of the routine operations NVSP,gg or NVSP itst value.

O NVHP,,,= [NVSPgy,) _ [10) (2-17)

NVHP,,,g = [NVSP g ,g)~[10] (2-18):

where:

NVHP7 ,y, = WRAM total effluent channel North Vent High Setpoint Noble Gas Whole. Body; (yci/sec).

'NVHP yg ,g = WRAM total effluent channel North Vent High'Setpoint Noble Gas Skin (pCi/sec).

NVSPgy, = WRAM' total offluent channel' North-Vent-Setpoint - Noble Gas Whole Body

(#Ci/sec).

NVSPucsK = WRAM total effluent channel North, Vent Setpoint - Noble Gas.-Skin (pCi/sec).

10 = l multiplication factor.to ca)culate'High value (unitless) 2.2.5-3 Hich Setooint Determination - Containment 4 Purae Ooerations- ,

During routine purge operations via Northi Stack, the setpoint will be-determined prior to initiation;of the' purge. based on the containment noble gas grab sample required by ODCM 13.3-3A. The WRAM-high setpoint is set at or below the lesser of the WRSP,apy, OR-WRSP value. .At no time.will the setpoint' be-hherthen6.58E+8'#Ci/sec(Ref:

Specification.-Table'3.3.2-2 limit of 5 2.1 pCi/cc converted to pCi/sec:(2.1 #Ci/cc is based on maximum 2 unit North Vent flow rate).

(VFyyml [500] [E C ,}

gp"" g [1.10E+1) 3 E [ (Cj,) (Kj)

(2-19)

(VFuym) (3000) (E Cic) y9y (1.10E1] E ( ( C3 ,) (Lj +1.1Nj) )

j' c, ' ODCM Rav.'14~

h.'5 ' '

Paga 90 z

j; 6/94 where:

'WRSP . -= WRAM Purge-Setpoint'- Noble Gas Whole Body (pCi/sec.)

WRSPm =. WRAM Purge Setpoint.-LNoble Gas

. Skin (pCi/sec.)

f' VFgg = . Fractional contribution.to' site boundary noble. gas dose rate from North Vent as calculated in equation 2-7'-(unitless)..

t 500 = Total' body dose rate limit (mrem /yr).

3000 = Skin dose rate limit (mrem /yr)..

IC g = Total. noble gas activity from containment grab sample,(gci/cc).

1.1El = Conversion factor .

. (pCi) (sec) .

.(pCl) (m3) i ,

(1.1B-5 sec/m3) (1B6pCl/pCl) (1/60 min /sec) (2.832E4 cc/fc3) (2 -21) 472 min-ce sec-fc3 where:

L 1.1E-5 = highest annual average - X/Q (sec/m 3 ) (NE sector).

l 1E6 = units conversion;(pci/pCi)-

l 1/60 =. units' conversion (min /sec) ,

2 832E4 = units conversion (cc/ft )3 472 = units conversion

!- min-cc '

L .sec/fc3 Cg = concentration of' noble gas nuclide i'as c i determined by radioanalysis'of containment L grab sample.(gCi/cc).

p.

Kg = Total body dose conversion factor for noble gas nuclide 1 (arem/yr per pC1/m3 from Table 2-1).

l.

g '~* ~ , . .-

t

.'k. l x !

r 3Cr

' #$ 1 I _ .ODCMlRiviE14?

$ , l; :Page 911 Sg I. >

6/94!

l

'L] =l -Betafskin dose'conversionifact'r.for' o noble .R

gas ;nuclide 1- (arem/yr per' pci/m3: fro'm- ;

cl ,

Table'2-1).: '

'l M' - := sGamma air' dose conversion factor.for noble.

3 gas nuclide 11(arad perl pci/m from Table .2-

~ '

1 ) '.

Gaseous' Efflue'nt Dose ' EvaluationJ 2.3 ,

.i

, l The' Annual gaseous ~ effluent dose evaluations are' performed? ;

.using,the. computer based-RM-21Afreport processor.: . !

~

JInstantaneous Offsite Dose Calculations are performed withi q

'the MesoRem.Jr. Common Dose Model computer;programi'The

~

following sections ~ describe.the; computational'models, j assumptions and bases. . Emergency, dose. calculations lare l performed using the MesoRem Jr Common Dose Model; computer ;

program.

. - - i Monthly dose l calculations.are performed. based on limiting-sector average annual meteorological-dispersion .

parameters. For the: noble gas monthly-doseLealculation,,

effluent release data are; based on the: latest grab sample j analysis for.radionuclide composition:and.the-hourly j average effluent monitor response.forstotal:-release: ( ]

activity. For.the iodine and particulate monthly dose- q calculations, the. effluent' release-radionuclide: )

composition 7and release activity are based'onithe a

continuous composite samples-for the time period of..the dose calculation.

The quarterly dose calculations are a' summation of the applicable. monthly dose results.

The annual dose calculations are based:on the actual meteorological conditions. concurrent with:the effluent releases. Wind direction, temperature lapses-rate,1 ambient-temperature, ground level windspeed, and: release elevationi windspeed are provided for each. hour of the' year.y The-meteorological dispersion values (X/Q, depleted X/Q, and?

D/Q) are calculated for each hournand linkedLwith the-corresponding' release data. The effluent release- __

radionuclide_ composition and activity.are based on-the- !

same parameters as the monthly dose analyses ~..

1 i

l i

l 1

~

+....[w,. . . . . A.. . .- . . , - , - , . - . . . , , . . ,,m._ .e - . . - . - , , - - . . . - , . - - .,~.,..--~.--o . . - _ , - ..

's- ODCM RSv. 14 8

Paga 92

- 6/94 1

2.3.1 Site Boundarv Dose Rate - Noble Gases ODCM I3.3.2.a limits the dose rate at the SITE BOUNDARY due to noble gas releases to $500 mrem /yr total body and $3000 mrem /yr skin. Radiation-monitor alarm setpoints are established to ensure that these release limits are not exceeded. In the event any gaseous releases from the station results in an alarm setpoint being exceeded, an evaluation of the SITE BOUNDARY dose rate resulting from the release would be performed using ST-6-104-880-0.

Simultanecus releases from the North and South Vents are considered in evaluating compliance with the release rate limits of ODCM I3.3.2.a following any releases exceeding the alarm setpoints.

Monitor indications (readings) are averaged over time periods not to exceed 15 minutes when determining noble gas release rate based on correlaticn of the monitor reading and monitor sensitivity. The 15-min averaging allows for reasonable monitor response to'potentially changing radioactive material concentrations ~and to exclude potential electronic spikes in monitor-readings that may be unrelated to radioactive material releases. When identified, electronic spiking monitor responses are being excluded from the dose calculation.

NOTE: For administrative purposes, more conservative alarm setpoints than those required to meet 10 CFR 20 Dose Rate limits are imposed. However,. conditions exceeding these more limiting alarm-setpoints do not necessarily indicate radioactive material release rates exceeding the dose limits of CCCM I3.3.2.a. Provided actual releases do not result in radiation monitor indications exceeding values based on the dose rate limitr, of ODCM I3.3.2.a, no further analysis are required for demonstrating compliance with the limits of CCCM I3.3.2.a.

- ODCM Rsv. 14

= Pag a 9 3 -'

4-i R : j 6/94 In the event of a noble gas effluent release exceeding the setpoint value.specified in ODCM.II sections 2.2.1 (or 2.2.4-1),'2.2.2-(or 2.2.4-2),

and 2.2.10, the site boundary dose rate from the release is calculated using the methodology stated g

below. This methodology is. based on worst sector (NE) annual ~ average meteorological dispersion'but, if.further refinement is required to' meet the requirements of ODCM I3.3.2.a, actual meteorological data from the time period of concern may.be used to calculate actual meteorological dispersion.-

D,pn,= (53. 882) (X/0) (( (F yy) (Ojyy) + (Fj,y) (Ojj,y) + (F 2SV) (O lssv) ] Kj]' ( 2 -2 li -

17 ~

E Dp ,g= (53. 882) (X/0)

' (((Fyy) (Ojyy) + (F2 SV) (Oj2,y) + (F2 SV) (O ssv)]L ) + '

i 1 11

' (SF) E [(Fyy) (Ojyy) + (F1 SV) (Ojj,y) v (F2sv)(Oi ssv)3 M l (1*11)

,1 = 3 (2-23)-

where:

D,pg = Total. Body. Plume Dose Rate (rem /hr)

Dpsg =

Skin Plume Dose Rate (rem /hr) 53.882 = Units conversion factor rem-m 3 -pCi-yr-min-cc

,pCi-hr-mrem-m -sec-ft X/Q = 1.1E-05 highest annual average relative l concentration (NE Sector) . (sec/m 3)

F,y =

North Vent Flow Rate (cfm)

Q , ,y = concentration of noble gas nuclide i during period of release from North Vent (pC1/cc)

F isy =

Unit 1 South Vent Flow Rate (cfm)

Qnsy = Concentration of noble gas nuclide i during period of release from Unit 1 South Vent (pCi/cc).

F2sv =

Unit 2 South Vent Flow Rate (cfm)

}l1 ODCM-R v. 14

.f Pcgn 94 cv (l 6/94

.Q12sv

= Concentration.of noble gas-nu'clide'i during

~

period of release from Unit 2' South Vent

(#Ci/cc).

.K g = Total' body dose factor for noble gas.nuclide i ." Values are' listed in Table 2-1.

mrem-m' pCi-yr .

L, = Skin dose factor for the beta-contribution-for noble gas nuclide 1. Values are;11sted' in-Table 2-1.

mrem-m 3 pCi-yr 1.11 = the average ratio of tissue to air energy absorption coefficients (mrem / mrad) ~ (Ref:

, Regulatory Guidec1.109 Section 2.2)

SF~ = 0.7 is the attenuation factor that accounts-for the dose reduction due to shielding provided by residential structure j (dimensionless) (Ref: Regulatory Guide 1.109 Table E-15).

Mi = Gamma air dose factor for noble gas nuclide l 1. Values are listed in Table 2-1.

mrad-m3 pCi-yr 2.3.2 Site Boundarv' Dose Rate Radioiodine and Particulates-ODCM I3.3.2.d limits-the dose rate to.51500 mrem /yr to any organ (inhalation pathways only) for I-131, I-133, Tritium, and all radionuclides in particulatelform_with half-lives greater than 8 days in gaseous ~ effluents.

Compliance with ODCM I3.3.2.d is determined monthly by.

performance of.ODCM II Section 2.3.4.

l l Simultaneous releases from the North and. South Vents are considered in evaluating compliance with the .

release rate limits of ODCM I3.3.2.b. -Release activity is based upon.the results of the continuous composite sampler analysis performed in-accordance.with ODCM Table I3.3-3.

" * ' "~ '

pg >

j- ~ i ,

s

[9 igg M3J ,ll s

ODCM '-R:v. r714 :

Mc -

j . . Page'95

- . -d:1l1

~ "

' 6/94

.This' methodology is based on the' worst" sector ,(NE) 0~ '

annual average' meteorological' dispersion.but,,if

" further refinement islrequiredLto meet.the. limits.of '

~ODCM I3.3.2.b, actual meteorological dataLfrom the time!

Lperiod of concern may-be usedito calculate actual:

meteorological dispersion. 1

~ 2.'3.3 Noble Gas Air Doses-

'ODCM'I3.3.3-limits the; air dose ~due'to noble gases _ .

~* -released..in gaseous l effluents (from'both-reactor. units) to areas at or.beyond the: SITE BOUNDARY 1to:

5 10.arad gamma.for any quarter

!$ 20 mrad beta forlany quarter-

5 20 mrad gamma during any calendar' year-s'40 mrad.betaLduring any calendar year.

As-required.by ODCM 13.3.3.1 Surveillance Requirement,. _

these doses' are calculated' at least once' per -311 days

~ using the results of the most.recent grab 1 samples for isotopic composition performed in accordance with-ODCM-Table'13.3-3 when' release point grab samples do not identify any radionuclides. . Total' release' activity. ',

i is based upon the hourly average-effluent monitor .

response. As identified, electronic spiking' monitor ,

responses are excluded from the release activity .

l

. analyses. The monthly. dose calculation'is performed 3 using the most limiting average annual-meteorol'ogical.

,.i dispersion values. The quarterly. doses.are based:en. H the' summation of the applicable monthly.results. .The annual dose. calculations are= based upon actual' release:

meteorological conditions as.describedrin Sectionc 2.3.5. The monthly dose. calculations are performed in accordance with the methodology below.

D, AIR = ( 0.1. .) (1.11E-5) (47 2 ) E [ (F,) ( C3 ,) + (F 2,y) ( C32,y) + (F 2,y)'( Cj,,y) ] Nj ' (2-24 ) '

1

.'Dp AIR = ( O'.114 ) (1.11E-5 ) (47 2 ) E [ (F,) ( C3 ,) + (F 2,y) ( C f2 ,y) + (F ,y) 2 ( Cj,,y) ] N . j( 2 -2 5 ) -

4 where:

f D gg = - Gamma air oose from noble gasf releases -(rad /hr) ;

D um = Beta air dose from noble gas. release (rad /hr) 0.114 = Units conversion rad-pCl-yr

, p ci-br-mrad 1.1E-5 = Highest average annual relative concentration:

(NE Sector) (sec/m3)

.+

j: ODCM R;v. 14 Pags 96

]. 6/94 472 = Units conversion' min /sec

.sec-ft' F,y = Average North Vent Flow rate for period of release (cfm)

C,,y = Concentration of noble gas nuclide i from North Vent effluent (pci/cc)

F uv = Average Unit 1' South-Vent flow rate for period-of release (cfm)~

C iuv = . concentration of' noble gas nuclide i from Unit 1 South Vent effluent (pCi/cc)

F3y = Average Unit:2 South Vent flow rate for period-of release (cfm)

C i3y = Concentration of noble. gas nuclide i from

- Unit 2 South Vent effluent (#Ci/cc)

Mi = Gamma air dose factor for noble gas nuclide i.

Values are listed in Table 2-1.

l mrad-m3 pCl-yr .

l N, = Beta air dose' factor for noble gas nuclide 1.

values are listed in Table 2-1. ,

mrad-m3 pCi-yr t 2.3.4 Radiciodine and Particulate Dose Calculations ODCM I3.3.4 limits'the dose (from both reactor L units) to a MEMBER OF THE PUBLIC from I-131, I-133, Tritium,<and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released to areas at or beyond the SITE BOUNDARY to: . .

$ 15 mrem to any organ during any calendar quarter

$ 30 mrem to any organ during any calendar-l year As required by ODCM I3.3.4.1 Surveillance Requirement, these doses are calculated at least once per 31 days using the results of the

gr - _ s ,

c '.

hk Q: ,

-. ODCM JR;v. !14 ---

r L# ,

- P g2 975

]hj; 6/94-continuous composite' sample' analysis performedLini s accordance with:ODCM Table I3.3-3.- Due to-the-

incorporation- of the' AIARA philosophy. in the P, ' design;and operation of the Limerick. effluent systems,.these' composite _ samples may not identify

, any_. radionuclides. Total relea'se activity is.

, ' based _upon detectable concentration of:the-continuous composite samples and: average . .

appropriate. vent; flow lduring the samplingLperiod.;

The monthly dose' calculation is performed using?

~ .the most limiting ~ average' annual:meteorologicalL

~ dispersion values.' The quarterly-;: doses are bassd

on the summation'of the' applicable monthlyf _ -

results. .The annual dose calculations lare based upon actual release meteorologyfas= described in.

Section 2.3.5.. The monthly dose calculations are-performed _in accordance withithe methodology-below.. Total organ dose is obtained by the:

summation of the organ-dose from.each pathway;for each receptor.

2.3.4-1 Ground Pathway Dam = (3.6E-6) (472) (1. 82E-9) Ee -

35 ' '

'En[(Fyy) (Ojyy) + (F 3,y) (Oj2,y) + (Fasv) (Of ssv) + (Fm) (Ojw) ] DFI ,r.L,n s (Te-

_ )' (2-26)l 1.is 2.3.4-2 Veaetation. Meat. Cow Milk, and Goat-Milk Pathway Dym = (3.6E-6) (472) A e

2

[ (F,y) (Oj,y) + (F _

3 ,y) (Djj,y) + (p,,y) (Dj,,y) + (Fw)-(Djm) ] (1.1E-5) DF

, I ,r,t,x

+

(T) e 33

[3, (Fnv) (Of uy) + (F 1 ,y) (Oj,,y) + (F 2 ,y) (Oj,,y) + (F,). (0 3 ) ]. (1. 82E-9 ) DFI ,r,L,n .

T l2'-27).:

4 e

.ll . ODCM Rav. 14-Page 98-

.. l . 6/94 2.3.4-3 Inhalation Pathway Dypu = (3. 6E-6) (472) E

'2 E [(Fyy) (Ojyy) + (F1 ,y)' (Oj2,y) + (F2 sv) (O f ssv) + (Fm) (Ojw) ) (1.1E-5) DFg ,t,y +

I* *

(T e)

' 35 E [ (F,y) (Ojyy) + (F2 ,y) (Oj,,y) + (Fasv) (01 :sv)+(Fm) (O lm) ] (1. OE-5) DFr .t.n 1 is .

( } ;

where:

Dopa, = dose from ground pathway due to release of particulates and iodines (rem).

Dyp3, .

= dose from vegetation, meat, cow milk, and goat milk, pathways due to releases of particulates, iodines, and tritium (rem)

Dip,, = dose from inhalation pathway due to release of particulates- iodines, and tritium (rem)

( 3.6E-6 = units conversion factor rem-Ci-sec hr-arem-p Ci l-l l

472 = U"its conversion factor

' min-cc

,sec-ft.

! 1.82E-9 = highest average annual deposition '(ESE Sector)

!- 1 ..

3 m

E = summation for each release time period. I j

t (unitless).

F,y = average North Vent flow rate during release (cfm).

l Q,,y = concentration of nuclide I from North Vent effluent (#Ci/cc).

-' -1

, . %, y

Sa ;

r '

e

< .;p 9 # ' 'ODCM;.RV.'14

' Pago 99:

.i :6/94f c

-o-(

Ff,y = average Unitil' South Vent flow-rate during.

release (cfm)..

g ; Qsisv. =-

concentration o.f nuclide11 from UnitLl' South

. Vent-effluent (gCi/cc). .

r.

' F2sv- ' = average. Unit 2 South Vent flow' rate'-during release -'(cfm) .

Qg,y = concentration of nuclide i-from Unit 2JSouth.

Vent effluent?(gCi/cc).. ,

F ,, = 1 average Hot Maintenance Shop; flow? rate duringi

_ release-(cfm).

H Q 1ms

= concentration:of nuclide.i from Hot.Maint'enance' effluent.(gCi/cc).

D F, ' g' g * ,

= dose factor for organ type k, age _ group 1,

pathway.' number n; dose' factors are based on a . i. -

s computer program which isLsimilar:to the NRCJ ;

program GASPAR results.from this1 program; provide input'datacin the form of a-lookup--

table -'~ values of DFm are provided'in Tablex2-2.

i = isotope. number (1 through 35) (3 'through 17 are noble gases).

K- = organ. type (1 through'8, where. total body.=11',<

GI tract ='2, bone'=.3, liver = 4, kidney l=55,7 l:

thyroid --6, lung = 7,-' skin = 8).

~

L = age group (1 through 4,-where adult =-1, teen = 2, child = 3, infant;= 4).

N = pathway number (1 through.7).

= time duration of release (hrs).' c T,

1.1E-5 = highest average annual X/Q (NE Sector) (sec/ n 3) .

~

1.0E-5 =

highest averag)e annual depleted .X/Q (NE Sector) (sec/m .

(

b 2.3.5 Annual Dose Evaluation ODCM I3.6 requires an Annual Dose' evaluation be performed and reported in accordance with-Regulatory' Guide 1.21 in the Semiannual. _ _

Radioactive Effluent Release Report' submitted 60 days after the-first of each year... This dose evaluation is processed by the RM-21A. In'the event that this computer model is' unavailable, this analysis can be performed using the same methodology. The liquid portion of this annual

P< c <

I(( #h ; j S .- ~

g' 'ODCM RLv.114 S;M . J 3 -

Paga 100 ~

L6/94-lf , ,

1;b < :

T., '

p ', , c

' dose calculation is described in Sectioncl.3 of; ~

ODCM-II. lThe annual gaseous dose.. calculation uses' the-'same' methodology described.in:Section 2.3.1, , n 2.3;3,c.and 2~.3.4.with the; exception of.

meteorology; which is based upon actual sector ,

m., -

average atmospheric dispersion valuesLusingJthe.

i - guidance of: Regulatory GuideEl.111-(Section C.lc).- 'E Finalized ' hourly values Lof wind ~ direction,: ground ;

' level and. release elevation wind speed,-ambient;

, temperature, Land temperatureslapse-rate (for.P-G-stability. class) are provided annually-bsing the .

instrumentation specified in"ODCM I3.1-1.< These

' values are calculated-for each hour.and linked-ito-the corresponding hourly averaged effluent release rate. Doses are then~ calculated for:each= hour at-

, the.various receptors of interest (depending,upon '

release direction)'.. Radioactive' material release-rate:is calculated as described in Sections:!2~3.3' . o and 2.3.4. Dose at each receptor.is accumulated: .

for the. year and the maximum doseafor plume, inhalation, and ingestion-pathways {are. reported. 4 The gaseous offluent dose receptors are, listed in. ~

Table 2-4 and the dose is calculatedtus'ing1the-methodology below.-

2.3.5-1 Plume Pathway 17

[-

- D,g (3.6 E-6 ) (472) E (X/0) E [ (Fyy) (Ojyy) + (F ,y) 1 (On,y) + (Fasv) (012sv)3 e , c2 3

[ (e Nd3 N )(DFju)

C T) e (2 -29 )

l l

L I 2.3.'5-2 Ground Pathway-1 l"

17 ,(Fyy)- (Ojyy) + (F3 SV) (0 3'#V) +

Darm= (3. 6 E-6) (472) E (X/0) :E (DFja) ( T e) -

e e2-3, (p,,y) j(g ,,y) + (p,) (g j ,) .

(2-29)c _

V l:

, 2.3.5-3 yeaetation. Meat, Cow' Milk, Goat Milk -

Pathway g- Dy ,g= . (3.6E-6) (472) E e

2 '

E - [ (Fyy) (Ojyy) + (F2 ,y) (On,y) + (Fasv) (03: sv) + (Fm) (Ojw)) [ (X/De) ) (DFj,g,t,y) +

J ,

1*1 ' ~

(T) e ,

v.

' 35-( E {(Fyy) (Ojyy) + (F2 ,y) (On,y) (F2 ,y) (On,y) + (Fm) (Ojw) ) [D/0] e (DFj ,x,t,y)

,1 18 (2 -31) .

l l

h g- sv vv - w= + p w F ') Sr v @ v h wf w * -~ e wo -- *=w

w j.

a

- ODCM Rsv. 14

, Pcgs-101:

]- 6/94

'2.3.5-4 Veaetation. Meat, Cow Milk. Goat Milk Pathway Dy ,m = (3.6E-6) (472) E E . [ (F yy ) (Ojyy) + (F 2 ,y) (0;j,y) + (F ,y) (Oj,,y) + (Fm) (O2%) ) [ (X/0,) ) (DFj,y,t,y)

+

J'1 (T e)

' 35

.E '( (F yy) (O fuv) + (Fisv) (012sv) + (Fasv) (04 :sv) + (Fm) (0j%) ) (D/Odpj] (DF j,g,c,y)

,J.is (2-32) where:

Dpt ,3 = annual dose from plume pathway (rem)

D ,,,, = annual dose from ground pathway (rem)

Dyp,,, = annual dose from vegetation, meat, cow milk, and goat milk pathways-(rem)-

Dgp,,, = annual dose from inhalation pathway.(rem) 3.6E-6 = units conversion' factor rem-Cl-sec br-mrem-p Ci ,

472 = units conversion factor

' min-cc

,sec-ft.

E = summation for each release time period i' t (unitless).

(X/Q), = relative concentration for time period "t" (sec/m3) .

F,y = average North Vent flow rate during release (cfm).

Qgy = concentration of nuclide i from North Vent effluent (pci/cc).

. F 1sv = average Unit 1 South Vent flow rate during.

release (cfm).

QMsv

= concentration of nuclide i from Unit 1 South Vent effluent (pCi/cc).

F2sv = average Unit 2 South Vent flow rate during release (cfm).

' - h: 4 < . -

%y

]h' 'ODCM Rsv.'14

, Paga~102-f f.. ? 6/ 94 .-

-- Qggy = concentrationLof.nuclideIl from Unit 2' South Vent effluent (yci/cc).

11; = decay constant of'nuclide-1 (seed).

dr -= : distance to receptor' "r".

u, = average windspeedifor time. period;"t"-

+

.(m/sec). '

4

=- dose factor.for organ type.k,'. age; group 1, DF I ,r,L,N pathway number n; dose: factors'are basedcon: '

-results of a computer program'that'is. based on and is similar to the-NRC program GASPAR; results from'this program provide. input. data in the form of-aLlookup table: ^ values of-

'DFgt , are provided in Table 2-2.

1 = isotope number (1 -through 35) (3 through 17

'are noble gases).

K = Lorgan type (1 through 8,.where total 1 .

body = 1, GI tract =-2,. bone = 3, liver ='4, kidney = 5, thyroid = 6,' lung = 7, skinL=-

8).

L = age group-(1^through 4,:where' adult =?l,

~

. teen = 2,-child - 3,-infant ='4).

N = pathway numberL(1 through 7).

T, = ' time duration of releaseL(hrs).

l. Fus = average Hot Maintenan'ce Shop flow' rate during-release 1(cfm).

Q i ms

= concentration of nuclide i from Hot Maintenance-Shop effluent 1(yci/cc).

(D/Q), = deposition concentration-for time. period "t" 2

(1/m ) .

(X/Q p) = relative depleted concentration for time

. period "t" . (sec/m 3) .

2.4 Gaseous Effluent' Dose Proiection l'

ODCM I3.3.5 requires the VENTILATION EXHAUST' TREATMENT SYSTEM be used to reduce radioactive material levels prior

- to discharge when projected doses.from both units-to.areasL at and:beyond the SITE BOUNDARY would exceed 0.6 mrem to any organ in a:31 day period.

p l

t

'o - - , - _ . _ . .

p ll ODCM R;v. 14-Paga 103

-l' 6/94 The applicable gaseous processing systems for maintaining radioactive material releases ALARA are the Gaseous Radwaste Treatment System and Exhaust Treatment System in l Figures 2-1 and 2-2.

l A dose projection is performed at least once per 31-days l

by the following equation:

Dmaxp = (Dmax/d) = 31d (2-33) whare:

Dmaxp = maximum organ dose projection for current 31-day period (mrem)

Dmax = maximum organ dose to date'for current calendar quarter as determined by equation (2-26) (2-27) or (2-28) (mrem).

d = number of days remaining in current calendar quarter. The minimum time elapsed is seven (7) days.

31d = the number of days of concern.

3.0 Soecial Dose Analysis 3.1 Total Dose to MEMBERS OF THE PUBLIC ODCM I3.3.7 requires that the annual dose.or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from the uranium fuel cycle shall be limited to:

5 25 mrem whole body or any organ except thyroid 5 75 mrem thyroid ODCM I3.3.7.2 Surveillance Requirement requires that cumulative dose contributions from direct radiation from operations be evaluated when the calculated dose fron. the i release of radioactive materials in liquid or gaseous effluents exceed twice the limits of ODCM I3.2.3.a, 3.2.3.b, 3.3.3.a, 3.3.3.b, 3.3.4.a, or 3.3.4.b. The direct radiation contribution shall be determined by the i methodology described below. This methodology calculates '

the direct radiation contribution which then must be added i to the dose or dose commitment deter !ned in accordance with sections ODCM III.3.1, 2.3.3, anu 2.3.4 to determine total dose from all pathways. This evaluation of direct i radiation contribution is in accordance with !

ANSI /ANS 6.6.1-1979 Section 7. The error using this !

method is estimated to be approximately 8%. The following evaluation is performed for each receptor of concern.

Do,3 =D TTLo1 D, ,gg -D ig,,g (3-1)

, , .- . , , . - , . . .~_ - - , .

=~ r L-

, qp .e, 1 -

m ' : O D C M ' R *.,v 3 14" J g N ~7 '

Paga:104i .

q

,l,? '

i J6/94 e , 7' 3

E,M ' ' ~'

lwhere:N r .A

~

4 l

dp- .D g l= cumulative' dose contribution ~from' direct: .

+

" -radiation at~ receptor _l'(mrem).- '

i n, .. _,

~

NOTE: .Due to theistatistics of radiation measurements and to l the conservation of effluent calculations'it is q

u

. plausible the De -may yield a5 negative value. ~In:this~

situation the<value for Dou shall be, reported ~as: ;

zero(0).

= total dose at receptor of' interest [(as; 4 D mo . ,

evaluated by TLD measurement) (mrem) . _

NOTE: If there is not a TLD location at-the actual. receptor. l location,-a more conservative location will be'used to' l evaluate Total Dose. j s

DxsKG = mean of'the background dose as: evaluated by.

~

l TLDs at background sites-(mrem). . q D ig ,,g = effluent contribution'to' dose (as evaluated in', ;

. sections 2.3.3 and 2.3.4.1)'.. .

i t

L 3.2 Doses Due to Activities Inside the' SITE BOUNDARY In accordance with ODCM I3.6, the ' Semiannual" :

'i

~

Radioactive affluent Release Report submitted within 60 days'after January 1.of each yearcshall~ include ~am t assessment'of radiation dose from radioactive liquid- ;

and gaseous' effluents to MEMBERS.0F THE PUBLIC-due'to' 1 their activities-_inside.the' SITE BOUNDARY.

There are three locations within the-SITE BOUNDARY l that are accessible to MEMBERS'OFLTHE PUBLIC for !

l activities unrelaced- to the' operation of Limerick Station.- These locations are:' 1) the railroad tracks-which run along the. river within the SITE ~ BOUNDARY; .

2) the Limerick Atomic Information Center, on Longview:

Road next to the 500kV substation; and-3).Fricks Lock :j p environmental laboratory, operated by RMC D Environmental Services, Inc. ,Of-these three locations, the railroad tracksLare the closest to the' l plant coniines. 'The highest annual dose-for the three ,

locations should be determined by; calculating dosefat j the railroad track location.

l i

r:

-l 41

.r-L

- , . ,- _ m_ , f

'[b s

.ODCM R;v. 14, Pngo 105' l 6/94 The_following methodology is used to evSluate dose at!

the railroad tracks, Information Center, and'Fricks.

-Lock locations. This dose assessment is~ based on the

~

.results of the annual dose. evaluation outlined'in ODCM Section 2.3.5.' The maximum dose calculated will.be reported.

R I D,,,,x = D,,x . * = 0.25 (3-2) ,

where:

Desex = Dose to MEMBERS OF.THE PUBLIC within the SITE {

BOUNDARY in Sector"X" (mrem). ,

D3 ,x =

Dose at SITE BOUNDARY in Sector."X" (mrem).

X/Qsex

= Relative average annualjatmospheric dispersion

.for year of interest at SITE BOUNDARY in Sector "X" (sec/m3) .

X/Q,g = Relative average annual atmospheric dispersion for year of interest at railroad, Information Center or Fricks Lock for distances listed below in Sector "X" (sec/m3)

Sector Distance to Location (m)

Railroad Tracks:

S 300 SSW 225 SW 225 WSW 225

-W 225 WNW 345 NW 450 Information Center:

ESE 884 Fricks Lock:

WSW 450 0.25 = maximum occupancy factor for railroad tracks, Limerick Atomic Information Center or Fricks Lock Environmental Laboratory (unitless).

~

g,

~

x , -

ji ~ ODCM.Rsv. 14 Paga 106.

> ^

,,^], p, ,

, 6/94 s

4'. 0 - Radiolocical Environmental-Monitorina Procram 4.1 Samolina Procram The' operational' phase of the Ra'iological d

4 Environmental; Monitoring ' Program t (REMP) 11s conducted -

in accordance with the requirements of ODCM/I3.4-3..

The objectives'of the program are:

- To provide data on. measurable'levelsLof1 radiation and radioactiva materials in'the site environs.-

- To evaluate the relationship between' quantities of-radioactive materials released from LGS and resultant radiation doses to individuals'from:'

principal pathways of. exposure.

The sampling requirements (type.of. samples, collection frequency, and analysis) and sample locations are presented in Appendix B.

4.2 Interlaboratory Compariaon Procram Technical Specification 6.8.4.e.3 requires analyses be performed on radioactive material supplied as-part of'an Interlaboratory Comparison.

Participation in an approved Interlaboratory Comparison Program provides a check on'the. preciseness of.

-measurements of radioactive' material'in environmental' samples. A summary of the Interlaboratory-Comparison:

Program results is provided in the Annual _ Radiological' Environmental Operating Report pursuantitoJODCM I3.5.;

i a

TABLES t

. .c:

3

< ., i

. l,! . , ,

ODCM Rev.f14- 'I

f ,

P gs.J107. .!

; l '

6/94: .q

,l d

r s ;, ?

1 TABLE-1-1 ii INGESTION INDIVIDUAL DOSE FACTORS (Dgpy )

~

For liquid effluents. i Units For All Ingestion Pathways are:

mrem /pci I i

'j

i i

+'

s a 1 i

i 4

4

l- ODCM Rev. 14 Pago 108

! 6/94 i

Table 1-1 Licuid Dose Factors From Table E-11 or Reg. Guide 1.109 IngOstion Dose Factors For Adult:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 1.050E-07 1.050E-07 1.050E-07 1.050E-07 1.050E-07 1.050E-07

'C14 2.840E-06 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 5.680E-07 NO24 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 1.700E-06 P32 1.930E-04 1.200E-05 7.460E-06 0.000E+00 0.000E+00 0.000E+00 2.170E-05 Cr51 0.000E+00 0.000E+00 2.660E-09 1.590E-09 5.860E-10 3.530E-09 6.690E-07 Mn54 0.000E+00 4.570E-06 8.720E-07 0.000E+00 1.360E-06 0.000E+00 1.400E-05 Mn56 0.000E+00 1.150E-07 2.040E-08 0.000E+00 1.460E-07 0.000E+00 3.670E-06 fos 5 2.750E-06 1.900E-06 4.430E-07 0.000E+00 0.000E+00 1.060E-06 1.090E-06 Fo59 4.340E-06 1.020E-05 3.910E-06 0.000E+00 0.000E+00 2.850E-06 3.400E-05 CoS8 0.000E+00 7.450E-07 1.670E-06 0.000E+00 0.000E+00 0.000E+00 1.510E-05 Co60 0.000E+00 2.140E-06 4.720E-06 0.000E+00 0.000E+00 0.000E+00 4.020E-05 N163 1.300E-04 9.010E-06 4.360E-06 0.000E+00 0.000E+00 0.000E+00 1.880E-06 Ni65 5.280E-07 6.860E-08 3.130E-08 0.000E+00 0.000E+00 0.000E+00 1.740E-06 Cu64 0.000E+00 8.330E-08 3.910E-08 0.000E+00 2.100E-07 0.000E+00 7.100E-06 Zn65 4.840E-06 1.540E-05 6.960E-06 0.000E+00 1.030E-05 0.000E+00 9.700E-06 Zn69 1.030E-08 1.970E-08 1.370E-09 0.000E400 1.280E-08 0.000E+00 2.960E-09 Br83 0.000E+00 0.000E+00 4.020E-08 0.000E+00 0.000E+00 0.000E+00 5.790E-08 Br84 0.000E+00 0.000E+00 5.210E-08 0.000E+00 0.000E+00 0.000E+00 4.090E-13 Br85 0.000E+00 0.000E+00 2.140E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.110E-05 9.830E-06 0.000E+00 0.000E+00 0.000E+00 4.160E-06.

Rb88 0.000E+00 6.050E-08 3.210E-08 0.000E+00 0.000E+00 0.000E+00 8.360E-19 Rb89 0.000E+00 4.010E-08 2.820E-08 0.000E+00 0.000E+00 0.000E+00 2.330E-21 Sr89 3.080E-04 0.000E+00 8.840E-06 0.000E+00 0.000E+00 0.000E+00 4.940E-05 Sr90 7.580E-03 0.000E+00 1.860E-03 0.000E+00 0.000E+00 0.000E+00 2.190E-04 Sr91 5.670E-06 0.000E+00 2.290E-07 0.000E+00 0.000E+00 0.000E+00 2.700E-05 Sr92 2.150E-06 0.000E+00 9.300E-08 0.000E+00 0.000E+00 0.000E+00 4.260E-05 Y90 9.620E-09 0.000E+00 2.580E-10 0.000E+00 0.000E+00 0.000E+00 1.020E-04 Y91m 9.090E-11 0.000E+00 3.520E-12 0.000E+00 0.000E+00 0.000E+00 2.670E-10 Y91 1.410E-07 0.000E+00 3.770E-09 0.000E+00 0.000E+00 0.000E+00 7.670E-05 Y92 8.450E-10 0.000E+00 2.470E-11 0.000E+00 0.000E+00 0.000E+00 1.480E-05 Y93 2.680E-09 0.000E+00 7.400E-11 0.000E+00 0.000E+00 0.000E+00 8.500E-05 Zr95 3.040E-08 9.750E-09 6.600E-09 0.000E+00 1.530E-08 0.000E+00 3.090E-05 Zr97 1.680E-09 3.390E-10 1.550E-10 0.000E+00 5.120E-10 0.000E+00 1.050E-04 Nb95 6.220E-09 3.460E-09 1.860E-09 0.000E+00 3.420E-09 0.000E+00 2.100E-05 Mo99 0.000E-00 4.310E-06 8.200E-07 0.000E+00 9.760E-06 0.000E+00 9.990E-06 Tc99m 2.470E-10 6.980E-10 8.890E-09 0.000E+00 1.060E-08 3.420E-10 4.130E-07 Tc101 2.540E-10 3.660E-10 3.590E-09 0.000E+00 6.590E-06 1.870E-10 1.100E-21 Rul03 1.850E-07 0.000E+00 7.970E-08 0.000E+00 7.060E-07 0.000E+00 2.160E-05 Rul05 1.540E-08 0.000E+00 6.080E-09 0.000E+00 1.990E-07 0.000E+00 9.420E-06 Rul06 2.750E-06 0.000E+00 3.480E-07 0.000E+00 5.310E-06 0.000E+00 1.780E-04 Ag110m 1.600E-07 1.480E-07 8.790E-08 0.000E+00 2.910E-07 0.000E+00 6.040E-05 Tc125m 2.860E-06 9.170E-07 3.590E-07 8.060E-07 1.090E-05 0.000E+00 1.070E-05 To127m 6.770E-06 2.420E-06 8.250E-07 1.730E-06 2.750E-05 0.000E+00 2.270E-05

'Ta127 1.100E-07 3.950E-08 2.380E-08 8.150E-08 4.480E-07 0.000E+00 8.680E-06 Te129m 1.150E-05 4.290E-06 1.820E-06 3.950E-06 4.800E-05 0.000E+00 5.790E-05 Tol29 3.140E-08 1.180E-08 7.650E-09 2.410E-08 1.320E-07 0.000E+00 2.370E-08

l ODCM Rav. 14 Page 109 l 6/94 Table 1-1 (Continued' j Licuid Dose Factors From Table E-11 or Reg. Guide 1.109 Ing:stion Dose Factors For Adult:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI TJ131m 1.730E-06 8.460E-07 7.050E-07 1.340E-06 8.570E-06 0.000E+00 8.400E-05 To131 1.970E-08 8.230E-09 6.220E-09 1.620E-08 8.630E-08 0.000E+00 2.790E-09 Ta132 2.520E-06 1.630E-06 1.530E-06 1.800E-06 1.570E-05 0.000E+00 7.710E-05 1130 7.560E-07 2.230E-06 8.800E-07 1.890E-04 3.480E-06 0.000E+00 1.920E-06 ,

I131 4.160E-06 5.950E-06 3.410E-06 1.950E-03 1.020E-05 0.000E+00 1.570E-06 !

I132 2.030E-07 5.430E-07 1.900E-07 1.900E-05 8.650E-07 0.000E+00 1.020E-07 i I133 1.420E-06 2.470E-06 7.530E-07 3.630E-04 4.310E-06 0.000E+00 2.220E-06 l I134 1.060E-07 2.880E-07 1.030E-07 4.990E-06 4.580E-07 0.000E+00 2.510E-10 1135 4.430E-07 1.160E-06 4.280E-07 7.650E-05 1.860E-06 0.000E+00 1.310E-06 Cs134 6.220E-05 1.480E-04 1.210E-04 0.000E+00 4.790E-05 1.590E-05 2.590E-06 Cs136 6.510E-06 2.570E-05 1.850E-05 0.000E+00 1.430E-05 1.960E-06 2.920E-06 Cs137 7.970E-05 1.090E-04 7.140E-05 0.000E+00 3.700E-05 1.230E-05 2.110E-06 Cs138 5.520E-08 1.090E-07 5.400E-08 0.000E+00 8.010E-08 7.910E-08 4.650E-13 B2139 9.700E-08 6.910E-11 2.840E-09 0.000E+00 6.460E-11 3.920E-11 1.720E-07 Ba140 2.030E-05 2.550E-08 1.330E-06 0.000E+00 8.670E-09 1.460E-08 4.180E-05 i Ba141 4.710E-08 3.560E-11 1.590E-09 0.000E+00 3.310E-11 2.020E-11 2.220E-li Ba142 2.130E-08 2.190E-11 1.340E-09 0.000E+00 1.850E-11 1.240E-11 3.000E-26 La140 2.500E-09 1.260E-09 3.330E-10 0.000E+00 0.000E+00 0.000E+00 9.250E-05 l La142 1.280E-10 5.820E-11 1.450E-11 0.000E+00 0.000E+00 0.000E+00 4.250E-07 Ca141 9.360E-09 6.330E-09 7.180E-10 0.000E+00 2.940E-09 0.000E+00 2.420E-05 Cc143 1.650E-09 1.220E-06 1.350E-10 0.000E+00 5.370E-10 0.000E+00 4.560E-05 C3144 4.880E-07 2.040E-07 2.620E-08 0.000E+00 1.210E-07 0.000E+00 1.650E-04 Pr143 9.200E-09 3.690E-09 4.560E-10 0.000E+00 2.130E-09 0.000E+00 4.030E-05 Pr144 3.010E-11 1.250E-11 1.530E-12 0.000E+00 7.050E-12 0.000E+00 4.330E-18 Nd147 6.290E-09 7.270E-09 4.350E-10 0.000E+00 4.250E-09 0.000E+00 3.490E-05 W187 1.030E-07 8.610E-08 3.010E-08 0.000E+00 0.000E+00 0.000E+00 2.820E-05 Np239 1.190E-09 1.170E-10 6.450E-11 0.000E+00 3.650E-10 0.000E+00 2.400E-05

l ODCM Rtv. 14 Pago 110 l 6/94 l

Table 1-1 (Continued)

Liould Dose Factors Frem Table E-12 or Reg. Guide 1.109 Ing:stion Dose Factors For Teen:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 1.060E-07 C14 4.060E-06 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 8.120E-07 NO24 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 2.300E-06 3.300E-06 P32 2.760E-04 1.710E-05 1.070E-05 0.000E+00 0.000E+00 0.000E+00 2.320E-05 Cr51 0.000E+00 0.000E+00 3.600E-09 2.000E-09 7.890E-10 5.140E-09 6.050E-07 Mn54 0.000E+00 5.900E-06 1.170E-06 0.000E+00 1.760E-06 0.000E+00 1.210E-05 Mn56 0.000E+00 1.580E-07 2.810E-08 0.000E+00 2.000E-07 0.000E+00 1.040E-05 Fs55 3.780E-06 2.680E-06 6.250E-07 0.000E+00 0.000E+00 1.700E-06 1.160E-06 Fn59 5.870E-06 1.370E-05 5.290E-06 0.000E+00 0.000E+00 4.320E-06 3.240E-05 CoS8 0.000E+00 9.720E-07 2.240E-06 0.000E+00 0.000E+00 0.000E+00 1.340E-05 Co60 0.000E+00 2.810E-06 6.330E-06 0.000E+00 0.000E+00 0.000E+00 3.660E-05 N163 1.770E-04 1.250E-05 6.000E-06 0.000E+00 0.000E+00 0.000E+00 1.990E-06 Ni65 7.490E-07 9.570E-08 4.360E-08 0.000E+00 0.000E+00 0.000E+00 5.190E-06 Cu64 0.000E+00 1.150E-07 5.410E-08 0.000E+00 2.910E-07 0.000E+00 8.920E-06 Zn65 5.760E-06 2.000E-05 9.330E-06 0.000E+00 1.280E-05 0.000E+00 8.470E-06 Zn69 1.470E-08 2.800E-08 1.960E-09 0.000E+00 1.830E-08 0.000E+00 5.160E-08 Br83 0.000E+00 0.000E+00 5.740E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 7.220E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 3.050E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 2.980E-05 1.400E-05 0.000E+00 0.000E+00 0.000E+00 4.410E-06

'Rb88 0.000E+00 8.520E-08 4.540E-08 0.000E+00 0.000E+00 0.000E+00 7.300E-15 Rb89 0.000E+00 5.500E-08 3.890E-08 0.000E+00 0.000E+00 0.000E+00 8.430E-17 Sr89 4.400E-04 0.000E+00 1.260E-05 0.000E+00 0.000E+00 0.000E+00 5.240E-05 Sr90 8.300E-03 0.000E+00 2.050E-03 0.000E+00 0.000E+00 0.000E+00 2.330E-04 Sr91 8.070E-06 0.000E+00 3.210E-07 0.000E+00 0.000E+00 0.000E+00 3.660E-05 Sr92 3.050E-06 0.000E+00 1.300E-07 0.000E+00 0.000E+00 0.000E+00 7.770E-05

'Y90 1.370E-08 0.000E+00 3.690E-10 0.000E+00 0.000E+00 0.000E+00 1.130E-04 Y91m 1.290E-10 0.000E+00 4.930E-12 0.000E+00 0.000E+00 0.000E+00 6.090E-09 Y91 2.010E-07 0.000E+00 5.390E-09 0.000E+00 0.000E+00 0.000E+00 8.240E-05 Y92 1.210E-09 0.000E+00 3.500E-11 0.000E+00 0.000E+00 0.000E+00 3.320E-05 Y93 3.830E-09 0.000E+00 1.050E-10 0.000E+00 0.000E+00 0.000E+00 1.170E-04

! Zr95 4.120E-08 1.300E-08 8.940E-09 0.000E+00 1.910E-08 0.000E+00 3.000E-05 Zr97 2.370E-09 4.690E-10 2.160E-10 0.000E+00 7.110E-10 0.000E+00 1.270E-04 lNb95 8.220E-09 4.560E-09 2.510E-09 0.000E+00 4.420E-09 0.000E+00 1.950E-05

'Mo99 0.000E+00 6.030E-06 1.150E-06 0.000E+00 1.380E-05 0.000E+00 1.080E-05 Tc99m 3.320E-10 9.260E-10 1.200E-08 0.000E+00 1.380E-08 5.140E-10 6.080E-07

'Tc101 3.600E-10 5.120E-10 5.030E-09 0.000E+00 9.260E-09 3.120E-10 8.750E-17 Rul03 2.550E-07 0.000E+00 1.090E-07 0.000E+00 8.990E-07 0.000E+00 2.130E-05 2.180E-08 0.000E+00 8.460E-09 0.000E+00 2.750E-07 0.000E+00 1.760E-05 lRul05 Rul06 3.920E-06 0.000E+00 4.940E-07 0.000E+00 7.560E-06 0.000E+00 1.880E-04

'Ag110m 2.050E-07 1.940E-07 1.180E-07 0.000E+00 3.700E-07 0.000E+00 5.450E-05 To125m 3.830E-06 1.380E-06 5.120E-07 1.070E-06 0.000E+00 0.000E+00 1.130E-05 lTol27m 9.670E-06 3.430E-06 1.150E-06 2.300E-06 3.920E-05 0.000E+00 2.410E-05 Tc127 1.580E-07 5.600E-08 3.400E-08 1.090E-07 6.400E-07 0.000E+00 1.220E-05 Ta129m 1.630E-05 6.050E-06 2.580E-06 5.260E-06 6.820E-05 0.000E+00 6.120E-05

'Te129 4.480E-08 1.670E-08 1.090E-08 3.200E-08 1.880E-07 0.000E+00 2.450E-07 lTs131m 2.440E-06 1.170E-06 9.760E-07 1.760E-06 1.220E-05 0.000E+00 9.390E-05

!Te131 2.790E-08 1.150E-08 8.720E-09 2.150E-08 1.220E-07 0.000E+00 2.290E-09 (Te132 3.490E-06 2.210E-06 2.080E-06 2.330E-06 2.120E-05 0.000E+00 7.000E-05

l ODCM Rev. 14 Pago 111 l- 6/94 1 Table 1-1 (Continued)

Llauld Dose Factors From Table E-12 or Reg. Guide 1.109 Ing:stion Dose Factors For Teen:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 1.030E-06 2.980E-06 1.190E-06 2.430E-04 4.590E-06 0.000E+00 2.290E-06 I131 5.850E-06 8.190E-06 4.400E-06 2.390E-03 1.410E-05 0.000E+00 1.620E-06 I132 2.790E-07 7.300E-07 2.620E-07 2.460E-05 1.150E-06 0.000E+00 3.180E-07 I133 2.010E-06 3.410E-06 1.040E-06 4.760E-04 5.980E-06 0.000E+00 2.580E-06 I134 1.460E-07 3.870E-O'i 1.390E-07 6.450E-06 6.100E-07 0.000E+00 5.100E-09 I135 6.100E-07 1.570E-06 5.820E-07 1.010E-04 2.480E-06 0.000E+00 1.740E-06 Cn134 8.370E-05 1.970E-04 9.140E-05 0.000E+00 6.260E-05 2.390E-05 2.450E-06 C3136 8.590E-06 3.380E-05 2.270E-05 0.000E+00 1.840E-05 2.900E-06 2.720E-06 C2137 1.120E-04 1.490E-04 5.190E-05 0.000E+00 5.070E-05 1.970E-05 2.120E-06 Cs138 7.760E-08 1.490E-07 7.450E-08 0.000E+00 1.100E-07 1.280E-08 6.760E-11 B2139 1.390E-07 9.780E-11 4.050E-09 0.000E+00 9.220E-11 6.740E-11 1.240E-06 B2140 2.840E-05 3.480E-08 1.830E-06 0.000E+00 1.180E-08 2.340E-08 4.380E-05 Bn141 6.710E-08 5.010E-11 3.240E-09 0.000E+00 4.650E-11 3.430E-11 1.430E-13 Ba142 2.990E-08 2.990E-11 1.840E-09 0.000E+00 2.530E-11 1.990E-11 9.180E-20 La140 3.480E-09 1.710E-09 4.550E-10 0.000E+00 0.000E+00 0.000E+00 9.820E-05 La142 1.790E-10 7.950E-11 1.980E-11 0.000E+00 0.000E+00 0.000E+00 2.420E-06 Cc141 1.330E-08 8.880E-09 1.020E-09 0.000E+00 4.180E-09 0.000E+00 2.540E-05 Co143 2.350E-09 1.710E-06 1.910E-10 0.000E+00 7.670E-10 0.000E+00 5.140E-05 Cn144 6.960E-07 2.880E-07 3.740E-08 0.000E+00 1.72GE-07 0.000E+00 1.750E Pr143 1.310E-08 5.230E-09 6.520E-10 0.000E+00 3.040E-09 0.000E+00 4.310E-05 Pr144 4.300E-11 1.760E-11 2.180E-12 0.000E+00 1.010E-11 0.000E+00 4.740E-14 Nd147 9.380E-09 1.020E-08 6.110E-10 0.000E+00 5.990E-09 0.000E+00 3.680E-05 W187 1.460E-07 1.190E-07 4.170E-08 0.000E+00 0.000E+00 0.000E+00 3.220E-05 Np239 1.760E-09 1.660E-10 9.220E-11 0.000E+00 5.210E-10 0.000E+00 2.670E-05 l

l ODCM Rev. 14 Pago 112 l 6/94 Table 1-1 (Continued)

Licuid Dose Factors Frem Table E-13 or Reg. Guide 1.109 Ing^stion Dose Factors For Child:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 2.030E-07 C14 1.210E-05 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 2.420E-06 N324 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 5.800E-06 P32 8.250E-04 3.860E-05 3.180E-05 0.000E+00 0.000E+00 0.000E+00 2.280E-05 Cr51 0.000?+00 0.000E+00 8.900E-09 4.940E-09 1.350E-09 9.020E-09 4.720E Mn54 0.000E+00 1.070E-05 2.850E-06 0.000E+00 3.000E-06 0.000E+00 8.980E-06 Mn56 0.000E+00 3.340E-07 7.540E-08 0.000E+00 4.040E-07 0.000E+00 4.840E-05 Fa55 1.150E-05 6.100E-06 1.890E-06 0.000E+00 0.000E+00 3.450E-06 1.130E-06 FC59 1.650E-05 2.670E-05 1.330E-05 0.000E+00 0.000E+00 7.740E-06 2.780E-05 CoS8 0.000E+00 1.800E-06 5.510E-06 0.000E+00 0.000E+00 0.000E+00 1.050E-05 Co60 0.000E+00 5.290E-06 1.560E-05 0.000E+00 0.000E+00 0.000E+00 2.930E-05 Ni63 5.380E-04 2.880E-05 1.830E-05 0.000E+00 0.000E+00 0.000E+00 1.940E-06 Ni65 2.220E-06 2.090E-07 1.220E-07 0.000E+00 0.000E+00 0.000E+00 2.560E-05 CuG4 0.000E+00 2.450E-07 1.480E-07 0.000E+00 5.920E-07 0.000E+00 1.150E-05 Zn65 1.370E05 3.650E-05 2.270E-05 0.000E+00 2.300E-05 0.000E+00 6.410E-06 Zn69 4.380E-08 6.330E-08 5.850E-09 0.000E+00 3.840E-08 0.000E+00 3.990E-06 Br83 0.000E+00 0.000E+00 1.710E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 1.980E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 9.120E-09 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 6.700E-05 4.120E-05 0.000E+00 0.000E+00 0.000E+00 4.310E-06 Rb88 0.000E+00 1.900E-07 1.320E-07 0.000E+00 0.000E+00 0.000E+00 9.320E-09 Rb89 0.000E+00 1.170E-07 1.040E-07 0.000E+00 0.000E+00 0.000E+00 1.020E-09 Sr89 1.320E-03 0.000E+00 3.770E-05 0.000E+00 0.000E+00 0.000E+00 5.110E-05 l Sr90 1.700E-02 0.000E+00 4.310E-03 0.000E+00 0.000E+00 0.000E+00 2.290E-04 Sr91 2.400E-05 0.000E+00 9.060E-07 0.000E+00 0.000E+00 0.000E+00 5.300E-05 Sr92 9.030E-06 0.000E+00 3.620E-07 0.000E+00 0.000E+00 0.000E+00 1.710E-04

!Y90 4.110E-08 0.000E+00 1.100E-09 0.000E+00 0.000E+00 0.000E+00 1.170E-04

'Y91m 3.820E-10 0.000E+00 1.390E-11 0.000E+00 0.000E+00 0.000E+00 7.480E-07 Y91 6.020E-07 0.000E+00 1.610E-08 0.000E+00 0.000E+00 0.000E+00 8.020E-05 lY92 3.600E-09 0.000E+00 1.030E-10 0.000E+00 0.000E+00 0.000E+00 1.040E-04 iY93 1.140E-08 0.000E+00 3.130E-10 0.000E+00 0.000E+00 0.000E+00 1.700E-04

'Zr95 1.160E-07 2.550E-08 2.270E-08 0.000E+00 3.650E-08 0.000E+00 2.660E-05 Zr97 6.990E-09 1.010E-09 5.960E-10 0.000E+00 1.450E-09 0.000E+00 1.530E-04 Nb95 2.250E-08 8.760E-09 6.260E-09 0.000E+00 8.230E-09 0.000E+00 1.620E-05 lMo99 0.000E+00 1.330E-05 3.290E-06 0.000E+00 2.840E-05 0.000E+00 1.100E-05 Tc99m 9.230E-10 1.810E-09 3.000E-08 0.000E+00 2.630E-08 9.190E-10 1.030E-06 Tc101 1.070E-09 1.120E-09 1.420E-08 0.000E+00 1.910E-08 5.920E-10 3.560E-09 Rul03 7.310E-07 0.000E+00 2.810E-07 0.000E+00 1.840E-06 0.000E+00 1.890E-05 Rul05 6.450E-08 0.000E+00 2.340E-08 0.000E+00 5.670E-07 0.000E+00 4.210E-05 Rul06 1.170E-05 0.000E+00 1.460E-06 0.000E+00 1.580E-05 0.000E+00 1.820E-04

,Ag110m 5.390E-07 3.640E-07 2.910E-07 0.000E+00 6.780E-07 0.000E+00 4.330E-05

!Ts125m 1.140E-05 3.090E-06 1.520E-06 3.200E-06 0.000E+00 0.000E+00 1.100E-05 ITa127m 2.890E-05 7.780E-06 3.430E-06 6.910E-06 8.240E-05 0.000E+00 2.340E-05

,Tc127 4.710E-07 1.270E-07 1.010E-07 3.260E-07 1.340E-06 0.000E+00 1.840E-05 lTo129m 4.870E-05 1.360E-05 7.560E-06 1.570E-05 1.430E-04 0.000E+00 5.940E-05 To129 1.340E-07 3.740E-08 3.180E-08 9.560E-08 3.920E-07 0.000E+00 8.340E-06 To131m 7.200E-06 2.490E-06 2.650E-06 5.120E-06 2.410E-05 0.000E+00 1.010E-04 iTc131 8.300E-08 2.530E-08 2.470E-08 6.350E-08 2.510E-07 0.000E+00 4.360E-07

.To132 1.010E-05 4.470E-06 5.400E-06 6.510E-06 4.150E-05 0.000E+00 4.500E-05

l ODCM Rev. 14 Page 113 l- 6/94 Table 1-1 (Continued)

Licuid Dose Factors From Table E-13 or Reg. Guide 1.109

.Ingsstion Dose Factors For Child:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI I130 2.920E-06 5.900E-06 3.040E-06 6.500E-04 8.820E-06 0.000E+00 2.760E-06 I131 1.720E-05 1.730E-05 9.830E-06 5.720E-03 2.840E-05 0.000E+00 1.540E-06 I132 8.000E-07 1.470E-06 6.760E-07 6.820E-05 2.250E-06 0.000E+00 1.730E-06 I133 5.920E-06 7.320E-06 2.770E-06 1.360E-03 1.220E-05 0.000E+00 2.950E-06 I134- 4.190E-07 7.780E-07 3.580E-07 1.790E-05 1.190E-06 0.000E+00 5.160E-07 I135 1.750E-06 3.150E-06 1.490E-06 2.790E-04 4.830E-06 0.000E+00 2.400E-06 Cs134 2.340E-04 3.840E-04 8.100E-05 0.000E+00 1.190E-04 4.270E-05 2.070E-06 Cn136 2.350E-05 6.460E-05 4.180E-05 0.000E+00 3.440E-05 5.130E-06 2.270E-06 Cs137 3.270E-04 3.130E-04 4.620E-05 0.000E+00 1.020E-04 3.670E-05 1.960E-06 CD138 2.280E-07 3.170E-07 2.010E-07 0.000E+00 2.230E-07 2.400E-08 1.460E-07 B3139- 4.140E-07 2.210E-10 1.200E-08 0.000E+00 1.930E-10 1.300E-10 2.390E-05 Ba140 8.310E-05 7.280E-08 4.850E-06 0.000E+00 2.370E-08 4.340E-08 4.210E-05 Ba141 2.000E-07 1.120E-10 6.510E-09 0.000E+00 9.690E-11 6.580E-10 1.140E-07 Ba142 8.740E-08 6.290E-11 4.880E-09 0.000E+00 5.090E-11 3.700E-11 1.140E-09 La140 1.010E-08 3.530E-09 1.190E-09 0.000E+00 0.000E+00 0.000E+00 9.840E-05 La142 5.240E-10 1.670E-10 5.230E-11 0.000E+00 0.000E+00 0.000E+00 3.310E-05 Co141 3.970E-08 1.980E-08 2.940E-09 0.000E+00 8.680E-09 0.000E+00 2.470E-05 Ca143 6.990E-09 3.790E-06 5.490E-10 0.000E+00 1.590E-09 0.000E+00 5.550E-05 Cc144 2.080E-06 6.520E-07 1.110E-07 0.000E+00 3.610E-07 0.000E+00 1.700E-04 Pr143 3.930E-08 1.180E-08 1.950E-09 0.000E+00 6.390E-09 0.000E+00 4.240E-05 Pr144 1.290E-10 3.990E-11 6.490E-12 0.000E+00 2.110E-11 0.000E+00 8.590E-08

,Nd147 2.790E-08 2.260E-08 1.750E-09 0.000E+00 1.240E-08 0.000E+00 3.580E-05 W187 4.290E-07 2.540E-07 1.140E-07 0.000E+00 0.000E+00 0.000E+00 3.570E-05 Np239 5.250E-09 3.770E-10 2.650E-10 0.000E+00 1.090E-09 0.000E+00 2.790E-05 l

i i

l' ODCM Rav. 14 Pago 114 l 6/94

'able 1-1 (Continued)

Liauld Dose Factors From Table E-14 or Reg. Guide 1.109 Ingsstion Dose Factors For Infant:

BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H3 0.000E+00 3.080E-07 3.080E-07 3.080E-07 3.080E-07 3.080E-07 3.080E-07 C14 2.370E-05 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 5.060E-06 Na24 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 1.010E-05 P32 1.700E-03 1.000E-04 6.590E-05 0.000E+00 0.000E+00 0.000E+00 2.300E-05 Cr51 0.000E+00 0.000E+00 1.410E-08 9.200E-09 2.010E-09 1.790E-08 4.110E-07 Mn54 0.000E+00 1.990E-05 4.510E-06 0.000E+00 4.410E-06 0.000E+00 7.310E-06 Mn56 0.000E+00 8.180E-07 1.410E-07 0.000E+00 7.030E-07 0.000E+00 7.430E-05 FcS5 1.390E-05 8.980E-06 2.400E-06 0.000E+00 0.000E+00 4.390E-06 1.140E-06 FcS9 3.080E-05 5.380E-05 2.120E-05 0.000E+00 0.000E+00 1.590E-05 2.570E-05 CoS8 0.000E+00 3.600E-06 8.980E-06 0.000E+00 0.000E+00 0.000E+00 8 670E-06 Co60 0.000E+00 1.080E-05 2.550E-05 0.000E+00 0.000E+00 0.000E+00 2.670E-05 Ni63 6.340E-04 3.920E-05 2.200E-05 0.000E+00 0.000E+00 0.000E+00 1.950E-06 Ni65 4.700E-06 5.320E-07 2.420E-07 0.000E+00 0.000E+00 0.000E+00 4.050E-05 Cu64 0.000E+00 6.090E-07 2.820E-07 0.000E+00 1.030E-06 0.000E+00 1.250E-05 Zn65 1.840E-05 6.310E-05 2.910E-05 0.000E+00 3.060E-05 0.000E+00 5.330E-05 Zn69 9.330E-08 1.680E-07 1.250E-08 0.000E+00 6.980E-08 0.000E+00 1.370E-05 Br83 0.000E+00 0.000E+00 3.630E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br84 0.000E+00 0.000E+00 3.820E-07 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Br85 0.000E+00 0.000E+00 1.940E-08 0.000E+00 0.000E+00 0.000E+00 0.000E+00 Rb86 0.000E+00 1.700E-04 8.400E-05 0.000E+00 0.000E+00 0.000E+00 4.350E-06 Rb88 0.000E+00 4.980E-07 2.730E-07 0.000E+00 0.000E+00 0.000E+00 4.850E-07 Rb89 0.000E+00 2.860E-07 1.970E-07 0.000E+00 0.000E+00 0.000E+00 9.740E-08 Sr89 2.510E-03 0.000E+00 7.200E-05 0.000E+00 0.000E+00 0.000E+00 5.160E-05 Sr90 1.850E-02 0.000E+00 4.710E-03 0.000E+00 0.000E+00 0.000E+00 2.310E-04 Sr91 5.000E-05 0.000E+00 1.810E-06 0.000E+00 0.000E+00 0.000E+00 5.920E-05 Sr92 1.920E-05 0.000E+00 7.130E-07 0.000E+00 0.000E+00 0.000E+00 2.070E-04 Y90 8.690E-08 0.000E+00 2.330E-09 0.000E+00 0.000E+00 0.000E+00 1.200E-04

'Y91m 8.100E-10 0.000E+00 2.760E-11 0.000E+00 0.000E+00 0.000E+00 2.700E-06 Y91 1.130E-06 0.000E+00 3.010E-08 0.000E+00 0.000E+00 0.000E+00 8.100E-05 Y92 7.650E-09 0.000E+00 2.150E-10 0.000E+00 0.000E+00 0.000E+00 1.460E-04 l Y93 2.430E-08 0.000E+00 6.620E-10 0.000E+00 0.000E+00 0.000E+00 1.920E-04

'Zr95 2.060E-07 5.020E-08 3.560E-08 0.000E+00 5.410E-08 0.000E+00 2.500E-05 Zr97 1.480E-08 2.540E-09 1.160E-09 0.000E+00 2.560E-09 0.000E+00 1.620E-04 Nb95 4.200E-08 1.730E-06 1.000E-08 0.000E+00 1.240E-08 0.000E+00 1.460E-05

,Mo99 0.000E+00 3.400E-05 6.630E-06 0.000E+00 5.080E-05 0.000E+00 1.120E-05 ;

! Tc99m 1.920E-09 3.960E-09 5.100E-08 0.000E+00 4.260E-08 2.070E-09 1.150E-06 l Tc101 2.270E-09 2.860E-09 2.830E-08 0.000E+00 3.400E-08 1.560E-09 4.860E-07

'Rul03 1.480E-06 0.000E+00 4.950E-07 0.000E+00 3.080E-06 0.000E+00 1.800E-05 1 Rul05 1.360E-07 0.000E+00 4.580E-08 0.000E+00 1.000E-06 0.000E+00 5.410E-05 (RulO6 2.410E-05 0.000E+00 3.010E-06 0.000E+00 2.850E-05 0.000E+00 1.830E-04

!Ag110m 9.960E-07 7.270E-07 4.810E-07 0.000E+00 1.040E-06 0.000E+00 3.770E-05 lTc125m 2.330E-05 7.790E-06 3.150E-06 7.840E-06 0.000E+00 0.000E+00 1.110E-05 To127m 5.850E-05 1.940E-05 7.080E-06 1.690E-05 1.440E-04 0.000E+00 2.360E-05

'Tc127 1.000E-06 3.350E-07 2.150E-07 8.140E-07 2.440E-06 0.000E+00 2.100E-05 To129m 1.000E-04 3.430E-05 1.540E-05 3.840E-05 2.500E-04 0.000E+00 5.970E-05

'Te129 2.840E-07 9.790E-08 6.630E-08 2.380E-07 7.070E-07 0.000E+00 2.270E-05 Ta131m 1.520E-05 6.120E-06 5.050E-06 1.240E-05 4.210E-05 0.000E+00 1.030E-04 tTe131 1.760E-07 6.500E-08 4.940E-08 1.570E-07 4.500E-07 0.000E+00 7.110E-06 To132 2.080E-05 1.030E-05 9.610E-06 1.520E-05 6.440E-05 0.000E+00 3.810E-05 1

[l - ODCM Rav. 14'

. Page:115

l 6/94 Table 1-1.(Continued) -

?Liuuid Dose Factors

>From Table E-14 or Reg. Guide 1.109 -

'Ingsstion Dose Factors For Infant:

BONE ' LIVER T. BODY THYROID KIDNEY. LUNG GI-LLI I130 6.000E-06 1.320E-05 5.300E-06 1.480E-03 1.450E-05.0.000E+00 2.830E-06 I131 3.590E-05 4.230E-05 1.860E-05 1.390E-02'4.940E-05 0.000E+00 1.510E-06'

-I132 1.660E-0613.370E-06-1.200E-06 1.580E-04 3.760E-06 0.000E+00 2.730E-06

I133' 1.250E-05-1.820E-05 5.330E-06 3.310E-03 2.140E-05 0.000E+00 3.080E-06 LI134 8.690E-07 1.780E-06 6.330E-07 4.150E-05 1.990E-06 0.000E+00 1.840E-06 I135 3.640E-06 7.240E-06 2.640E-06 6.490E-04 8.070E-06 0.000E+00.2.620E-06 Cs134 3.770E-04 7.030E-04 7.100E-05 0.000E+00 1.810E-04~7.420E-05 1.910E-06

-Cs136- 4.590E-05 1.350E-04 5.040E-05 0.000E+00 5.380E-05 1.100E-05.2.050E-06

.-Cs137' 5.220E-04 6.110E-04 4.330E-05 0.000E+00 1.640E-04 6.640E-05 1.910E-06 Ca138 4.810E-07 7.820E-07 3.790E-07 0.000E+00 3.900E-07 6.090E-08 1.250E-06 <

Bm139 8.810E-07 5.840E-10 2.550E-08 0.000E+00 3.510E-10 3.540E-10 5.580E-05 i Ba140' 1.710E-04 1.710E-07 8.810E-06 0.000E+00 4.060E-08 1.050E-07 4.200E-05 4 ,Bn141 4.250E-07 2.910E-10 1.340E-08 0.000E+00 1.750E-10 1.770E-10 5.190E-06 Ba142 1.840E-07 1.530E-10 9.060E-09 0.000E+00 8.810E-11 9.260E-11 7.590E-07 i La140 2.110E-08 8.320E-09 2.140E-09 0.000E+00 0.000E+00 0.000E+00 9.770E-05 La142 1.100E-09 4.040E-10 9.670E-11 0.000E+00 0.000E+00 0.000E+00 6.860E-05

, Ce141 7.870E-08 4.800E-08 5.650E-09 0.000E+00 1.480E-08 0.000E+00 2.480E-05 Co143 1.480E-08 9.820E-06 1.120E-09 0.000E+00 2.860E-09 0.000E+00 5~.730E-05 Ce144 ~2.980E-06 1.220E-06 1.670E-07 0.000E+00 4.930E-07 0.000E+00 1.710E Pr143 8.130E-08 3.040E-08 4.030E-09 0.000E+00 1.130E-08 0.000E+00 4.290E-05 Pr144 2.740E-10 1.060E-10 1.380E-11 0.000E+00 3.840E-11 0.000E+00 4.930E-06 i Nd147 5.530E-08 5.680E-08 3.480E-09 3.000E+00 2.190E-08 0.000E+00.3.600E-05

W187 9.030E-07 6.280E-07 2.170E-07 0.000E+00 0.000E+00 0.000E+00 3.690E-05' Np239. 1.110E-08 9.930E-10 5.610E-10 0.000E+00 1.980E-09 0.000E+00 2.870E-05 j

i l

i J

..# < . ; - ~ ~ - - -

.> _ . - . - m qQif f __ .W~

~ '

1 ,

g ^

/ODCM'R$v.314 -

sw js s , ~Paga:116-Ef!E]d ' [ *

~6/94 ,

2 ,

%g# - Table 1-2~

Assuinptions used iniLimerick ' Liqui'd - +

EffluentiDose Evaluation.

IndSX.. .= .

Descrintion value 117Fr0ction_offproduce from local' garden .7.600E-01

12fFraction ofLleafy veg from local garden 1.000E+00' d

'3 Scil' density in' plow: layer 0(kg/m**2)' ~

2~.400E+02; 9 4! Fraction of activity retained on_ sprayed-vegetation 2.500E-01 j 5 Shielding ~ factor-for residential structures' 7.000E-01: *

(6 4 POriod of buildup. of activity 1in soil (hr) ~

1.752E+05 ]

3 7iPariod.of pasture grass exposure to activityL(hr)- .7.200E+02

8 Pariod of crop exposure to activity (hr) 1.440E+03

~

. L9; Holding time in animal. drinking water pond (hr) .

0.'000E+00- :

910LDelay time'for ingestion:of grass by animals (hr) 0.000E+00. "

4 L11 Delay time for ingestion of stored fee by animals (hr)- 2.160E+03c ;

p 12 Delay time for ingestion. of leaf veg by man (hr) 2.400E+01 113 Delay _ time forfingestion of other veg by' man-(hr) 1.440E+03

14 Transport time milk-man _(hr) .

4.800E+01 15 TimeLbetween slaughter and consumption of meat. animal (hr) 4.800E+02 ,

?l6_' Grass. yield, wet wt (kg/m**2) _

7.000E-01 E17 Other vegetation yield,._ wet wt (kg/m**2) 2.000E+00 r 3 L'18' Wacthering rate constant _ for activity on vegetation -(1/hr) 2.100E-03--

5.000E+01.

i19 Milk cow feed consumption rate-(kg/ day wet) 20.Gost. feed consumption' rate =(kg/ day wet) 6.'000E+00-21 Baof cattle feed consumption < rate (kg/ day wet) 5.000E+01 i l22 Milk cow' water consumption rate-(1/ day) 6.000E+01; , s "23:Gont water consumption rate ~(1/ day) . 8.000E+00-24}Basf cattle water consumption rate-(1/ day) -5.000E+01 25'Enytl transit time for water ingestion-(hr) 1.200E+01:

26 Enytl transit time for fish ingestion'(hr) 2.400E+01' L27fEnytl transit' time for_ invertebrate ingestion-(hr) 2.400E+01 ,

L28 Enyt1 transit-time for shore' exposure (hr) 'O.000E+00 -

l29Wateringestion(1/yr) adult 7.300E+02 l30' Water ingestion (1/yr) teen '

'5.100E+02-31 Water ingestion (1/yr) child 5.100E+02?

32 Water ingestion (1/yr) infant 3.'300E+02-33 Shore exposure (hr/yr) adult '1.200E+01, l34-Shore exposure (hr/yr) teen 6.700E+01 l35_ Shore exposure-(hr/yr) child 1.400E+01'-

'36--Shore exposure (hr/yr) infant 'O.000E+00 37'Frach water sport fish ingestion (kg/yr) adult 2.100E+01' l l381 Fresh water sport fish ingestion (kg/yr) teen 1.600E+01 r l39 Frach water sport fish ingestion _(kg/yr) child 6.900E+00

!40. Frosh water sport fish. ingestion (kg/yr) infant. 0.000E+00 41uFrechLwater commercial fish ingestion (kg/yr) adult 2.100E+01 42 Frash water. commercial fish ingestion (kg/yr) teen 1.600E+01 ,

!43' Frech water commercial fish ingestion (kg/yr) child 6.900E+00 l44 ' Fresh water commercial fish ingestion (kg/yr) infant 0.000E+00-i45~ Fresh water invertebrate ingestion (kg/yr) adult' 5.000E+00 '

l46 Fresh water 4 invertebrate ingestion (kg/yr) teen 3.800E+00 (47 Frcsh water invertebrate ingestion (kg/yr) child 1.700E+00 48 Frach water invertebrate ingestion (kg/yr) infant 0.000E+00 ,

p i

l ODCM Rav. 14 Pago 117 l 6/94 Table 1-2 I Assumptions used in Limerick Liquid Effluent Dose Evaluation Index Descriotion Value 49 . Salt Water Sport Fish Ingestion (kg/yr) Adult 2.100E+01 '

50 Salt Water Sport Fish Ingestion (kg/yr) Teen 1.600E+01

- 51' Salt Water Sport Fish Ingestion (kg/yr) Child 6.900E+00 ,

15 2 Salt Water Sport Fish Ingestion (kg/yr) Infant 0.000E+00 l

'53 Salt Water Commercial Fish Ingestion (kg/yr) Adult 2.100E+01 54' Salt Water Commercial Fish Ingestion (kg/yr) Teen 1.600E+01 !

-55 Salt Water Commercial Fish Ingestion (kg/yr) Child- 6.900E+00 -l

.56 Salt Water Commercial Fish Ingestion (kg/yr) Infant 0.000E+00 1 57 Salt Water Invertebrate Ingestion (kg/yr) Adult 5.000E+00 l

.58 Salt Water Invertebrate Ingestion (kg/yr) Teen 3.800E+00 i 59 Salt Water Invertebrate Ingestion (kg/yr) Child 1.700E+00 60 Salt Water Invertebrate Ingestion (kg/yr) Infant 0.000E+00 61 Irrigated Leafy Vegetable Ingestion (kg/yr) Adult 6.400E+01

'62 Irrigated Leafy Vegetable Ingestion (kg/yr) Teen 4.200E+01 53 Irrigated Leafy Vegetable Ingestion (kg/yr) Child 2.600E+01 64 ' Irrigated Leafy Vegetable Ingestion (kg/yr) Infant 0.000E+00 1 65 Irrigated Other Vegetable Ingestion (kg/yr) Adult 5.200E+02 I 66 Irrigated Other Vegetable Ingestion (kg/yr) Teen 6.300E+02 67 Irrigated Other Vegetable Ingestion (kg/yr) Child 5.200E+02 68 Irrigated.Other Vegetable Ingestion (kg/yr) Infant 0.000E+00 4 69 Irrigated Root Vegetable Ingestion.(kg/yr) Adult 5.200E+02 70 Irrigated Root Vegetable Ingestion (kg/yr) Teen 6.300E+02 71 Irrigated Root Vegetable Ingestion (kg/yr) Child 5.200E+02 72 Irrigated Root Vegetable Ingestion (kg/yr) Infant 0.000E+00 73 Irrigated Cow Milk Ingestion (1/yr) Adult 3.100E+02 74 Irrigated Cow Milk Ingestion (1/yr) Teen 4.000E+02 75 Irrigated Cow Milk Ingestion (1/yr) Child 3.300E+02 76 Irrigated Cow Milk Ingestion (1/yr) Infant 3.300E+02 77 Irrigated Goat Milk Ingestion (1/yr) Adult 3.100E+02 78 Irrigated Goat Milk Ingestion (1/yr) Teen 4.000E+02 79 Irrigated Goat Milk Ingestion (1/yr) Child 3.300E+02 80 Irrigated Goat Milk Ingestion (1/yr) Infant 3.300E+02 81 Irrigated Beef Ingestion (1/yr) Adult 1.100E+02

'82 Irrigated Beef Ingestion (1/yr) Teen 6.500E+01 83 Irrigated Beef Ingestion (1/yr) Child 4.100E+01-84 Irrigated Beef Ingestion (1/yr) Infant 0.000E+00

._ g-

$ j ODCM.Rsv.' 14

~P gs 118

]c 6/94

, Table 2-1 Dose Factors for Noble Gas- ;

Total Body. Beta' Skin Gamma-Air- Beta Air .;

Dose Factor Dose Factor Dose ~ Factor Dose Factor Ki (arem/yr' 'Li (mram/yr Mi'(mrad.yr Ni-(mrad /yr per per per per

'Index Radionuclide pCi/m 3) pCi/m 3)- pC1/m3) pCi/m 3) 3 Ar-41 8.84E-03 2.69E-03 9.30E-03 3.28E-03

.4- Kr-83m 7.56E-08 -------

1.93E-05 2.88E-04 5- Kr-85m 1.17E-03 1.46E-03 1.23E-03 1.97E-03 6' Kr-85 1.61E-05 1.34E-03 1.72E-05 1.95E-03 -j l

7 Kr-87 5.92E-03 9.73E-03: 6.17E-03 1.03E-02 3 8 -Kr-88 1.47E-02 2.37E-03 1.52E-02 2~93E-03 9 Kr-89 1.66E-02 1.01E-02 1.73E-02 1.06E-02 l

'10 Kr-90 1.56E-02 7.29E-03 1.63E-02 7.83E .

L .

p 11 Xe-131m 9.15E-05 4.76E-04 1.56E-04 '1.11E-03 12- Xe-133m- 2.51E-04 9.94E-04 3.27E-04 . 1.48E-03

13. Xe-133 2.94E-04 3.06E 3.53E-04 1.05E l L 14 Xe-135m 3.12E-03 7.11E-04 3.36E-03 7.39E-04 l

15F Xe-135 1.81E-03 1.86E-03 1.92E-03 2.46E-03 L 16 ~Xe-137 1.42E-03 1.22E-02 1.51E-03 1.27E-02 t I

17 Xe-138 8.83E-03 4.13E-03 9.21E-03 4.75E-03

-l J

L

.y +

'l 4 ODCM Riv. 14

-Pcga'119

.ll 6/94 TABLE 2-2 INGESTION INDIVIDUAL DOSE FACTORS (DFggy) .

For Gaseous Effluents UNITS FOR AIRBORNE ~ PATHWAYS (Pathtwy Numbers'1 and 7) are:

3 mrem-m /Ci-sec UNITS FOR DEPOSITION PATHWAYS

-(Pathway Numbers 2-6) are:

2 mrem-m /Ci Pathway No. Pathway 1 Plume 2 Ground 3 Vegetable 4 Meat 5 Cow Milk 6 Goat Milk ,

7 Inhalation 1

l

l. ODCM Rev. 14 I Pago' 120 l l 6/94 Table 2-2

' INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: H3 For Pathway: Plume

.T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Child! 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.53E+01 6.53E+01 0.00E+00 6.53E+01 6.53E+01 6.53E+01 6.53E+01 0.00E+00 Tenn: 7.75E+01 7.75E+01 0.00E+00 7.75E+01 7.75E+01 7.75E+01 7.75E+01 0.00E+00 Child: 1.21E+02 1.21E+02 0.00E+00 1.21E+02 1.21E+02 1.21E+02 1.21E+02 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 7.98E+00 7.98E+00 0.00E+00 7.98E+00 7.98E+00 7.98E+00 7.98E+00 0.00E+00 Taant 4.75E+00 4.76E+00 0.00E+00 4.76E+00 4.76E+00 4.76E+00 4.76E+00 0.00E+00 Child: 5.75E+00 5.75E+00 0.00E+00 5.75E+00 5.75E+00 5.75E+00 5.75E+00 0.00E+00

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.88E+01 1.88E+01 0.00E+00 1.88E+01 1.88E+01 1.88E+01 1.88E+01 0.00E+00 Tenn: 2.45E+01 2.45E+01 0.00E+00 2.45E+01 2.45E+01 2.45E+01 2.45E+01 0.00E+00 Child: 3.87E+01 3.87E+01 0.00E+00 3.87E+01 3.87E+01 3.87E+01 3.87E+01 0.00E+00 Infant: 5.87E+01 5.87E+01 0.00E+00 5.37E+01 5.87E+01 5.87E+01 5.87E+01 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 3.83E+01 3.88E+01 0.00E+00 3.83E+01 3.83E+01 3.83E+01 3.83E+01 0.00E+00 iTeen: 4.99E+01 4.99E+01 0.00E+00 4.99E+01 4.99E+01 4.99E+01 4.99E+01 0.00E+00 iChild: 7.89E+01 7.89E+01 0.00E+00 7.89E+01 7.89E+01 7.89E+01 7.89E+01 0.00E+00

' Infant: 1.20E+02 1.20E+02 0.00E+00 1.20E+02 1.20E+02 1.20E+02 1.20R+02 0.00E+00 lFor Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 4.01E+01 4.01E+01 0.00E+00 4.01E+01 4.01E+01 4.01E+01 4.01E+01 0.00E+00 lToen 4.03E+01 4.03E+01 0.00E+00 4.03E+01 4.03E+01 4.03E+01 4.03E+01 0.00E+00 l Child: 3.57E+01 3.57E+01 0.00E+00 3.57E+01 3.57E+01 3.57E+01 3.57E+01 0.00E+00 (Infant: 2.05E+01 2.05E+01 0.00E+00 2.05E+01 2.05E+01 2.05E+01 2.05E+01 0.00E+00 l

l ODCM Rev. 14 Paga 121 l 6/94 i

Table 2-2 (Continued) ,

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: C14 i l

For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 5.22E+03 5.22E+03 2.61E+04 5.22E+03 5.22E+03 5.22E+03 5.22E+03 0.00E+00 l Tecn: 8.79E+03 8.79E+03 4.39E+04 8.79E+03 8.79E+03 8.79E+03 8.79E+03 0.00E+00 l Child: 2.14E+04 2.14E+04 1.07E+05 2.14E+04 2.14E+04 2.14E+04 2.14E+04 0.00E+00 1 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.64E+03 1.64E+03 8.22E+03 1.64E+03 1.64E+03 1.64E+03 1.64E+03 0.00E+00 ,

Tson: 1.39E+03 1.39E+03 6.94E+03 1.39E+03 1.39E+03 1.39E+03 1.39E+03 0.00E+00' I Child: 2.61E+03 2.61E+03 1.31E+04 2.61E+03 2.61E+03 2.61E+03 2.61E+03 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 Tctn: 3.31E+03 3.31E-03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child: 8.13E+03 8.13E-03 4.07E+04 8.13E+03 3.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.79E+03 1.79E+03 8.97E+03 1.79E+03 1.79E+03 1.79E+03 1.79E+03 0.00E+00 l Teen: 3.31E+03 3.31E+03 1.65E+04 3.31E+03 3.31E+03 3.31E+03 3.31E+03 0.00E+00 Child: 8.13E+05 8.13E+03 4.07E+04 8.13E+03 8.13E+03 8.13E+03 8.13E+03 0.00E+00 Infant: 1.70E+04 1.70E+04 7.97E+04 1.70E+04 1.70E+04 1.70E+04 1.70E+04 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.08E+02 1.08E+02 5.76E+02 1.08E+02 1.08E+02 1.08E+02 1.08E+02 0.00E+00 Tcen: 1.54E+02 1.54E+02 8.24E+02 1.54E+02 1.54E+02 1.54E+02 1.54E+02 0.00E+00 Child: 2.13E+02 2.13E+02 1.14E+03 2.13E+02 2.13E+02 2.13E+02 2.13E+02 0.00E+00 Infant: 1.68E+02 1.68E+02 8.39E+02 1.68E+02 1.68E+02 1.68E+02 1.68E+02 0.00E+00

l l

ODCM Rav. 14 I Page 122 l 6/94 l

Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ar41 For Pathway: Plume l SKIN T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG Adults 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 )

Tc:n 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 j Child 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 ,

Infont: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tarn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 .

l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant'. 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tonn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00Et00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk

, T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lFor Pathway: Goat Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lTecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

l l

l ODCM Rsv. 14 Pago.123 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cr51 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 tin: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 )

l For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 l Tecn 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 i Child: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 Infant: 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.43E+05 1.69E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.06E+03 2.66E+05 0.00E+00 0.00E+00 2.33E+02 6.31E+02 1.40E+03 0.00E+00 Tecn: 1.55E+03 2.61E+05 0.00E+00 0.00E+00 3.40E+02 8.61E+02 2.21E+03 0.00E+00 i Child: 3.05E+03 1.62E+05 0.00E+00 0.00E+00 4.63E+02 1.70E+03 3.10E+03 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 )

l For Pathway: Meat i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.29E+02 3.23E+04 0.00E+00 0.00E+00 2.83E+01 ?.68E*01 1.71E+02 0.00E+00 Tacn: 1.03E+02 1.73E+04 0.00E+00 0.00E+00 2.25E+01 5.71E+01 1.47E+02 0.00E+00 ,

Child: 1.60E+02 8.50E+03 0.00E+00 0.00E+00 2.43E+01 8.90E+01 1.62E+02 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.20E+02 1.31E+05 0.00E+00 0.00E+00 1.15E+02 3.11E+02 6.91E+02 0.00E+00 ;

Tecn: 9.09E+02 1.53E+05 0.00E+00 0.00E+00 1.99E+02 5.05E+02 1.30E+03 0.00E+00 Child: 1.85E+03 9.83E+04 0.00E+00 0.00E+00 2.81E+02 1.03E+03 1.88E+03 0.00E+00 Infant: 2.94E+03 8.56E+04 0.00E+00 0.00E+00 4.19E+02 1.92E+03 3.73E+03 0.00E+00 For Pathway: Goat Milk

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.24E+01 1.57E+04 0.00E+00 0.00E+00 1.38E+01 3.73E+01 8.29E+01 0.00E+00 i Toen: 1.09E+02 1.83E+04 0.00E+00 0.00E+00 2.39E+01 6.06E+01 1.56E+02 0.00E+00 Child: 2.22E+02 1.18E+04 0.00E+00 0.00E+00 3.37E+01 1.23E+02 2.25E+02 0.00E+00 Infant: 3.52E+02 1.03E+04 0.00E+00 0.00E+00 5.02E+01 2.30E+02 4.47E+02 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.17E+00 1.05E+02 0.00E+00 0.00E+00 7.23E-01 1.89E+00 4.56E+02 0.00E+00

Tecn: 4.29E+00 9.51E+01 0.00E+00 0.00E+00 9.74E-01 2.38E+00 6.64E+02 0.00E+00 l Child: 4.89E+00 3.44E+01 0.00E+00 0.00E+00 7.71E-01 2.71E+00 5.38E+02 0.00E+00 I Infant: 2.84E+00 1.13E+01 0.00E+00 0.00E+00 4.19E-01 1.82E+00 4.07E+02 0.00E+00 l

l l

l

l ODCM Rev. 14 Paga 124 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Mn54 Fcr Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 T :n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 Tcon: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 Child: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 Infant: 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.23E+07 4.96E+07 i

For Pathway: Vegetable l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 1.61E+06 2.58E+07 0.00E+00 8.43E+06 2.51E+06 0.00E+00 0.00E+00 0.00E+00 Tscn: 2.53E+06 2.61E+07 0.00E+00 1.27E+07 3.80E+06 0.00E+00 0.00E+00 0.00E+00 Child: 5.03E+06 1.59E+07 0.00E+00 1.89E+07 5.30E+06 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Psthway: Meat l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 3.21E+04 5.16E+05 0.00E+00 1.68E+05 5.01E+04 0.00E+00 0.00E+00 0.00E+00 Tecn: 2.55E+04 2.63E+05 0.00E+00 1.28E+05 3.83E+04 0.00E+00 0.00E+00 0.00E+00 child: 3.91E+04 1.23E+05 0.00E+00 1.47E+05 4.12E+04 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 2.94E+04 4.73E+05 0.00E+00 1.54E+05 4.59E+04 0.00E+00 0.00E+00 0.00E+00 lTocn: 5.10E+04 5.27E+05 0.00Et00 2.57E+05 7.67E+04 0.00E+00 0.00E+00 0.00E+00 (Child: 1.02E+05 3.23E+05 0.00E+00 3.85E+05 1.08E+05 0.00E+00 0.00E+00 0.00E+00 lInfcnt: 1.62E+05 2.63E+05 0.00E+00 7.15E+05 1.59E+05 0.00E+00 0.00E+00 0.00E+00 1

For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 3.53E+03 5.67E+04 0.00E+00 1.85E+04 5.51E+03 0.00E+00 0.00E+00 0.00E+00 iTecn: 6.12E+03 6.33E+04 0.00E+00 3.09E+04 9.?OE+03 0.00E+00 0.00E+00 0.00E+00 ichild: 1.23E+04 3.87E+04 0.00E+00 4.62E+04 1.29E+04 0.00E+00 0.00E+00 0.00E+00 IInfant: 1.95E+04 3.15E+04 0.00E+00 8.58E+04 1.90E+04 0.00E+00 0.00E+00 0.00E+00

!For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 2.00E+02 2.45E+03 0.00E+00 1.26E+03 3.12E+02 0.00E+00 4.44E+04 0.00E+00

Tenn: 2.66E+02 2.12E+03 0.00E+00 1.62E+03 4.03E+02 0.00E+00 6.29E+04 0.00E+00 l Child: 3.01E+02 7.26E+02 0.00E+00 1.36E+03 3.18E+02 0.00E+00 5.00E+04 0.00E+00 l Infant: 1.58E+02 2.24E+02 0.00E+00 8.03E+02 1.58E+02 0.00E+00 3.17E+04 0.00E+00 i

l- ODCM Rnv. 14 l Pago 125 l 6/94 Table 2-2 (Continued) i INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: CoS8 For Pathway: Plume l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 Tsen 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 l Child: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 I Infant: 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 1.16E+07 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.76E+06 1.59E+07 0.00E+00 7.85E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsant 2.72E+06 1.63E+07 0.00E+00 1.18E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Child 5.43E+06 1.04E+07 0.00E+00 1.77E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.30E+05 6.60E+06 0.00E+00 3.26E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 5.79E+05 3.46E+06 0.00E+00 2.51E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 8.98E+05 1.71E+06 0.00E+00 2.93E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.89E+05 1.71E+06 0.00E+00 8.42E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 3.27E+05 1.95E+06 0.00E+00 1.42E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 6.63E+05 1.26E+06 0.00E+00 2.17E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 1.08E+05 1.08E+06 0.00E+00 4.33E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.26E+04 2.05E+05 0.00E+00 1.01E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 3.92E+04 2.35E+05 0.00E+00 1.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 7.96E+04 1.52E+05 0.00E+00 2.60E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 1.30E+05 1.30Ei05 0.00E+00 5.20E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pothway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.57E+01 3.37E+03 0.00E+00 5.02E+01 0.00E+00 0.00E+00 2.94E+04 0.00E+00 Tacn: 8.80E+01 3.02E+03 0.00E+00 6.57E+01 0.00E+00 0.00E+00 4.26E+04 0.00E+00 Child: 1.00E+02 1.09E+03 0.00E+00 5.62E+01 0.00E+00 0.00E+00 3.51E+04 0.00E+00 Infant: 5.77E+01 3.53E+02 0.00E+00 3.87E+01 0.00E+00 0.00E+00 2.46E+04 0.00E+00

'f ODCM Rev. 14 Page 126

l. 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS - _f0R ISOTOPE: Fe59

-For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

. Adult:> -0.00E+00'O.00E+00 0.00rF00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn 0.00E+00 0.00E+00 0.00Lv00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Infant: ' O. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 0. 00E+00 For-Pathway: Ground T. BODY GI-TRACT BONE . LIVER KIDNEY THYROID LUNG SKIN Adult 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Tecn: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 j

.Childs' 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 Infcnt: 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 8.34E+06 9.80E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

. Adult:- 2.80E+06 2.43E+07 3.11E+06 7.30E+06 0.00E+00 0.00E+00 2.04E+06 0.00E+00 Tecn 4.28E+06 2.62E+07 4.75E+06 1.11E+07 0.00E+00 0.00E+00 3.50E+06 0.00E+00 Child 8.69E+06 1.32E+07 1.08E+07 1.75E+07 0.00E+00 0.00E+00 5.06E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

. Adult: 4.29E+06 3.73E+07 4.76E+06 1.12E+07 0.00E+00 0.00E+00 3.12E+06 0.00E+00 Toen 3.43E+06 2.10E+07 8.87E+06 8.87E+06 0.00E+00 0.00E+00 2.80E+06 0.00E+00 Child: 5.43E+06 1.14E+07 6.74E+06 1.09E+07 0.00E+00 0.00E+00 3.16E+06 0.00E+00 1 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 H 1 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN' i Adult: 4.79E+05 4.17E+06 5.32E+05 1.25E+06 0.00E+00 0.00E+00 3.49E+05 0.00E+00 ;

Toon: 8.37E+05 5.12E+06 9.28E+05 2.17E+06 0.00E+00 0.00E+00 6.83E+05 0.00E+00 Child: 1.74E+06 3.63E+06 2.15E+06 3.48E+06 0.00E+00 0.00E+00 1.01E+06 0.00E+00 Infant: 2.77E+06 3.35E+06 4.02E+06 7.02E+06 0.00E+00 0.00E+00 2.07E+06 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ,

Adult: 6.23E+03 5.42E+04 6.91E+03 1.63E+04 0.00E+00 0.00E+00 4.54E+03 0.00E+00 Teen: 1.09E+04 6.66E+04 1.21E+04 2.82E+04 0.00E+00 0.00E+00 8.88E+03 0.00E+00 child: 2.26E+04 4.71E+04 2.80E+04 4.53E+04 0.00E+00 0.00E+00 1.31E+04 0.00E+00 Infant: 3.60E+04 4.36E+04 5.22E+04 9.12E+04 0.00E+00 0.00E+00 2.70E+04 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN .

Adult: 3.35E+02 5.96E+03 3.73E+02 8.80E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00

'Toon: 4.54E+02 5.66E+03 5.05E+02 1.17E+03 0.00E+00 0.00E+00 4.84E+04 0.00E+00 Childs 5.29E+02 2.24E+03 6.56E+02 1.06E+03 0.00E+00 0.00E+00 4.02E+04 0.00E+00 ,

Infant: 3.00E+02 7.86E+02 4.30E+02 7.46E+02 0.00E+00 0.00E+00 3.22E+04 0.00E+00

l 'ODCM Rev. 14 Page 127 l 6/94 )

l Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Co60 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

TO:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 InfOnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Tcan: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Child: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 Infant: 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 7.09E+08 8.34E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.02E+07 8.68E+07 0.00E+00 4.62E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 1.61E+07 9.29E+07 0.00E+00 7.13E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.24E+07 6.08E+07 0.00E+00 1.10E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat j T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.11E+06 2.65E+07 0.00E+00 1.41E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 2.46E+06 1.42E+07 0.00E+00 1.09E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j Child: 3.83E+06 7.19E+06 0.00E+00 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 1 Adult: 6.78E+05 5.77E+06 0.00E+00 3.07E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

Tecn: 1.17E+06 6.78E+06 0.00E+00 5.21E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.38E+06 4.48E+06 0.00E+00 8.09E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 3.90E+06 3.93E+06 0.00E+00 1.65E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.13E+04 6.93E+05 0.00E+00 3.69E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Tsen: 1.41E+05 8.14E+05 0.00E+00 6.25E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.86E+05 5.37E+05 0.00E+00 9.70E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 4.68E+05 4.71E+05 0.00E+00 1.98E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.69E+02 9.03E+03 0.00E+00 3.65E+02 0.00E+00 0.00E+00 1.89E+05 0.00E+00 Toen: 6.29E+02 8.22E+03 0.00E+00 4.79E+02 0.00E+00 0.00E+00 2.76E+05 0.00E+00 Child: 7.18E+02 3.05E+03 0.00E+00 4.16E+02 0.00E+00 0.00E+00 2.24E+05 0.00E+00 Infant: 3.73E+02 1.01E+03 0.00E+00 2.54E+02 0.00E+00 0.00E+00 1.43E+05 0.00E+00

.- _ - _ _ _ _ - . ~- . ._- _

1 ODCM Rev. 14 Page 128

.l 6/94 Table 2-2-(Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Zn65 l

For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY' THYROID LUNG SKIN.

Adults- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TaOn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 CChild 0.00E+00 0.00E+00.0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

> Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

For Pathway:_ Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN g Adult: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07

Toons 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.63E+07

' Child: 2.29E+07 2.29E+07 2.29E+07-2.29E+07 2.29E+07_2.29E+07 2.29E+07 2.63E+07 Infant: 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.29E+07 2.6?E+07 lFor Pathway: Vegetable T. BODY GI-TRACT -BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.58E+07 2.20E+07 1.10E+07 3.50E+07 2.34E+07 0.00E+00 0.00E+00 0.00E+00-iToan 2.43E+07 2.25E+07-1.53E+07 5.32E+07 3.40E+07 0.00E+00 0.00E+00 0.00E+00 IChild: 4.93E+07 1.39E+07 2.98E+07 7.93E+07 5.00E+07 0.00E+00 0.00E+00 0.00E+00

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat t T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.08E+07 1.50E+07 7.50E+06 2.39E+07 1.60E+07 0.00E+00 0.00E+00 0.00E+00 Tean: 8.54E+06 7.75E+06 5.27E+06 1.33E+07.1.17E+07'O.00E+00 0.00E+00 0.00E+00 child 1.31E+07 3.70E+06 7.91E+06 2.11E+07 1.33E+07-0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE' LIVER KIDNEY THYROID LUNG SKIN q Adult: 4.15E+07 5.79E+07 2.89E+07 9.20E+07 6.15E+07 0.00E+00 0.00E+00 0.00E+00 Tocn: 7.19E+07 6.63E+07 4.44E+07 1.54E+08 9.86E+07 0.00E+00 0.00E+00 0.00E+00 Child: 1.44E+08 4.07E+07 8.71E+07 2.32E+08 1.46E+08 0.00E+00 0.00E+00 0.00E+00 l Infant: 1.85E+08 3.39E+08 1.17E+08 4.01E+08 1.95E+08 0.00E+00 0.00E+00 0.00E+00 I i

i For Pathway: Goat Milk T. BODY GI-TRACT LIVER KIDNEY THYROID LUNG SKIN BONE ;

I Adult: 4.99E+06 6.95E+06 3.47E+06 1.10E+07 7.38E+06 0.00E+00 0.00E+00 0.00E+00 I lToon: 8.63E+06 7.83E+06 5.33E+06 1.85E+07 1.18E+07 0.00E+00 0.00E+00 0.00E+00 (Child: 1.73E+07 4.89E+06 1.05E+07 2.78E+07 1.75E+07 0.00E+00 0.00E+00 0.00E+00

, Infant: 2.22E+07 4.07E+07 1.40E+07 4.81E+07 2.33E+07 0.00E+00 0.00E+00 0.00E+00 lFor Pathway: Inhalation

' T. BODY - GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 1.43E+08 1.69E+03 1.03E+03 3.27E+03 2.19E+03 0.00E+00 0.00E+00 0.00E+00

!Toen: 1.93E+08 1.48E+03 1.22E+03 4.24E+03 2.74E+03 0.00E+00 0.00E+00 0.00E+00 (Child 2.23E+03 5.17E+02 1.35E+03 3.59E+03 2.26E+03 0.00E+00 0.00E+00 0.00E+00 l Infant: 9.85E+02 1.63E+03 6.12E+02 1.98E+03 1.03E+03 0.00E+00 0.00E+00 0.00E+00 l

l

l ODCM Rav. 14 Paga 129 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr83m For Pnthway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 TO:n 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Child: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 Infcnt: 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 1.68E-03 9.39E-02 4.75E-01 For Pathway: Ground '

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tc n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Os00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tenn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l- ODCM Rev. 14 Page 130 l, 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS-FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr85 For Pathway:. Plume T. BODY GI-TRACT BONE - LIVER KIDNEY THYROID LUNG- SKIN ,

Adult: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-0114.29E+01 '

Tacn: 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 ,

Childs 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 Infant: -3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 3.57E-01 9.50E-01 4.29E+01 1

For Pathway: Ground T. BODY GI-TRACT. BONE LIVER' KIDNEY. THYROID- LUNG- SKIN-LAdult:- 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00, Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIONEY THYROID LUNG SKIN

' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00'O.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.

. Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG -SKIN Adult: .0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j.Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00S+00 0.00E+00 0.00E+00 0.00E+00-t Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-LInfant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

1 For Pathway: Cow Milk

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 .00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1

. Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00.

For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 -

Tecn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, ~ -- --m- -w w

l ODCM Rsv. 14 Page 131 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr85m For Pcthway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Tcan: 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Child: 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 Infant: 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.60E+01 2.66E+01 7.66E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00C+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 C.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lToon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

l- ODCM Rev. 14

.Pago 132 l l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr87 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 i Tran ' 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Child 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 Infcnt: 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.31E+02 1.35E+02 4.60E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00Z+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

.Tosn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat ,

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

,Tsan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG' SKIN '

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

! Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 :

For. Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l ODCM Rav. 14 Page 133 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr88 l

For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 TOOn: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 ,

Child: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 l Infant: 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.26E+02 3.27E+02 4.50E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0. 00E+00 0. 00E+00 0. 00E+ 00 0. 00E+00 0. 00E+00 0. 00E+00 0.00E+00 0.00E+00 T:2n: 0.00E+00 0.00E+00 0.00E+UO 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat THYROID T. BODY GI-TRACT BONE LIVER KIDNEY LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

! Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00Et00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

'Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00-Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l

l l

l i

l ODCM Rnv. 14 Paga 134 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr89 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 Tecn 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 Child: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 Infcnt: 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.72E+02 7.46E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+03 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

For Pathway: Goat Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l To n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l

.For Pathway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tonn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

i

1 l ODCM Rev. 14 Paga 135 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sr89 For Pathway: Plume l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.09E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 Tsan 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 Child: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 Infant: 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 6.62E+02 7.68E+02 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.42E+06 4.14Et07 2.58E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsant 1.20E+07 5.00E+07 4.20E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.91E+07 3.95E+07 1.02E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.68E+05 9.41E+05 5.86E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 1.42E+05 5.90E+05 4.95E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.68E+05 3.63E+05 9.37E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 8.09E+05 4.52E+06 2.82E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Tc0n: 1.49E+06 6.19E+06 5.20E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j Child: 3.67E+06 4.98E+06 1.29E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 Infant: 7.02E+06 5.03E+06 2.45E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adults 1.70E+06 9.50E+06 5.92E+07 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tsan: 3.13E+06 1.30E+07 1.09E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 7.72E+06 1.05E+07 2.70E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

Infant: 1.47E+07 1.06E+07 5.14E+08 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l For Pathway: Inhalation 2 T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.76E+02 1.11E+04 9.64E+03 0.00E+00 0.00E+00 0.00E+00 4.44E+04 0.00E+00 '

Tsen: 3.96E+02 1.18E+04 1.38E+04 0.00E+00 0.00E+00 0.00E+00 7.66E+04 0.00E+00 Child: 5.47E+02 5.30E+03 1.90E+04 0.00E+00 0.00E+00 0.00E+00 6.84E+04 0.00E+00 Infant: 3.62E+02 2.03E+03 1.26E+04 0.00E+00 0.00E+00 0.00E+00 6.44E+04 0.00E+00 !

l ODCM RLv. 14 Paga 136 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Kr90 I

For P;thway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 )

3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 Tacn:

Child: 3.46E402 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 )

i InfCnt: 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.46E+02 3.49E+02 6.33E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tarn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00Et00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

! Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

( For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lTcen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tasn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Inhalation

, T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

l

l ODCM Rsv. 14 Pags 137 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sr90 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tren: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

-For Pcthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.38E+10 1.63E+09 5.64E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc2n: 1.79E+10 2.04E+09 7.27E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.09E+10 1.54E+09 1.22E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIM l Adult: 4.45E+08 5.24E+07 1.81E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tcan: 2.90E+08 3.29E+07 1.17E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 3.84E+08 2.04E+07 1.52E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i l

For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.67E+09 1.97E+08 6.32E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Teen: 2.38E+09 2.70E+08 9.64E+09 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 4.13E+09 2.19E+08 1.63E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 4.51E+09 2.21E+08 1.77E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.51E+09 4.14E+08 1.43E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 5.00E+09 5.68E+08 2.02E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 8.67E+09 4.61E+08 3.42E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 9.47E+09 4.65E.08 3.72E+10 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.93E+05 2.28E+04 3.14E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 2.12E+05 2.42E+04 3.42E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 2.04E+05 1.09E+04 3.20E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 8.21E+04 4.15E+03 1.30E+06 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l ODCM Rev. 14 l

Pago 138 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Zr95 l For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tccn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Psthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Tenn: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Child: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 Infant: 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 7.48E+06 8.67E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.46E+03 3.03E+07 2.98E+04 9.55E+03 1.50E+04 0.00E+00 0.00E+00 0.00E+00 Tosn: 1.01E+04 3.37E+07 4.63E+04 1.46E+04 2.15E+04 0.00E+00 0.00E+00 0.00E+00 Child: 2.07E+04 2.43E+07 1.06E+05 2.33E+04 3.33E+04 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

,For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

. Adult: 7.26E+03 3.40E+07 3.34E+04 1.07E+04 1.68E+04 0.00E+00 0.00E+00 0.00E+00 l7can: 5.81E+03 1.95E+07 2.68E+04 8.45E+03 1.24E+04 0.00E+00 0.00E+00 0.00E+00

' Child: 9.30E+03 1.09E+07 4.75E+04 1.05E+04 1.50E+04 0.00E+00 0.00E+00 0.00E+00 j

Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

'For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 3.65E+00 1.71E+04 1.68E+01 5.40E+00 8.47E+00

[

0.00E+00 0.00E+00 0.00E+00 lTesn: 6.39E+00 2.14E+04 2.94E+01 9.29E+00 1.36E+01 0.00E+00 0.00E+00 0.00E+00 ,

jChild: 1.34E+01 1.57E+04 6.84E+01 1.50E+01 2.15E+01 0.00E+00 0.00E+00 0.00E+00 1 jInfant: 2.10E+01 1.47E+04 1.21E+02 2.96E+01 3.19E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.39E-01 2.05E+03 2.02E+00 6.48E-01 1.02E+00 0.00E+00 0.00E+00 0.00E+00 lTosn: 7.66E-01 2.57E+03 3.53E+00 1.11E+00 1.64E+00 0.00E+00 0.00E+00 0.00E+00

! Child: 1.61E+00 1.88E+03 8.20E+00 1.80E+00 2.58E+00 0.00E+00 0.00E+00 0.00E+00

! Infant: 2.52E+00 1.77E+03 1.46E+01 3.55E+00 3.83E+00 0.00E+00 0.00E+00 0.00E+00 ;

For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 7.38E+02 4.77E+03 3.40E+03 1.09E+03 1.72E+03 0.00E+00 5.60E+04 0.00E+00 Tssn: 9.99E+02 4.72E+03 4.62E+03 1.45E+03 2.14E+03 0.00E+00 8.52E+04 0.00E+00 Child: 1.17E+03 1.94E+03 6.02E+03 1.33E+03 1.89E+03 0.00E+00 7.07E+04 0.00E+00 <

Infant: 6.44E+02 6.88E+02 3.66E+03 8.83E+02 9.85E+03 0.00E+00 5.55E+04 0.00E+00 l

1

l ODCM Rev. 14 Page 139 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Sb124 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tscn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEl THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tctn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tssn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

r ,

l ODCM Rcv. 14 Page 140 j l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: 1131 For Pathway: Plume i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TcOn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0. 00E+00 0.00E+00 0.00E+00 0. 00E+00 0. 00E4 00 0. 00E+00 0. 00E+00 0. 00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 j Tssnt 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 l Child: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 {

Infcnt: 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 2.63E+05 3.19E+05 i For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j Adult: 4.43E+05 2.04E+05 5.41E+05 7.74E+05 1.33E+06 2.54E+08 0.00E+00 0.00E+00 j Tecn: 4.02E+05 1.48E+05 5.35E+05 7.48E+05 1.29E+06 2.18E+08 0.00E+00 0.00E+00 )

Child: 5.83E+05 9.13E+04 1.02E+06 1.03E+06 1.68E+05 3.39E+08 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.70E+04 4.01E+04 1.06E+05 1.52E+05 2.60E+05 4.98E+07 0.00E+00 0.00E+00 Tran: 6.64E+04 2.44E+04 8.82E+04 1.24E+05 2.13E+05 3.60E+07 0.00E+00 0.00E+00 Child: 9.35E+04 1.46E+04 1.64E+05 1.65E+05 2.70E+05 5.44E+07 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.39E+06 1.10E+06 2.92E+06 4.17E+06 7.16E+06 1.37E+09 0.00E+00 0.00E+00 Toen 3.98E+06 1.47E+06 5.30E+06 7.42E+06 2.2?E+07 2.16E+09 0.00E+00 0.00E+00 Child: 7.34E+06 1.15E+06 1.28E+07 1.29E+07 2.12E+07 4.27E+09 0.00E+00 0.00E+00 Infcnt: 1.39E+07 1.13E+06 2.68E+07 3.16E+07 3.69E+07 _.04E+10 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.87E+06 1.32E+06 3.50E+06 5.01E+06 8.59E+06 1.64E+09 0.00E+00 0.00E+00 Toon: 4.78E+06 1.76E+06 6.36E+06 8.90E+06 1.53E+07 2.60E+09 0.00E+00 0.00E+00 Child: 8.81E+06 1.38E+06 1.54E+07 1.55E+07 2.55E+07 5.13E+09 0.00E+00 0.00E+00 Infant: 1.67E+07 1.35E+06 3.22E+07 3.79E+07 4.43E+07 1.25E+10 0.00E+00 0.00E+00 t3r Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.49E+02 1.99E+02 7.99E+02 1.13E+03 1.94E+03 3.78E+05 0.00E+00 0.00E+00 Tc:n: 8.37E+02 2.06E+02 1.12E+03 1.56E+03 2.66E+03 4.64E+05 0.00E+00 0.00E+00 Child: 8.64E+02 9.01E+01 1.52E+03 1.52E+03 2.50E+03 5.15E+05 0.00E+00 0.00E+00 Infant: 6.21E+02 3.36E+01 1.20E+03 1.41E+03 1.64E+03 4.70E+04 0.00E+00 0.00E+00

.l ODCM Rav. 14 Pago 141 l 6/94 l

Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe131m For Pcthway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 Tcan: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 Child 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 ,

' Infant: 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.03E+00 2.38E+00 1.89E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.0#.E'00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TO:n: 0.00E+00 0.00EtCL O.00Ev00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E'00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tean: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l

For Pathway: Cow Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Teen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.0GE+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inht '.ation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l ODCM Rov. 14 Page 142 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: I133 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+?O 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00F+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Tcent 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 '

Child 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 Infcnt: 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 3.75E+04 4.56E+04 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 7.07E+03 2.08E+04 1.33E+04 2.32E+04 4.05E+04 3.41E+06 0.00E+00 0.00E+00 Tonn: 6.41E+03 1.59E+04 1.24E+04 2.10E+04 3.69E+04 2.93E+06 0.00E+00 0.00E+00 Child: 1.06E+04 1.13E+04 2.26E+04 2.79E+04 4.65E+04 5.19E+06 0.00E+00 0.00E+00 '

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat I T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

' Adult: 2.01E-03 5.93E-03 3.79E-03 6.60E-03 1.15E-02 9.70E-01 0.00E+00 0.00E+00 Toon: 1.64E-03 4.07E-03 3.17E-03 5.38E-03 9.44E-03 7.52E-01 0.00E+00 0.00E+00 Child: 2.76E-03 2.94E-03 5.90E-03 7.29E-03 1.22E-02 1.35E+00 0.00E+00 0.00E+00 ,

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 j For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.07E+04 6.12E+04 3.91E+04 6.91E+04 . 19E+05 1.00E+07 0.00E+00 0.00E+00 '

Toon: 3.70E+04 9.17E+04 7.15E+04 1.21E+05 2.13E+05 1.69E+07 0.00E+00 0.00E+00 Child 8.12E+04 8.65E+04 1.74E+05 2.15E+05 3.58E+05 3.99E+07 0.00E+00 0.00E+00 Infant: 1.56E+05 9.03E+04 3.67E+05 5.34E+05 6.28E+05 9.71E+07 0.00E+00 0.00E+00 ,

l 1 l

'For Pathway: Goat Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

lAdult: 2.49E+04 7.34E+04 4.69E+C4 8.17E+04 1.42E+05 1.20E+07 0.00E+00 0.00E+00 lTson: 4.44E+04 1.10E+05 8.57E+04 1.45E+05 2.55E+05 2.03E+07 0.00E+00 0.00E+00 i l Child 9.75E+04 1.04E+05 2.08E+05 2.58E+05 4.29E+05 4.79E+07 0.00E+00 0.00E+00

' Infant: 1.88E+05 1.08E+05 4.40E+05 6.41E+05 7.53E+05 1.16E+08 0.00E+00 0.00E+00 l lFor Pathway: Inhalation j T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN j l Adult: 1.43E+02 2.81E+02 2.74E+02 4.69E+02 8.19E+02 6.82E+04 0.00E+00 0.00E+00 l lTcon: 1.97E+02 3.27E+02 3.85E+02 6.49E+02 1.14E+03 9.26E+04 0.00E+00 0.00E+00

! Child: 2.44E+02 1.74E+02 5.25E+02 6.44E+02 1.07E+03 1.22E+05 0.00E+00 0.00E+00 l Infant: 1.78E+02 6.83E+01 4.20E+02 6.08E+02 7.10E+02 1.13E+05 0.00E+00 0.00E+00 i

l l

l ODCM Rsv. 14 Page 143

-l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSB FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe133 For Pathway: Plume l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN 4 Adult: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Tacn: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 Child: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 l Inf0nt: 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.52E+00 6.86E+00 1.84E+01 1 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 I Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 <

Tson: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

l ODCM Rev. 14 Pagn 144 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe133m For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 TCCn: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Childs 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 Infcnt: 5.57E+00 5.57E+00 5.57E+00 5.57E+005.57E+00 5.57E+00 6.03E+00 3.96E+01 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tocn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+10 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

lFor Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

iChild 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

! Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

For Pathway: Inhalation l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

. Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

.Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i

' Infant: 0.00E+00~0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l l

l

l ODCM R0v. 14 Pagn 145 l l 6/94 1 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs134 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 For Pcthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Tran: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 Child: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 ,

Infcnt: 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.11E+08 2.46E+08 ]

l For Pathway: Vegetable !

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 2.50E+08 5.34E+06 1.28E+08 3.05E+08 9.88E+07 0.00E+00 3.28E+07 0.00E+00 Tcen: 2.21E+08 5.93E+06 2.03E+08 4.77E+08 1.52E+08 0.00E+00 5.79E+07 0.00E+00 Child: 1.60E+08 4.10E+06 4.63E+08 7.60E+08 2.36E+08 0.00E+00 8.46E+07 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.38E+07 5.10E+05 1.22E+07 2.91E+07 9.43E+06 0.00E+00 3.13E+06 0.00E+00 l Tecn: 1.06E+07 2.35E+05 9.74E+06 2.29E+07 7.28E+06 0.00E+00 2.78E+06 0.00E+00 Child: 5.94E+06 1.52E+05 1.72E+07 2.82E+07 8.73E+06 0.00E+00 3.13E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.05E+08 4.38E+06 1.05E+08 2.50E+08 8.11E+07 0.00E+00 2.69E+07 0.00E+00 Tonn: 2.00E+08 5.35E+06 1.83E+08 4.30E+08 1.37E+08 0.00E+00 5.22E+07 0.00E+00 Child: 1.46E+08 3.73E+06 4.22E+08 6.92E+08 2.14E+08 0.00E+00 7.69E+07 0.00E+00 Infcnt: 1.28E+08 3.44E+06 6.79E+08 1.27E+09 3.26E+08 0.00E+00 1.34E+08 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.14E+08 1.32E+07 3.16E+08 7.51E+08 2.43E+08 0.00E+00 8.07E+07 0.00E+00 Trcn: 5.99E+08 1.61E+07 5.48E+08 1.29E+09 4.10E+08 0.00E+00 1.57E+08 0.00E+00 Child: 4.38E+08 1.12E+07 1.26E+09 2.08E+09 6.43E+08 0.00E+00 2.31E+08 0.00E+00 Infant: 3.84E+08 1.03E+07 2.04E+09 3.80E+09 9.i.E+08 0.00E+00 4.01E+08 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.31E+04 3.30E+02 1.18E+04 2.69E+04 9.10E+03 0.00E+00 3.09E+03 0.00E+00 Teen: 1.74E+04 3.09E+02 1.59E+04 3.58E+04 1.19E+04 0.00E+00 4.64E+03 0.00E+00 child: 7.12E+03 1.22E+02 2.06E+04 3.21E+04 1.05E+04 0.00E+00 3.84E+03 0.00E+00 Infcnt: 2.36E+03 4.23E+01 1.26E+04 2.23E+04 6.04E+03 0.00E+00 2.53E+03 0.00E+00

r l l

l ODCM Rev. 14 Pago 146 l 6/94 Table 2-2 (Continued) 1 INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe135m For Pathway: Plume ;

T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adults 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 TcCn: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 l~

Child: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 Infant: 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.92E+01 6.95E+01 1.05E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00D+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN '

, Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

l For Pathway: Meat l T. BODY GI-TRACT 3ONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 C.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

lForPathway: Cow Milk i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 iChild: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 lToen: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

l

l ODCM R v. 14 Pcgn 147 l 6/94 Table 2-2 (Continued) l l

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xo135 l l

For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 l TG:n: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 i Child 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 l Infcnt: 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.02E+01 4.09E+01 1.06E+02 !

For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

, Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tron: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ,

Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Totn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 ;

For Pathway: Cow Milk l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

TOsn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

m 1 l

ODCM Rov. 14 Page 148 j 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs136 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 tin: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 Tarn: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 Child: 4.50E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 Infant: 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 4.60E+06 5.21E+06 For Pathway: Vegetable T . T;ODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.99E+05 3.15E+05 7.01E+05 2.77E+06 1.54E+06 0.00E+00 2.11E+05 0.00E+00 Tcan 2.14E+06 2.57E+05 8.10E+05 3.19E+06 1.74E+06 0.00E+00 2.74E+05 0.00E+00 Child: 2.88E+06 1.57E+05 1.62E+06 4.46E+06 2.37E+06 0.00E+00 3.54E+05 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.53E+05 1.03E+05 2.30E+05 9.08E+05 5.05E+05 0.00E+00 6.92E+04 0.00E+00 l Tonn: 4.74E+05 5.68E+04 1.79E+05 7.05E+05 3.84E+05 0.00E+00 6.05E+04 0.00E+00

! Child 5.50E+05 2.99E+04 3.09E+05 8.50E+05 4.53E+05 0.00E+00 6.75E+04 0.00E+00 fInfant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.43E+07 2.26E+06 5.03E+06 1.99E+07 1.10E+07 0.00E+00 1.51E+06 0.00E+00 Torn: 2.26E+07 2.71E+06 8.56E+06 3.37E+07 1.83E+07 0.00E+00 2.89E+06 0.00E+00 Child: 3.44E+07 1.87E+06 1.93E+07 5.31E+07 2.83E+07 0.00E+00 4.22E+06 0.00E+00 Infant: 4.14E+07 1.69E+06 3.77E+07 1.11E+08 4.42E+07 0.00E+00 9.05E+06 0.00E+00 l l

'For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult 4.29E+07 6.77E+06 1.51E+07 5.96E+07 3.31E+07 0.00E+00 4.54E+06 0.00E+00 i iTotne 6.79E+07 8.13E+06 2.57E+07 1.01E+08 5.50E+07 0.00E+00 8.67E+06 0.00E+00

' Child: 1.03E+08 5.60E+06 5.80E+07 1.59E+08 8.49E+07 0.00E+00 1.27E+07 0.00E+00 Infcnt: 1.24E+08 5.06E+06 1.13E+08 3.33E+08 1.33E+08 0.00E+00 2.71E+07 0.00E+00 !

For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l

Adult: 3.50E+03 3.70E+02 1.24E+03 4.64E+03 2.71E+03 0.00E+00 3.80E+02 0.00E+00 1

!Tstn: 4.34E+03 3.45E+02 1.63E+03 6.14E+03 3.50E+03 0.00E+00 5.63E+02 0.00E+00 )

Child: 3.68E+03 1.33E+02 2.06E+03 5.42E+03 3.03E+03 0.00E+00 4.61E+02 0.00E+00 l Infant: 1.68E+03 4.53E+01 1.53E+06 4.26E+03 1.79E+03 0.00E+00 3.73E+02 0.00E+00 !

l l

l

{ l l ODCM Rsv. 14 !

Page 149 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Cs137 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

, Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 {

Tcan: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Child: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 Infant: 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 3.98E+08 4.64E+08 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.88E+08 5.56E+06 2.10E+08 2.87E+08 9.75E+07 0.00E+00 3.24E+07 0.00E+00 Tcen: 1.61E+08 6.57E+06 3.47E+08 4.62E+08 1.57E+08 0.00E+00 6.11E+07 0.00E+00 Child: 1.17E+08 4.97E+06 8.29E+08 7.94E+08 2.59E+08 0.00E+00 9<31E+07 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.63E+07 4.80E+05 1.81E+07 2.48E+07 8.42E+06 0.00E+00 2.80E+06 0.00E+00 Tecn: 6.98E+06 2.85E+05 1.51E+07 2.00E+07 6.82E+06 0.00E+00 2.65E+06 0.00E+00 Child: 3.92E+06 1.66E+05 2.77E+07 2.66E+07 8.65E+06 0.00E+00 3.11E+06 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.38E+08 4.07E+06 1.54E+08 2.10E+08 7.13E+07 0.00E+00 2.37E+07 0.00E+00 Toon: 1.29E+08 5.27E+06 2.78E+08 3.70E+08 1.26E+08 0.00E+00 4.90E+07 0.00E+00 Child: 9.48E+07 4.02E+06 6.71E+08 6.42E+08 2.09E+08 0.00E+00 7.53E+07 0.00E+00 Infant: 8.88E+07 3.92E+06 1.07E+09 1.25E+09 3.36E+08 0.00E+00 1.36E+08 0.00E+00 l

lFor Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.13E+08 1.22E+07 4.61E+08 6.30E+08 2.14E+08 0.00E+00 7.11E+07 0.00E+00 lTcen: 3.87E+08 1.58E+07 8.35E+08 1.11E+09 3.78E+08 0.00Z+00 1.47E+08 0.00E+00

} Child: 2.84E+08 1.21E+07 2.01E+09 1.93E+09 6.28E+08 0.00E+00 2.26E+08 0.00E+00 Infant: 2.66E+08 1.18E+07 3.21E+09 3.76E+09 1.01E+09 0.00E+00 4.09E+08 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.36E+04 2.66E+02 1.52E+04 1.97E+04 7.05E+03 0.00E+00 2.38E+03 0.00E+00 Tecn: 9.87E+03 2.69E+02 2.13E+04 2.69E+04 9.64E+03 0.00E+00 3.83E+03 0.00E+00 Child: 4.07E+03 1.15E+02 2.87E+04 2.62E+04 8.95E+03 0.00E+00 3.30E+03 0.00E+00 Infant: 1.44E+03 4.23E+01 1.74E+04 1.94E+04 5.46E+03 0.00E+00 2.26E+03 0.00E+00 c

j' ODCM Rav. 14 Pags 150 l 6/94 Table 2-2 (Continued) l INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe137 Fcr Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 TcOns 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 Childs 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 l Infcnt: 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.15E+01 3.54E+01 4.24E+02 For Pcthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 To n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tacn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Torn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

ODCM Rev. 14 Page 151 l

6/94 Table 2-2 (Continued) 1 i

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Xe138

.For Pathway: Plume T. BODY GI-TRACT BCNE LIVER KIDNEY THYROID LUNG SKIN '

Adult: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 Toen: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02-

' Child: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 j Infant: 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.96E+02 1.98E+02 3.58E+02 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tcan: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN

' Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN ]

Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Toon: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Toen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00Et00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l

j For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN I Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tann: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00. i For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 '

Tenn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00

' Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 l Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 !

1 l

l

l ODCM Rnv. 14 Page 152 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ba140 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 TOCn: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Childs 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 TO:n: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Child: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 Infant: 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 6.27E+05 7.16E+05 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.36E+05 4.29E+06 2.08E+06 2.62E+03 8.89E+02 0.00E+00 1.50E+03 0.00E+00 i Totn: 1.62E+05 3.88E+06 2.52E+06 3.09E+03 1.05E+03 0.00E+00 2.07E+03 0.00E+00 1 Child 3.13E+05 2.72E+06 5.36E+06 4.69E+03 1.53E+03 0.00E+00 2.80E+03 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i i

l For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.61E+04 1.13E+06 5.50E+05 6.91E+02 2.35E+02 0.00E+00 3.96E+02 0.00E+00 Tosn 2.93E+04 7.02E+05 4.55E+05 5.58E+02 1.89E+02 0.00E+00 3.75E+02 0.00E+00 iChild: 4.90E+04 4.25E+05 8.40E+05 7.36E+02 2.40E+02 0.00E+00 4.39E+03 0.00E+00 lInfant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.37E+04 1.06E+06 5.15E+05 6.47E+02 2.20E+02 0.00E+00 3.70E+02 0.00E+00 Toen: 5.99E+04 1.43E+06 9.29E+05 1.14E+03 3.86E+02 0.00E+00 7.66E+02 0.00E+00 Child: 1.31E+05 1.14E+06 2.24E+06 1.97E+03 6.40E+02 0.00E+00 1.17E+03 0.00E+00 Infant: 2.38E+05 1.13E+06 4.62E+06 4.62E+03 1.10E+03 0.00E+00 2.83E+03 0.00E+00 l

lFor Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.05E+03 1.27E+05 6.18E+04 7.76E+01 2.64E+01 0.00E+00 4.44E+01 0.00E+00 lToon: 7.18E+03 1.72E+05 1.12E+05 1.37E+02 4.63E+01 0.00E+00 9.19E+01 0.00E+00 Child: 1.57E+04 1.36E+05 2.69E+02 2.36E+02 7.68E+01 0.00E+00 1.41E+02 0.00E+00 Infant: 2.85E+04 1.36E+05 5.54E+05 5.54E+02 1.32E+02 0.00E+00 3.40E+02 0.00E+00

,For Pathway: Inhalation i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.14E+01 6.92E+03 1.24E+03 1.55E+00 5.30E-01 0.00E+00 4.03E+04 0.00E+00 Tcen: 1.12E+02 7.25E+03 1.73E+03 2.13E+00 7.23E-01 0.00E+00 6.44E+04 0.00E+00 Child: 1.37E+02 3.23E+03 2.35E+03 2.05E+00 6.70E-01 0.00E+00 5.52E+04 0.00E+00 Infant: 9.19E+01 1.22E+03 1.78E+03 1.78E+00 4.26E-01 0.00E+00 5.06E+04 0.00E+00

l ODCM Rev. 14 Page 153 l 6/94 Table 2-2 (Continued)

INDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce141 For Pathway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tc:n: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+0J 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 i Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pcthway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Tcen: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 Childs 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 ,

Infcnt: 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.17E+05 4.70E+05 l For Pathway: Vegetable l T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN i Adult: 3.55E+02 1.20E+07 4.63E+03 3.13E+03 1.45E+03 0.00E+00 0.00E+00 0.00E+00 l Tssn: 5.57E+02 1.39E+07 7.26E+03 4.85E+03 2.28E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.29E+02 1.08E+07 1.74E+04 8.67E+03 3.80E+03 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1 1

For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.95E+01 6.56E+05 2.54E+02 1.72E+02 7.97E+01 0.00E+00 0.00E+00 0.00E+00 Taen: 1.63E+01 4.07E+05 2.13E+02 1.42E+02 6.70E+01 0.00E+00 0.00E+00 0.00E+00 Child: 2.97E+01 2.50E+05 4.01E+02 2.00E+02 8.77E+01 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 6.71E+00 2.26E+05 8.75E+01 5.92E+01 2.75E+01 0.00E+00 0.00E+00 0.00E+00 Tecn: 1.23E+01 3.06E+05 1.60E+02 1.07E+02 5.04E+01 0.00E+00 0.00E+00 0.00E+00 Child: 2.93E+01 2.46E+05 3.95E+02 1.97E+02 8.64E+01 0.00E+00 0.00E+00 0.00E+00 Infant: 5.62E+01 2.47E+05 7.83E+02 4.78E+02 1.47E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 8.06E-01 2.72E+04 1.05E+01 7.10E+00 3.30E+00 0.00E+00 0.00E+00 0.00E+00 Tcon: 1.48E+00 3.68E+04 1.93E+01 1.29E+01 6.05E+00 0.00E+00 0.00E+00 0.00E+00

. Child: 3.51E+00 2.95E+04 4.74E+01 2.37E+01 1.04E+01 0.00E+00 0.00E+00 0.00E+00 Infcnt: 6.75E+00 2.96E+05 9.40E+01 5.73E+01 1.77E+01 0.00E+00 0.00E+00 0.00E+00 For Pathway: Inhalation T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.84E+01 3.80E+03 6.31E+02 4.29E+02 1.99E+02 0.00E+00 2.46E+05 0.00E+00 Tecn: 6.87E+01 4.01E+03 9.00E+02 6.01E+02 2.81E+02 0.00E+00 4.24E+05 0.00E+00 Child: 9.13E+01 1.79E+03 1.24E+03 6.19E+02 2.71E+02 0.00E+00 3.79E+05 0.00E+00 Infant: 6.30E+01 6.83E+02 8.79E+02 5.28E+02 1.66E+02 0.00E+00 3.12E+05 0.00E+00

l ODCM Rev. 14 Page 154 l 6/94 Table 2-2 (Continued)

IUDIVIDUAL DOSE FACTORS FOR GASEOUS EFFLUENTS -- FOR ISOTOPE: Ce144 For P:thway: Plume T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tecn 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Child: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Infcnt: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Ground T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Tecn: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Child: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 Infant: 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.12E+06 2.45E+06 For Pathway: Vegetable T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 4.63E+04 2.91E+08 8.62E+05 3.60E+05 2.14E+05 0.00E+00 0.00E+00 0.00E+00 Tecn: 7.73E+04 3.62E+08 1.44E+06 5.95E+05 3.56E+05 0.00E+00 0.00E+00 0.00E+00 Child: 1.87E+05 2.87E+08 3.51E+06 1.10E+06 6.10E+05 0.00E+00 0.00E+00 0.00E+00 Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Meat T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 1.41E+03 8.90E+06 2.63E+04 1.10E+04 6.53E+03 0.00E+00 0.00E+00 0.00E+00 Toon: 1.19E+03 5.58E+06 2.22E+04 9.18E+03 5.43E+03 0.00E+00 0.00E+00 0.00E+00 Child: 2.23E+03 3.42E+06 4.18E+04 1.31E+04 7.26E+03 0.00E+00 0.00E+00 0.00E+00 l

Infant: 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 For Pathway: Cow Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN Adult: 3.47E+02 2.18E+06 6.46E+03 2.70E+03 1.60E+03 0.00E+00 0.00E+00 0.00E+00 Tcan: 6.39E+02 2.99E+06 1.19E+04 4.92E+03 2.94E+03 0.00E+00 0.00E+00 0.00E+00 Child: 1.56E+03 2.40E+06 2.93E+04 9.19E+03 5.09E+03 0.00E+00 0.00E+00 0.00E+00 Infant: 2.35E+03 2.41E+06 4.20E+04 1.72E+04 6.95E+03 0.00E+00 0.00E+00 0.00E+00 For Pathway: Goat Milk T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 4.16E+01 2.62E+05 7.75E+02 3.24E+02 1.92E+02 0.00E+00 0.00E+00 0.00E+00 lTecn 7.67E+01 3.59E+05 1.43E+03 5.90E+02 3.53E+02 0.00E+00 0.00E+00 0.00E+00 l Child: 1.88E+02 2.88E+05 3.52E+03 1.10E+03 6.11E+02 0.00E+00 0.00E+00 0.00E+00 lInfcnt: 2.82E+02 2.89E+05 5.04E+03 2.06E+03 8.34E+02 0.00E+00 0.00E+00 0.00E+00 l

iFor Pathway: Inhalation i T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN l Adult: 5.83E+03 2.59E+04 1.09E+05 4.54E+04 2.69E+04 0.00E+00 2.46E+05 0.00E+00

Tecn 8.32E+03 2.74E+04 1.55E+05 6.42E+04 3.83E+04 0.00E+00 4.24E+05 0.00E+00 l Child: 1.15E+04 1.23E+04 2.15E+05 6.71E+04 3.72E+04 0.00E+00 3.79E+05 0.00E+00 l Infant: 5.59E+03 4.70E+03 1.01E+05 3.84E+04 1.70E+04 0.00E+00 3.12E+05 0.00E+00 l

~

'jJ .ODCM Rsv. 14 Paga 155

]. .

6/94 I

TABLE 2-3 Assumptions Used in Limerick Gaseour, Effluent Dose Evaluation Indsx. Description Value j l

il -Fraction of produce from local _ garden.

~

O'.76 2 Fraction of leafy vegetable from local garden '1.00

3 Soil density in plow layer (kg/m**2) 240.0 4 Fraction of deposited particulates retained on vegetation 0.20' !

5- Fraction of deposited iodines retained.on vegetation 1.0.

26 Shielding factor of residential structures 0.7.

7~ -Period of buildup of activity in soil (hr) 175200.0 8 Period of pasture grass exposure to activity (hr) 720.0

'9- Period of crop exposure to activity (hr) 1440.0 10 Transport time milkman (hr) 48.0

' ll Delay time for ingestion of. grass by animals (hr) 0.0 12 Delay time for ingestion of stored feed by animals (hr) 2160.0

' 13 Delay time for ingestion of leafy vegetable by man'(hr) 24.0 14 Delay time for ingestionLof otherl vegetable by man (hr)- .

1440.0 15 Time between slaughter and consumption of meat animal (hr) 480.0 i 16 Grass. yield, wet wt (kg/m**2) 0.7 17 Other vegetation yield, wet wt (kg/m**2) 2.0 '

18 Weathering rate constant for activity on veg (1./hr) . 0.0021

> 19 Milk cow feed consumption rate (kg/ day wet) 50.0 20 Beef cattle consumption rate (kg/ day wet) 50.0 L

21 Goat feed consumption rate (kg/ day wet)- 6.0 i

22 ' Plume exposure adult (hr/yr) 8760.0 23 Plume exposure teen (hr/yr) 8760.0 24 Plume exposure child (hr/yr) 8760.0 25 Plume exposure infant (hr/yr) 8760.0 26 Ground exposure adult (hr/yr) 8760.0 4

27 Ground exposure teen (hr/yr) 8760.0 28 Ground exposure child- (hr/yr) 8760.0

< 29 . Ground exposure infant (hr/yr) 8760.0 1 30 Inhalation exposure adult (m**3/yr) 8000.0 31- Inhalation exposure teen (m**3/yr) .8000.0 :

32 Inhalation exposure child (m**3/yr). 3700.0 33 Inhalation exposure infant (m**3/yr) 1400.0 .

34 Leafy veg exposure adult (kg/yr) 64.0

' - 35 Leafy veg exposure' teen (kg/yr) 42.0 i 36 Leafy veg exposure child (kg/yr) 26.0

'3 7_ Leafy veg exposure infant (kg/yr) 0.0 ;

38 lNon-leafy veg exposure adult (kg/yr) 520.0 ,

39 'Non-leafy veg exposure-teen (kg/yr) 630.0 ~

40 Non-leafy veg' exposure child (kg/yr) 520.0 j

. . 41 ' Non-leafy veg exposure infant (kg/yr) 0.0 42 Root veg consumption rate adult (kg/yr) 0.0 43 Root veg consumption rate teen (kg/yr) 0.0 44 Root veg consumption rate child (kg/yr) 0.0 i

~

xx h '-- /b

?l: .ODCM Rev. 14' Paga 156-

, g-- ;-l ,; ,- ~6/94

,s -TABLE 2-3 (Continued)

Assumptions,Used in. Limerick Gaseous Effluent Dose Evaluation fIndOxl Description. Value-

!.'4 5 ' Root veg! consumption rate infant (kg/yr) 0.0 46' ' Cow milk consumption rate. adult-(1/yr)- 310.0

. 47. Cow milk consumption rate teen'(1/yr) 400.0' -t e g48- Cow milk consumption rate child - (1/yr) 330.0 49 Cow milk consumption rate infant (1/yr) 330.0

' 50 Goat milk' consumption rate adult (1/yr) 310.0.

i 51" . Goat. milk' consumption rate teen (1/yr) .

400.0-

.- 52 Goat milk consumption rate child (hr/yr) 330.0 53- Goat milk consumption rate infant.' (hr/yr)- 330.0

- . 54 Meat consumption rate adult'(hr/yr) 110.0.

55 Meat consumption rate. teen (hr/yr) 65.'O

56. -Meat. consumption rate child-(hr/yr) 41.0

-5 7. . Meat consumption rate infant-(hr/yr) - 0. 0.

58 Fraction of year. animals on pasture 0.75 7

- 59 Fraction of feed from pasture when on pasture 0.88 i 60 Fraction of year leafy veg grown 0.42'

. 61 Atmosphere hydrogen: concentration (gm/m**3)~ 8.0 i

't i

'e esw-r , - -+ - - . . . - . _ . . . . ~ _ . . ~ . .- . , , - - . - _ - - - - , ., , , . - - - - - , ~

, n . . . . . . . . . - . - - . . ..

.1 j .I W ,

ODCM:Rzv. 14i ..

, Pcgn:157 j l. ~6/94

' TABLE 2-4l Nearest. Gaseous Effluent Dose Receptor Distances (Meters)

Plume Ground Inhalation. Vegetation Meat . Cow Goat fDirection" Pathways Pathway Pathway Pathway Pathway-

'N 805 2414 3414 7562 0

NNE 805 1609 1585 0 0 NE 965 3218 -1097 4183 On ENE 965 2414 3871' O O E- 805 1770 1890 6758- 0-

~ESE 965 805 4511 1770 1770 SE 1609 3862 7241 7241 -0.

SSE 1609- 1609 7224 7241- 0 S 1287 1931 3018 3701. -5654-SSW 1609 1609 1433 2896 0

'SW 965 1287 2835 4827. .0 eWSW 1287 1287 2134 2255 0 .; '

W 965 -2574 4084 0 0

WNW. 1126 1440 0. 0 0 NW 1126 2574 6660 0 '7401-

-1931 6325 9 NNW- 1448 0 =0 4

1 f

__._.=.____._..;___._ . . - _ , _ . _ , . _ . . _ _ _ , - . . . . , _ . , . , _ _

. <n--

ODCM R;v.-14

'l1 Pzg3 158

-l 6/94 APPENDIX A

=

.g-

'~

l= 'ODCM Rav..14

~'

. Paga'159' jw q=- 6/94:

W I

1 TABLE A-1 TechnicalJSpecification/ODCM Matrix.

~:

ODCM ODCM T6chnical . ..

Section I Equation

' Specification * .Reauirement Section II

' 3.'3.7.11- 3.2.1 1-1 1-2 1-3 ,

1-4 ..

t 3.3.7.12 3.3.1 2-1-(or 2-9). ,

2-2 (or'2-9) ,

2-4 (or 2-10) 2-5 (or 2-10)

'3.11.1.1 3.2.2 1-1 1-2 1_3-1-4.

~3.11.1.2 3.2.3 1-5 -

1-6' 1 3.11.1.3 3.2.4 1-8 ,

1-9 3.11.2.1 3.3.2 2-22

'2-23'

+

3.11.2.3 3.3.4 2-26 2-27 2-28 i

L3.11.2.2 3.3.3 2-24 - '

2-25 l

3.11.2.4 3.3.5 2-33 i l

- 3.11.2.7 3.3.6 2-4 )

2-5 :l

Trcnsferred to ODCM via'T.S. amendment # 48 for Unit 1 and'll for Unit 2.

l I

y . u.e , :

k, ;l[ ODCM Riv'. 14 Paga 160 P <

.l '6/94

-i.

m ' TABLE A-1.

' Technical Specification /ODCM' Matrix ;

ODCM ODCM'

-;Tcchnical Section I- Equation-lSp cification* ,

' Requirement 'Section II -4

> 6. 9 .1. 8' ' 3.6- 1-5 l' 1-6 1-7 l 2-24

.2-25 .

2-26

- 2-27 2-28 .

3.11.4 3.3.7 3-1 3.12.1 3.4.1 Section II-App. B 6.9.1.7 3.5 1-5

.3.12.3 3.4.3 1-6 1-7 ,

2-29, l 2-30 i 2-31 2-32 3 !

l g cTransferred to ODCM via T.S. amendment # 48 for Unit 1 and 11 for Unit 2.

i l

l 1

i

)

w

~, - . . , , m . - . - 1- - . . .-m. 4 1 '

4-s , .-

A_'_

2 s .g,- .ODCM:R;v W14.

m en '

.~P gs-161:

Dr=

. l _.

. . . i6/94 p

f b

t 4

{

1

-r

t

.- j.

c '-

APPENDIX B f

- RADIOLOGICAL ENVIRONMENTAL MCNITORING PROGRAM - ,

SAMPLE TYPE, LOCATION,.AND ANALYSIS t

't.

-r f

6

'- .W 1

-I

~ ,1 i

-l 4

-i l

=

I ODCM Rsv.:141

, P gn 162 6/94 TABLE B-1 DCM Limerick Generating Station Radiological Environmental Monitoring Program Pathway Station Code Location . Collection Method Analyses I. Direct 36S2 0.6 miles N of site. 1 set of four (4) TLDs Gamma dose 2E1 5.1 miles NNE of site from each~ location at quarterly 3S1 0.6 miles NNE of site least quarterly 4E1 4.6 miles NNE of site SS1 0.4 miles NE cf sita 5H1 C 25.8 miles NE of site 6C1 2.1 miles ENE of site 7S1 O.5 miles ENE of site 7El 4.2 miles ENE of site 9C1 2.2 miles E of site 10S3 0.5 miles E of site 10E1 3.9 miles E.of site 10F3 5.5-miles ESE of site 11S1 0.5 miles ESE of site 13C1 '2.9 miles SE of site 13E1 4.3 miles SE of site 14S1 'O.6 miles SE of site 15D1 3.2 miles SE of. site 16S2 0.6 miles SSE of.-site 17B1 1.6 miles S of site 18G1 C 12.9 miles-'S of site

, 18S1 0.3 miles S of site 19D1 3.6 miles S of' site 20D1 3.1 miles SSW of. site 20F1 5.2 miles'SSW of site 21S1 0.5 miles SSW of site 23S2 0.5 miles WSW of site C = Control Stations M % W + m P

ss:

s-

' ODCM - R2v. 14 ' ,

~

Q

-P g2 1G3 + -

1

~ 6/94 ~

. x

~Page 2Jof=4 TABLE B-1 T

Pathway Station Code Location Collection Method Analyses' I. Direct 24D1 3.9 miles SW of site Collected quarterly Gamma dose c (cont.) 25S1 0.5 miles SW of site quarterly

~

25D1 4.0 miles WSW of site 26S3 0.4 miles W of site 28D2 3.8 miles W of site 29S1 0.5 miles WNW of site 29El 4.9 miles WNW of: site 31D1 3.0 miles-NW offsite 31D2 3.9 miles NE of site 32S1 0.6 miles NW'of site 34S2 0.6 miles NNW of site 34E1 4.6 miles-NNW of site 35F1 4.2 miles N of site II. Airborne 10S3 0.5 miles E of site Approximately 1 cfm Gross beta analysis 1.

Particulates 11S1 0.5 miles-ESE of site continuous flow through on each weekly-sample.

14S1 0.6'ailes SE of' site glass fiber filter which- Gamma-spectrometry.

13C1 2.9-miles SE:of site is collected weekly. shall be done'when' 22G1 C 17.6 miles SW of site ' gross beta exceeds-ten times.the" yearly'mean

.of control station value.

t i ODCM Rsv. 14

., .Prgs.164 .

6/94 Page 3 of 4 TABLE B-1 Pathway Station Code Location Collection Method Analyses II. Airborne (cont.)

Particulates (cont.) Gross' bet ~a analysis-done 224 hr after sampling to allow for'-

Radon and Thoron daughter decay.

. Gamma isotopic ~ analysis on monthlyLeomposite.

Iodine 10S3 0.5 miles E of site A TEDA impregnated flow- Iodi.ne 131 11S1 0.5 miles ESE of site through cartridge is con-14S1 0.6 miles SE of site nected to air sampler and 13C1 2.9 miles SE of site is collected weekly at 22G1 C 17.6 miles SW of site filter char.ge.

III. Water 24S1 C 0.3 miles SSW of site Sample collected from a Gamma isotopic continuous water sampler, analysis monthly; Surface 13B1 1.8 miles ESE of. site monthly. In' event sampler H-3 on quarterly .

is inoperable, weekly grab composite.

samples will:be collected until sampler returned.to service.

Sediment 16C4 Vincent Dam, down- A sediment sample is taken Gamma isotopic stream of discharge semi-annually.. analysis.-

7

_#- cj ll ODCM ' Rav. .: 14 :

PIgn 165 l 6/94 t

Page 4Jof 4.

TABLE B-1 Pathway Station Code Location Collection Method LAnalyses IV. Incestion Milk 22F1 C 9.8 miles SW of site Sample of fresh milk is Gamma isotopic and 10B1 1.1 miles ESE of site collected from each farm .I-131 analyses on'each

25B1 1.3 miles.WSW of site biweekly when cows are on sample.

21B1 1.8 miles SSW of site pasture (April through October) , monthly at other times.

Drinking 15F7 5.2 miles SSE of site Sample collected from a Gross beta and. gamma:

28F3 C 5.9 miles WNW of site continuous water sampler- isotopic monthly, 15F4 7;8 miles SE.of site monthly. In' event sampler H-3'on quarterly 16C2 2.4 miles SSE of site in. inoperable, weekly grab : composite.

samples will be collected.

until sampler returned to service.

Fish _

Gamma isotopic 16C5 1.9 miles FSE of site' 'Two species of recrea- analyses on edible 29C1 C 3.2 : miles *Mt of site tionally important fish . portions.

(Predator and bottom.

feeder) sampled in season or' semiannually if not

-seasonal.

Food- Gamma isotopic and Products Two offsite locations of highest Samples of three-(3) dif- analysis.

predicted annual average ground ferent~ kinds of broad leaf level D/Q'and one location vegetation monthly when

=available if milk sampling (15-30 km distance) in.the-least prevalent wind direction-as' deter L s inot performed mined using the.results of-the most recent' annual Landuse~ Survey.

- _ _ _ _ _ _ - _ - _ . - - - _ _ _ . . . . --_-____=______:__-___.._ .. . . - . - . -. _ . - - -- - . _ _ - _ = _ _ - _ _ = _ - - ..

~

h FIGURES t

i I

t r

I I

t i

l l

l i

I l

i l

r

y-gg

g, g p: a g;.e ,

r- -

. . u.

' ~

UNIT 2

'7~

[". ,

-:Ilenctor 1.:ncl. - ,e

- linst IIxlintest '

4 f!1 tuck III 4 Ill' ' -

. ' 7000 clin -

s i l'ailleulato/inallne finalintion Monitor -

A s

.fqv

-l . . . . . . . . _ . . .~

V ,Ly jfM,. fQ- i

j. - -

k 4- -Decon- nit n -

\__.Q:~!

Inng I:llterr (tyliiga l) - Y

. I'lillmlntplifn tilecific' comgi.-

. l.imn Ich tiennenting Utntion '.

Il!!!]elA

' Gonorni 11clinir Aren unam>un IIHluant:

l'Inw Dingtam

' Ital _M!'l!!!!!!!!!!!G"_U!!!'l!

__ tiXIIAlltill 1 AN i ~.f.],4.. fjf... 1ll'IIIll'

ODCM, Rev.14:

3 ..c.c.<_.e e -

~

page 166;

.: 6/94 ,

I -

c _.,2 ..

___________________1_1.. __ . _ . - - .

t ,.

) .

Particulate

'h *"' h '"I Un t t ~ l 2 Particulate ,

todlne and El. 411' I*d'"' "d Noble Gas EI. 411' -

Continuous Continuous Noble Gas Monttor (2) Monitor (2)

I#I[ l p p (2)

\/

f 234.000 CFM 234.000 CFM D "

Max. Max.

Refueling Floor i 2 Refueling Floor Exhaust > T 4]l Exhaust (s)

(3) .

Reactor Enclosure Exhaust ( I y 4 Reactor Enclosure

' g 3, (8) d Exhauet CFM CFM Min. Min.

Equipment N i

k i Equipment xh :t 72 y i

T 1

yM ;;a;;'- '

III (2)

Ph!!adelphia Electric Comp.

Umerick Generating Station Units 1 & 2

' Gaseous Effluent Flow Diagram

( South Stack-ODCM, Rev 14 Page.167 6/94

~

l N North Vent Oss Monnot unire i a 2 N Wido 4 _j pangg Elev. 4sl' y y ,, , gg,,

/\ pa,teot ,e n. nae Accident.

and lodine g, p. Monitor Particutale, lodine & Continuees b Fitter Noble Gas Normal N Range Monitore f g, One Monitor p ,,,

4 (5) Tambine Enclosuse Enhaust

'h ese. coo Cru y 1subine Fncloetna Turbine Enclosure Enhauel III d -

Y Equip. Compait Enhaust n

+ +(2) Wl(2) Mecherical Vnc. Pump Turbine Enclosure Equip. Cornpart Exhaust (2) (2)

+ + 12) Battesy Roon Enheust 4k utn.

Mech. Vae. Pump Steam PacMng Enhauster Steam Pack. Enheuster 4 U" ***'* "* " ""'

j D/W Puece Rac%mste Encl. Equip.

(2) g _

4 Compartment Enhauster i l l Standby Gas Treat. Sye. ~5 - *** "* "" ***'* **'**"

[ '

Y (2, Y +- -

Unit : Conder.ser Oftges

(, a 4 ,, Unit 2 Condenser Off0as Fume Hood Exhaust ,

l ,

(2)

-1 4 Philadelphia Electric Comp.

Control Area Enhaust h t.lmerick Generating Station Units , t_& 2, (2)

Gaseous Ef tfuents Flow Diagram Nosth Stack ODCM, Rev.14

une : Chareaal System Page 168 V

I Exhaust Fan /J

[ Filter " u Choreoni sratem 6/94

,3

.' o (g 4 L.D. TANK Lg P ,

Leundry FE 7g RE Drain (LD) L D-Subsystem L.D.

-> FILTER SAMPLE -

8 p'.

TANK i To cooling

- I d Tower -

-> L.D TANK I d '

Blowdown Line 10 GPM (Nom.) ,

(Retense Polnij FD From Chem. _

Waste Tank SAMPLE l,d TANK #1 FD FD FD FD Floo' ->

~

Drain (FO) cott action 1 g FILTEll > DEMIN SAMPLE 7'g utneystem TANM (FDCT) TANK #2 >

sk -

6 .

in Comtansate FD to W aste lo Waste _200 GPM Stor ogo . lank

~ -

-> SUf1GE

-- Studge Tank Sludge lank (Nom)

TANK , ,

d ED -

) SAMPLE d

,r TANK A

'V ED ED Equipment cos t ecie'*

]_. p FILTEll ED

~ ~ ~

I DEMIN Dratn (ED) TANK Subsystem ,r ED

_. ) SAMPLE -

l

. _, b - > To Weste -> To W aste TANK B

~I -_

l Sludge Tank Sludge Tank lo FDCT Phltadelphla Electric Comp.

FE.83-053 Limeilck Generating Station CW p i. a RisH-es 012 OKso4 Units 1 & 2 (CW)

TANK i d Liquid Effluent Subsystem Flow Diagram ODCM, Rev.14 Page 169 6/94 v - ..

5

4 CDCM Rav.14-Pago'170-

9) FIGURE B-1 6/9 l lf ENVIRONMENTAL SAMPLING LOCATIONS ON-SITE OR Nt:AM- ;

l THE~ LIMERICK GENERATING STATION N

NNWf NNE' NW c:#- - hA ..%.

S2 NE 4

)

'~"

% ?34S2s: x ~ m, .. . a a.; *C ... ..a 3 % s WNW 9 32'S17 e 4?g v Q ENE

+

/

2ss,N~.a --

e u :

sr*e>

qS s

W

{.

2 s3 1

"' -qs 10 3 y/ ' E j ,

\ ~ s~ ., i i \.. 1 s1 23S2 ::

.d # -

WSW IM N zss1

/ESE !

>/ , -

1 .f O . . ..

g g

I a::.. : ,

SW -

S .,.. '^ . \ SE l

/-

g:. -

\ l 1

ssw x ~~

sse S

SITE EOUNDARY 4 36S2 EVERGREEN & S ANATCGA R . 20Si L35 CISCHARCE A:.I A 25* S AN ATC C A R . 2151 LGS IMPOUNDING E AS;N 531 PCSSUM HCLLOW RC. 23S: TRANSMISS10N TOWER 751 LCS TRA;NING CENTER 24S1 L3S INTAKE 1CS3 KEEN RO. 2E51 SW S ECTO R 11S1 LGS IN FC RM AT:C N CNTR. 26S3 MET. TCWER ::

14S1 LCNGVIEW RO. 29S1 WNW SECTOR 16S: LONGVIEW K*:. 3231 hW SECTOR 18S1 RA!LRC AO TRACKS 3452 MET. TOWE R , 1 e

ee is* .

I

lLllrG ODCM Rev.14.

Page 171 FIG URE. B-2 6/94

)!&-

- AIRBORNE 'AND TLD ENVIRONMENTAL SAMPLING LOCATIONS:

AT INTERMEDIATE DISTANCES.FROM LIMERICK GENERATING.

STATION -

N NNW NNE NW NE 5F1 2E1 34E1 ,

WNW

4E1

ENE 1D2e e

31 e '5 1 '

9E1 7E1 -

3 6 e 298$. .

W 28D2* E 2 SC1.

25D1 * - ]s 3 10E1 7B 10F3

/* e

24D1 15D e 20D1 e E1 WSW 19D1 ESE <

~ 20F1 e T 6F*1 SW SE SSW SSE .

S !

l tun mile radius 281 SAN ATOGA SUBSTATION 13E1 VAUGHN ROAD IGB1 OLD SCHUYLKILL RD j 2E1.' LAUGHING WATERS GSC 15D1 SPRING CITY SUBSTATION 2BD2 W. CEDARV!LLE RD 4E1 NElFFER ROAD 16F1 PIKELAND SUBSTATION 29B1 YOST ROAD l

i sci POTTSTOWN AIRPORT 1781 LINFIELD SUBSTATION 29E1 HIGH SUBSTATION 7E1 PHEASANT ROAD 1901 SNOWDEN SUBSTATION 31D1 LINCOLN SUBSTATION

! SC1 REED ROAD 20D1 ELLis WOODS ROAD 21D2 POPLAR SUBSTATION

.'10E1 ROYERSFORD RO AD 20F1 SHEEDER SUBSTATION 34E1 YARNELL RO AD

! 10F3 TRAPPE SUBSTATION 24D1 PORTERS MILL SUBSTATION 3581 PLEASANTVILLE RD 13C1 KING ROAD 25D1 HOFFECKER & KElM ST. 35F1 RINGING ROCKS SUB l.

t -

ODCM Rsv.14 Pags 172 ;

p.

t .6/94 FIGURE B-3 AQUATIC AND TERRESTRIAL ENVIRONMENTAL SAMPLING LOCATIONS AT INTERMEDIATE DISTANCES FROM LIMERICK GENERATING STATION N

NNW NNE NW NE GE1 e

WNW ENE 28F3 W 29C1 e E

, =

21 e 6C2 -

25C1e [

f605 e ESE WSWg 8f'18d4 18C1, 2

o 5F7 l SW 15F4 * . SE l

SSW g SSE ten mile radius .

10B1 FARM IN ESE SECTOR 1981 FARM IN SSW SECTOR 10F2 PERKlOMEN CREEK 21B1 FARM IN SW SECTOR 1381 VINCENT DAM 22C1 FARM IN SW SECTOR

~

15F4 PHIL. SUB. WATER CO. 22F1 FARM IN SW SECTOR 15F7 PHOENIXVILLE WATER CO. 25C1 FARM IN WSW' SECTOR 16B2 LINFIELD BRIDGE 28F3 POTTSTOWN WATER .AUTH.

16C2 CITIZENS HOME WATER CO. 29C1 POTTSTOWN VICINITY

' 16C4 VINCENT POOL 33A2 UPSTREAM OF LGS 16C5 VINCENT POOL 36E1 FARM IN N SECTOR 18C1 FARM IN S SECTOR

, r-~

4

m

$ (l ODCM-Rav.14 Page 173

ca.

FIGllRE B-4 6/94 '

f ENVIRONMENTAL. SAMPLING LOCATIONS AT REMOTE DISTANCES FROM LIMERICK GENERATING STATION N

NNW NNE s

NW NE o -

5H1 ,

WNW g) ENE 4

W e 9G1 E

-G~~%

e e N -

.. W S W 22G1 18G1 13H2 ~* ~[ ' ;

H4 SW SE SSW SSE g

fif ty mile radius .

EH1 BIRCH SUBSTATION

. SG1 FARM IN E SECTOR 13H2 BELMONT WATER WORKS 13H4 PECo EUILDING 18G1 PLANEBROOK SUBSTATION 22G1 MANOR SUBSTATION 32G1 FRIEDENBERG SUBSTATION l

l ODCM Rsv.14 Pago 174 l 6/94 REFERENCES l

I

1. Regulatory Guide 1.109, " Calculation of Annual Doses to Man from i Routine Releases of Reactor Effluents for the Purpose of Evaluating l Compliance with 10 CFR Part 50, Appendix I," Revision 1, U.S. Nuclear l Regulatory Commission, Washington, D.C. 20555, October 1977.

2. Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, July 1977.

3. Regulatory Guide 1.112, " Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Light-Water-Cooled Power Reactors," U.S. Nuclear Regulatory Commission, Washington, D.C.

20555, April 1976.

4. Regulatory Guide 1.113, " Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, April 1977.

5. U.S. Nuclear Regulatory Commission, " Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Boiling Water Reactors (BWR-GALE Code) ," USNRC Report NUREG-0016, Washington, D.C. 20555, April 1976.

6. U.S. Nuclear Regulatory Commission, "XOQD0Q, Program for the Methodological Evaluation of Routine Effluent Releases at Nuclear Power Stations," USNRC Report NUREG-0324, Washington, D.C. 20555, September, 1977.

7. Title 10, " Energy," Chapter I, Code of Federal Reculations; Part 20, Appendix B, U.S. Government Printing Office, Washington, D.C. 20402, January 1, 1977.

8. Title 10, " Energy," Chapter I, Code of Federal Reculations; Part 100, U.S. Government Printing Office, Washington, D.C. 20404, January 1, 1977.

9. Title 40, " Protection of Environment," Chapter I, p_ ode of Federal Reculations, Part 141, U.S. Government Printing Office, Washington, D.C. 20402, January 1, 1977.

10. Regulatory Guide 1.21, " Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, June 1974.

s

l ODCM RSv.14 Pugn 175

-l 6/94 REFERENCES

11. Title 40, " Protection of Environment," Chapter I, Code of Federal Reaulations, Part 190, Federal Register, Vol. 42, No. 9, Washington, D.C. 20402, January 13, 1977.

12. U.S. Nuclear Regulatory Commission, "Short Term Diffusion Estimates,"

Section 2.3.4, Standard Review Plan for the Review of Safety Analysis Reports for Nuclear Power Plants -

LWR Edition, USNRC Report NUREG-75/087, Washington, D.C. 20555, November 1975.

13. U.S. Nuclear Regulatory Commission, " Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," USNRC Report NUREG-0133, Washington, D.C. 20555, October 1978.

14. Letter From Thomas E. Marley, Director Office of Nuclear Reactor Regulations, To Thomas E. Tipton Vice President and Director Operations, Nuclear Management and Resources Council, 6/30/93.

15. ANSI N42.14-1991 (Revision of ANSI N42.14-1978) " Calibration and Use of Germanium Spectrometers For the Measurement of Gamma-Ray Emission Rates of Radionuclides", Sect. 6.2.2

16. EML Procedures Manual, H.L. Volchok and G. dePlangue, Editors, U.S.

Dept. Of Energy (Revised Annually)

17. L.A. Currie, " Limits For Qualitative Detection and Quantitative

Determination - Application to Radiochemistry", Analytical Chemistry, Vol. 40, pp. 586-593 (TABLE II), 1968 l 18. NUREG/CR-4007, " Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements", prepared by NRC by L.A. Currie (Chapter II, Sect. D.2; Chapter III, Sect. C.1), September 1984

19. Tech. Spec. Section 1.24 (Definitions)

I 20. USNRC Generic Letter, 89-01

! 1 l

I I

l

ML20080N140

Text

LLD (Grab Samples)

Navigation menu

Search